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Abstract
microRNAs (miRNAs) are 20~24nt small RNAs that are critical for many biological aspects, from
development to age-associated processes. Starting from the identification of the first miRNA, lin-4, hundreds
of miRNAs have been discovered across species. To reveal the role of miRNAs in aging, studies have profiled
changes in miRNA levels with age. However, increasing evidence suggests that miRNAs show heterogeneity in
length and sequence in different biological contexts. Despite the observation of such heterogeneity, it is largely
unknown how such heterogeneity is generated, and whether it is biologically regulated or important. Here we
report the characterization of a novel 3'-to-5' exonuclease, Nibbler (Nbr), that generates different length
miRNA isoforms in Drosophila. Small RNA deep-sequencing in flies followed by northern blots revealed a set
of miRNAs that depend on Nbr for their length patterns. We pursued the biological importance of nbr by
analyzing the impact of loss-of-function mutation of the nbr gene, as well as the effect of nbr loss on other
classes of small RNAs such as piRNAs and endo-siRNAs by small RNA deep-sequencing of ovary tissue. This
analysis revealed a critical role of nbr to regulate age-associated traits such as brain degeneration and
locomotion, as well as the length of piRNAs and endo-siRNAs. Detailed analysis revealed that, even though
most piRNA loci are affected, only select endo-siRNA loci are affected upon nbr loss. Finally, we report a
novel age-associated change in miRNA heterogeneity: the increase in 2'-O-methylation of select miRNA
isoforms with age. Detailed study by immunoprecipitation of Ago1 and Ago2, followed by northern blots and
RNA deep-sequencing showed that this reflects increased loading of miRNA isoforms into Ago2 (siRISC)
with age. Importantly, the loss of 2'-O-methylation of small RNAs by hen1 and ago2 mutations led to
accelerated brain degeneration and shorter lifespan. Together, this research has revealed an important
mechanism to generate 3' end heterogeneity of miRNAs by Nbr, and a novel age-associated heterogeneity of
miRNAs, 2'-O-methylation of miRNAs. Importantly, the lack of such heterogeneity led to accelerated age-
associated defects, implying the potential importance of regulating the 3' end heterogeneity of small RNAs on
age-dependent processes in Drosophila.
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ABSTRACT 
 
CHANGE AND IMPACT OF MICRORNA MODIFICATION WITH AGE 
IN DROSOPHILA MELANOGASTER 
Masashi Abe 
Nancy M. Bonini 
 
microRNAs (miRNAs) are 20~24nt small RNAs that are critical for many biological 
aspects, from development to age-associated processes. Starting from the identification of 
the first miRNA, lin-4, hundreds of miRNAs have been discovered across species. To 
reveal the role of miRNAs in aging, studies have profiled changes in miRNA levels with 
age. However, increasing evidence suggests that miRNAs show heterogeneity in length 
and sequence in different biological contexts. Despite the observation of such 
heterogeneity, it is largely unknown how such heterogeneity is generated, and whether it 
is biologically regulated or important. Here we report the characterization of a novel 3'-
to-5' exonuclease, Nibbler (Nbr), that generates different length miRNA isoforms in 
Drosophila. Small RNA deep-sequencing in flies followed by northern blots revealed a 
set of miRNAs that depend on Nbr for their length patterns. We pursued the biological 
importance of nbr by analyzing the impact of loss-of-function mutation of the nbr gene, 
as well as the effect of nbr loss on other classes of small RNAs such as piRNAs and 
endo-siRNAs by small RNA deep-sequencing of ovary tissue. This analysis revealed a 
critical role of nbr to regulate age-associated traits such as brain degeneration and 
  
vii
locomotion, as well as the length of piRNAs and endo-siRNAs. Detailed analysis 
revealed that, even though most piRNA loci are affected, only select endo-siRNA loci are 
affected upon nbr loss. Finally, we report a novel age-associated change in miRNA 
heterogeneity: the increase in 2'-O-methylation of select miRNA isoforms with age. 
Detailed study by immunoprecipitation of Ago1 and Ago2, followed by northern blots 
and RNA deep-sequencing showed that this reflects increased loading of miRNA 
isoforms into Ago2 (siRISC) with age. Importantly, the loss of 2'-O-methylation of small 
RNAs by hen1 and ago2 mutations led to accelerated brain degeneration and shorter 
lifespan. Together, this research has revealed an important mechanism to generate 3' end 
heterogeneity of miRNAs by Nbr, and a novel age-associated heterogeneity of miRNAs, 
2'-O-methylation of miRNAs. Importantly, the lack of such heterogeneity led to 
accelerated age-associated defects, implying the potential importance of regulating the 3' 
end heterogeneity of small RNAs on age-dependent processes in Drosophila. 
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CHAPTER 1 
INTRODUCTION 
CONTROLLING BRAIN AND ORGANISMAL AGING  
BY MICRORNAS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The sections of this chapter marked with an asterisk (*) have been published in:  
Abe M and Bonini NM (2012)  
MicroRNAs and neurodegeneration: role and impact 
Trends in Cell Biology 23, 30-36. 
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The aim of this dissertation work was to reveal the role and impact of miRNA 
heterogeneity with age. In the thesis, I first describe the discovery of Nibbler (Nbr), a 3'-
to-5' exonuclease that generates different length of miRNAs in Drosophila. Next, based 
on this finding, I characterized the biological importance of nbr in more detail, as well as 
assessed the effect of Nbr on other classes of small RNAs such as piRNAs and endo-
siRNAs. Finally, I report another age-associated phenomenon revealed while performing 
detailed analysis of nbr-modulated miRNAs: the increase of the 2’-O-methylation of 
select miRNA isoforms with age in Drosophila. This observation was correlated with the 
increased loading of specific miRNA isoforms into Ago2, but not Ago1, with age. Thus, 
this work revealed the importance of nbr both biologically and in controlling the length 
of multiple classes of small RNAs, but also provides evidence that the increase in the 
level of 2'-O-methylation of miRNAs, which is correlated with differential loading 
between the two Ago-RISC complexes, is associated with age. 
 
In the following introduction, I will start by describing the biogenesis pathway of animal 
miRNAs. Next I will address the biological importance of miRNAs in the aging context, 
with a focus on organismal and brain age-associated processes. Finally I will discuss the 
emerging evidence for heterogeneity of miRNAs with respect to length and sequence in 
different biological contexts, which is background for the pursuit of the studies as 
described in Chapters 2, 3, and 4.  
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ANIMAL MICRORNA BIOGENESIS 
       microRNAs (miRNAs) are approximately 20~24nt small RNAs that regulate a 
variety of biological processes, such as development and diseases (Esquela-Kerscher and 
Slack 2006; Kosik 2006; Krichevsky et al. 2006; Ambros 2011). The study of miRNAs 
started with the discovery of the first miRNA, lin-4, as a developmental timing gene in C. 
elegans (Lee et al. 1993; Wightman et al. 1993). However, it was only after 7 years that 
the second miRNA, let-7, another developmental timing gene in C. elegans, was found 
and characterized (Reinhart et al. 2000), which led to the emerging realization that small 
RNAs may be a class of genes of fundamental importance in organisms. The 
conservation of the let-7 sequence across species, from Drosophila to human (Pasquinelli 
et al. 2000), facilitated the study of miRNAs in other species. By now, hundreds of 
miRNAs have been identified and are intensively studied in different species, from plants, 
Drosophila, to mammals including human (see miRbase).  
 
The biogenesis of miRNAs starts with the transcription of the primary miRNA transcripts 
(pri-miRNAs) from miRNA-coding genes by RNA polymerase II, with 5' methylated 
caps and 3' poly A tails (Bracht et al. 2004; Cai et al. 2004; Lee et al. 2004a). miRNA 
genes can be separate genes, but can also be located in protein coding genes and non-
protein coding genes: some are located in introns of protein-coding genes, while others 
are located in exons and introns of ncRNA transcriptional units (Finnegan and Pasquinelli 
2013). After the transcription of the pri-miRNAs, they are cleaved by RNase III in a 
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complex with its partner protein, Drosha/Pasha in Drosophila and Drosha/DGCR8 in 
mammals, to generate pre-miRNAs (Figure 1.1) (Lee et al. 2003b; Denli et al. 2004; 
Gregory et al. 2004; Han et al. 2004; Landthaler et al. 2004; Han et al. 2006). Following 
export of the pre-miRNA to the cytoplasm by Exportin-5 (Yi et al. 2003; Bohnsack et al. 
2004; Lund et al. 2004), the pre-miRNAs are cleaved by another complex with RNase III 
and its partner protein, Dicer-1 (Dcr-1)/Loquacious-PB (Loqs-PB) in Drosophila and 
Dcr/TAR RNA binding protein (TRBP) in mammals, to generate miRNA duplexes 
(Bernstein et al. 2001; Chendrimada et al. 2005; Forstemann et al. 2005; Jiang et al. 
2005; Saito et al. 2005; Miyoshi et al. 2010a). The resulting miRNA duplex is loaded into 
Argonaute protein (Ago1 in Drosophila, Ago2 in mammals), the core component of 
miRISC. The loading of miRNA duplexes into Ago is facilitated by a chaperone complex 
Hsp90/Hsp70 (Iki et al. 2010; Iwasaki et al. 2010; Miyoshi et al. 2010b). Upon loading, 
one of the strands of miRNA duplex (the guide strand) is preferentially retained in Ago 
through the binding of the 5' end to MID, and 3' end to PAZ domains of Ago protein (Ma 
et al. 2004; Ma et al. 2005; Parker et al. 2005; Schirle and MacRae 2012). Eventually, the 
miRNA guide strand induces translational repression and mRNA destabilization 
(Djuranovic et al. 2012; Fabian and Sonenberg 2012). In addition to Ago protein, 
miRNA-mediated translational repression and mRNA decay require the aid of other 
miRISC components, such as GW182, CCR4-NOT and PAN2-PAN3 complexes, which 
are critical to induce miRNA-mediated translational repression and mRNA decay 
followed by deadenylation (Fabian and Sonenberg 2012).  
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In addition to the canonical miRNA biogenesis pathway, recent studies identified Drosha- 
or Dcr-independent miRNA biogensis pathways. For example, some intron-derived 
miRNAs require splicing, but not cleavage by Drosha, to generate pre-miRNAs 
(mirtrons) (Westholm and Lai 2011). In another example, the biogenesis of mouse and 
zebrafish miR-451 required cleavage by Drosha and Ago, but not by Dicer (Cheloufi et al. 
2010; Cifuentes et al. 2010; Yang et al. 2010). Intriguingly, pre-miR-451 is structurally 
unique in that the mature miR-451 sequence spans from the stem to the loop region of the 
pre-miR-451 (Cheloufi et al. 2010; Cifuentes et al. 2010; Yang et al. 2010). In addition, 
pre-miR-451 harbors a 42-nt hairpin and a short 17-nt stem, despite the fact that Dicer 
usually requires a stem region > 19nt to achieve proper cleavage (Cheloufi et al. 2010; 
Cifuentes et al. 2010; Yang et al. 2010; Finnegan and Pasquinelli 2013). This might 
explain why miR-451 does not require Dicer cleavage for its biogenesis. These studies 
also suggested that mature miRNAs could derive from non-base-paired regions in the 
pre-miRNA stem-loops. Consistent with this, recent studies showed that the loop region 
of folded pre-miRNAs is occasionally abundant and incorporated into miRISC, and is 
capable of inducing target silencing in Drosophila and human cells (Okamura et al. 2013; 
Winter et al. 2013). Together, these studies suggest that miRNA biogenesis pathway is 
highly diversified, adding further complexity to predicting functional miRNAs in the 
genome. Since each miRNA is capable of targeting many mRNA targets through partial 
complementarity at the seed region (2~8th nucleotide at the 5' end of miRNA) 
(Brennecke et al. 2005; Baek et al. 2008; Selbach et al. 2008; Bartel 2009), predicting 
genuine animal miRNA targets remains challenging (Bartel 2009; Witkos et al. 2011). 
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Recent development of novel techniques such as Cross-Linking and Immunoprecipitation 
(CLIP) (Chi et al. 2009; Darnell 2012), Photoactivatable-Ribonucleoside-Enhanced 
Crosslinking and Immunoprecipitation (PAR-CLIP) (Hafner et al. 2010a; Hafner et al. 
2010b), or purification of biotinylated miRNAs (Nonne et al. 2010; Hassan et al. 2013) 
have enabled identification of biologically relevant miRNA-mRNA interactions. 
However, even with the accumulating data to suggest miRNA-mRNA interactions, 
performing reporter assays for given mRNA targets is still the most reliable method to 
validate genuine miRNA targeting sequences in cells or organisms.  
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MIRNAS AND ORGANISMAL AGING 
Even though lin-4 was identified as the first miRNA to control developmental timing in 
1993, a study in 2005 revealed that lin-4 also regulates organismal lifespan in C. elegans 
(Boehm and Slack 2005; Kenyon 2010b; Smith-Vikos and Slack 2012). Loss-of-function 
mutation of lin-4 led to shorter life span, while upregulation of lin-4 resulted in longer 
life-span (Boehm and Slack 2005). By contrast, the loss-of-function of lin-14, a target of 
lin-4 led to longer life span, and lin-14 RNAi suppressed the shorter life-span caused by 
the loss-of-function of lin-4 (Boehm and Slack 2005). This suggests that lin-4 regulates 
life span through the same target used in developmental timing, lin-14 (Boehm and 
Slack2005). Importantly, the modulation of life span by lin-14 did not result from its 
developmental role in larval stage, because knockdown of lin-14 only in adulthood 
extended life-span of wild-type or lin-4 loss-of-function mutants. This iconic study in C. 
elegans suggested a potential pleiotropic nature of miRNA function in different 
developmental or adult stages of animals. Studies followed to identify more miRNAs to 
understand their roles on organismal and tissue age-associated processes, starting with the 
most straight-forward approach: investigating changes in abundance of miRNAs in the 
aging context. Here, we summarize the profiling studies of miRNAs with organismal age, 
as well as functional studies of a subset of those identified miRNAs to impact organimsal 
aging.  
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Profiling and functional study of miRNAs in organismal aging 
Various approaches, including microarray, realtime-PCR, northerns, and small RNA 
deep-sequencing, revealed differential expression patterns of miRNAs with age. One 
intriguing trend from these studies is the overall decline in miRNA accumulation with 
age; there are more miRNAs declining than those increasing with age (Liu et al. 2012; 
Ungvari et al. 2012; Xu et al. 2012; Inukai and Slack 2013). At least in rats, this is 
correlated with decreased Dicer1 expression with age (Ungvari et al. 2012).  
 
In C. elegans, microarray and deep-sequencing analyses identified the miRNAs that are 
differentially expressed with age (Ibanez-Ventoso et al. 2006; de Lencastre et al. 2010; 
Kato et al. 2011). Upregulated miRNAs include miR-246, miR-71, miR-34, miR-253, 
miR-238 and miR-239, while let-7 shows the greatest decrease with age (de Lencastre et 
al. 2010). Deletion of miR-71, miR-238, or miR-246 shows a significantly shorter 
lifespan, while the deletion of miR-239 shows increased lifespan (de Lencastre et al. 
2010). By contrast, the upregulation of miR-71 and miR-246 extend lifespan, while the 
upregulation of miR-239 shortens lifespan (de Lencastre et al. 2010). Importantly, these 
miRNAs did not show developmental or viability defects (Miska et al. 2007), indicating 
that these miRNAs do not act through an antagonistic pleiotropic function: these miRNAs 
affect lifespan, but are dispensable for early developmental stages, while genes that 
display antagonistic pleiotropy are beneficial in early stages (and thus maintained by 
evolution) but are detrimental in later (adult) stages of the organism life cycle (Hughes 
and Reynolds 2005; de Lencastre et al. 2010). miR-34 is a well-conserved miRNA that is 
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upregulated in both C. elegans and Drosophila with age (Ibanez-Ventoso et al. 2006; de 
Lencastre et al. 2010; Karp et al. 2011; Kato et al. 2011; Liu et al. 2012). However, 
although C. elegans miR-34 mutants either did not affect or extend life span (de 
Lencastre et al. 2010; Yang et al. 2013), Drosophila miR-34 deletion causes shorter 
lifespan, and upregulation extends life span (Liu et al. 2012). This suggests that the 
function of miRNAs on organismal lifespan might be diversified in detail from species to 
species (although impacting similar biological processes), even for highly conserved 
miRNAs such as miR-34.  
 
In addition to profiling and subsequent functional studies to reveal the role of miRNAs in 
organismal aging, disruption of global miRNA biogenesis also suggests a potential 
importance of miRNAs to impact organismal lifespan. In C. elegans, knockdown of alg-1, 
a miRNA-specific Argonaute protein, led to shorter lifespan (Kato et al. 2011). In 
addition, conditional knockout of DGCR8/pash-1 in C. elegans shortened lifespan 
(Lehrbach et al. 2012). In Drosophila, loss-of-function of Loqs, which is required for the 
cleavage of pre-miRNAs, leads to shorter lifespan and brain degeneration (Liu et al. 
2012). These studies supported a general importance of miRNAs to modulate organismal 
age-associated events.  
 
Targets of miRNAs that regulate organismal lifespan 
One important question is the target genes or pathways of these age-associated miRNAs 
to control organismal aging. Several pathways, such as insulin/insulin-like growth factor 
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1 (IGF1) signaling (IIS), DNA damage checkpoint, and mitochondrial function regulate 
organismal aging in animals (Kenyon 2010b; Smith-Vikos and Slack 2012). Among them, 
the best-characterized age-associated pathway that intersects with miRNAs is IIS 
pathway. Reduced IIS signaling extends lifespan from C. elegans (Kimura et al. 1997), 
Drosophila (Tatar et al. 2001), to mouse (Bluher et al. 2003) and potentially humans (van 
Heemst et al. 2005). The extended lifespan is associated with improved stress resistance 
and protein homeostasis (O'Neill et al. 2012). In the following, we will summarize the 
studies of C. elegans that revealed the role of the IIS pathway to regulation of organismal 
aging. Then we will discuss how miRNAs intersect with the IIS pathway to control 
organismal aging. 
 
In C. elegans, the mutation of daf-2, encoding an insulin/IGF1 receptor ortholog DAF-2, 
doubles animal lifespan (Kimura et al. 1997; Kenyon 2010b). This lifespan extension 
depended on daf-16 and hsf-1, both of which are transcription factors that induce 
expression of longevity and stress resistance genes (Lin et al. 1997; Hsu et al. 2003; Lee 
et al. 2003a; Murphy et al. 2003). Consistent with this, genetic and biochemical evidence 
shows that the IIS pathway indeed regulates DAF-16 and HSF-1 to control organismal 
aging. For example, activation of DAF-2 in normal conditions leads to the localization of 
DAF-16 , a homologoue of mammalian FOXO transcription factor (Lee et al. 2001; Lin 
et al. 2001), to the cytoplasm.  In response to stress or decreased insulin signaling (such 
as daf-2 mutation), DAF-16 becomes localized to the nucleus to activate longevity and 
stress resistance genes (Lee et al. 2001; Hsu et al. 2003; Lee et al. 2003a; Murphy et al. 
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2003; Kato and Slack 2013). In addition, recent biochemical evidence reveals that 
increased IIS signaling leads to inhibition of HSF-1 through formation of an inactive 
complex of HSF-1 with the two negative regulators, DDL-1 and DDL-2 (Chiang et al. 
2012). These data indicate that DAF-16 and HSF-1 are important downstream 
components to extend lifespan by decreased IIS signaling. 
 
lin-4 is one of the miRNAs that regulates organismal lifespan through the IIS pathway. 
Loss of function of lin-14, a target of lin-4, extends lifespan, which is suppressed by daf-
16 loss-of-function as well as hsf-1 RNAi (Boehm and Slack 2005). In addition, lin-4 is 
required for the lifespan extension caused by daf-2 RNAi (Boehm and Slack 2005). This 
suggests that daf-16 and hsf-1 are required to extend the lifespan caused by lin-14 loss-of-
function, and that the IIS pathway and lin-4 pathway potentially intersect to control 
organismal lifespan (Boehm and Slack 2005). Analogous to lin-4, the lifespan extension 
caused by the loss of miR-239 required DAF-16, while the lifespan extension caused by 
daf-2 loss required miR-71, suggesting that miR-71 and miR-239 also involve the IIS 
pathway to regulate lifespan (de Lencastre et al. 2010). Recent study also supports a 
potential role of miR-71 on the IIS pathway: neuronal function of miR-71 regulates the 
localization of DAF-16 in intestine non-cell autonomously to mediate the lifespan 
extension caused by the loss of germline cells (Boulias and Horvitz 2012). In addition to 
providing additional evidence for the role of miR-71 on IIS pathway, this study also 
suggests a possible signaling network among the germline, nervous system, and intestine 
to control organismal aging (Boulias and Horvitz 2012). Beyond the IIS pathway, miR-71 
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is also required for increased lifespan caused by the RNAi against DNA damage 
checkpoint pathway components (CDC-25.1 and CHK-1), suggesting that miR-71 
intersects with the DNA damage checkpoint pathway to regulate lifespan as well (de 
Lencastre et al. 2010).  
 
The studies discussed above suggested that IIS is a common pathway that intersects with 
multiple miRNAs to regulate organismal lifespan in C. elegans. However, this does not 
seem the case for other miRNAs that regulate organismal aging in C. elegans. By using 
temperature-sensitive mutants of DGCR8/pash-1 in C. elegans, disruption of miRNA 
biogenesis at the adult stage shortens lifespan (Lehrbach et al. 2012). Rescuing pash-1 
expression in neurons recovers lifespan, indicating the importance of neuronal miRNAs 
on lifespan (Lehrbach et al. 2012). Interestingly, even though the lifespan extension 
caused by caloric restriction and loss of germline stem cells depends on pash-1 (miRNA 
synthesis), the lifespan extension caused by decreased mitochondrial function and loss of 
DAF-2, an insulin receptor, is independent of pash-1 (Lehrbach et al. 2012). These 
results suggest that other miRNAs, except for lin-4, miR-71, and miR-239 as discussed 
above, regulate lifespan independently of the IIS pathway and mitochondrial function 
(Lehrbach et al. 2012). Important future directions include identifying the specific 
pathways that these other miRNAs regulate to control organismal aging. Considering the 
potential of each miRNA to regulate multiple targets (Baek et al. 2008; Selbach et al. 
2008), each miRNA might coordinate multiple different pathways to impact age-
associated processes, like in the case of miR-71.  
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In Drosophila and C. elegans, another pathway that regulates lifespan is a steroid 
hormone pathway, which involves dafachronic acid (DA) and the receptor DAF-12 in C. 
elegans, and 20-hydroxy-ecdysone (20E) and ecdysone receptor (EcR) in Drosophila 
(Galikova et al. 2011). In Drosophila, loss of miR-14 causes shorter lifespan, which is 
associated with the upregulation of an ecdysone receptor (EcR) target, 
E74/Eip74EF/E74A in pupae (Xu et al. 2003; Varghese and Cohen 2007). Interestingly, 
E74A is also upregulated as a confirmed target of Drosophila miR-34 in adults (Liu et al. 
2012). Lack of miR-14 or miR-34 leads to shorter lifespan, and rescuing the expression 
of E74A partially lengthens the lifespan of miR-34 loss-of-function mutants in 
Drosophila (Liu et al. 2012). In C. elegans, loss of the germline leads to upregulation of 
daf-36, which is required for the production of the ligand of DAF-12, causing increased 
DA signaling (Shen et al. 2012). Intriguingly, this results in the upregulation of let-7 
family members, miR-84 and miR-241, which are transcriptional targets of DAF-12 
(Shen et al. 2012). The lifespan extension after germline loss depends on miR-84 and 
miR-241, suggesting the importance of these two miRNAs to extend lifespan in the 
gonadal pathway (Shen et al. 2012). Furthermore, miR-84 and miR-241 target akt-1 and 
lin-14, both of which negatively regulate DAF-16/FOXO transcriptional activity (Shen et 
al. 2012). Therefore loss of gonadal tissue activates DAF-12 and the targets miR-84 and 
miR-241, which in turn downregulates akt-1 and lin-14, two negative regulators of DAF-
16/FOXO. The downregulation of akt-1 and lin-14 stimulates DAF-16/FOXO and the 
downstream targets, which extends lifespan (Shen et al. 2012). Together with the study of 
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miR-71 as mentioned above, it is intriguing that the three miRNAs, miR-71, miR-84, and 
miR-241, mediate lifespan extension by germline loss, and that these miRNAs converge 
on DAF-16/FOXO pathway. This finding suggests potential involvement of these three 
miRNAs on IIS pathway to control organismal aging.  
 
In addition to miRNAs, small RNA deep-sequencing in C. elegans reveals age-associated 
changes of other classes of small RNAs such as 26nt-G- and 22nt-G-RNAs (endo-
siRNAs), 21U-RNAs (piRNAs), and tRNA-derived small RNAs (Kato et al. 2011). 
Considering that transposable element-derived transcripts increase with age (Lund et al. 
2002; Li et al. 2013), it might be possible that endo-siRNAs or piRNAs modulate a 
change in transposon expression with age. Further studies are necessary to define 
functional significance of these non-miRNA classes of small RNAs on aging.  
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MIRNAS AND NEURODEGENERATIVE DISEASES* 
Neurodegenerative diseases are a group of typically late-onset, progressive disorders that 
lead to cognitive and/or movement disorders. Some of the most studied include 
Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), 
and polyglutamine (polyQ) disorders such as Huntington's disease (HD) and the 
spinocerebellar ataxias (SCAs)(Orr and Zoghbi 2007; Ballard et al. 2011; Ferraiuolo et al. 
2011; O'Brien and Wong 2011; Coelho and Ferreira 2012). These diseases share features 
such as the abnormal accumulation of protein, which includes plaques and tangles in AD, 
Lewy bodies in PD, bunina bodies in ALS, and nuclear and cytoplasmic accumulations in 
polyQ disease. In these diseases, key proteins accumulate, the genes of which are ones in 
which familial mutations can be found. Mechanisms that affect disease pathogenesis 
involve multiple fundamental cellular pathways, including protein folding and clearance 
processes. Thus, understanding the pathogenic mechanisms requires studying a broad 
spectrum of basic cellular machineries. 
 
Three main approaches have been used to study the effects of miRNAs on long-term 
brain integrity and neurodegenerative disease. First is the disruption of proper miRNA 
biogenesis followed by examination of the effect on the brain over time. Second is the 
identification of individual miRNAs that target specific disease genes and their impact. 
Third is the examination of the impact of disease-associated proteins on the miRNA 
pathway, such as miRNA biogenesis or mRNA-silencing function (Figure 1.2). Here, we 
  
16
describe recent advances in each approach that reveal critical roles of miRNAs in brain 
integrity. 
 
Disrupting the miRNA biogenesis pathway causes neurodegeneration* 
A range of approaches – including cloning of miRNAs, miRNA microarrays, and small 
RNA deep-sequencing analyses – have revealed expression of select miRNAs in the 
developing mammalian brain and primary neuronal cultures (Lagos-Quintana et al. 2002; 
Berezikov et al. 2006; Landgraf et al. 2007; Bak et al. 2008). Analysis of the expression 
pattern of miRNAs using in situ hybridization with locked nucleic acid (LNA) probes in 
zebrafish identified their tissue-specific patterns (Kapsimali et al. 2007). Such patterns 
indicated a potential role of miRNAs in neuronal development and function. Subsequent 
studies revealed roles of specific miRNAs, such as miR-124, in these 
processes (Visvanathan et al. 2007). 
 
A functional link between miRNAs and neurodegeneration was discovered in studies of 
the effect of global disruption of miRNA biogenesis on neuronal development. Mutants 
of Dicer in the mouse die early, before neurulation, precluding the ability to assess 
function in the brain (Bernstein et al. 2003). However, disruption of Dicer in zebrafish 
revealed an essential role in brain morphology and neural differentiation (Giraldez et al. 
2005). Injecting a miR-430 duplex rescued the defects in brain morphology, indicating 
the importance of this specific miRNA. Subsequently, conditional disruption of Dicer in 
different neuronal populations or cell lines revealed the effect of the miRNA pathway on 
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proliferation, migration, and differentiation, as well as long-term neural integrity (Kim et 
al. 2007; Schaefer et al. 2007; Choi et al. 2008; Damiani et al. 2008; Davis et al. 2008; 
McLoughlin et al. 2012). For example, depleting Dicer in embryonic stem (ES) cells 
reduces the ability of the cells to differentiate into midbrain dopaminergic neurons (Kim 
et al. 2007) – a major neural population compromised in PD. Transfecting the small RNA 
fraction from embryonic mouse midbrain cells rescues the defect, assigning the role to 
small RNAs. Consistent with this, deleting Dicer in midbrain dopaminergic neurons in 
the mouse causes progressive loss of the cells, concomitant with disruption of locomotion, 
reminiscent of PD (Kim et al. 2007). 
 
In another example, loss of Dicer from mouse cerebellar Purkinje cells did not impair 
cellular morphology or function at young ages (8–10 weeks). However, by 13 weeks of 
age, Purkinje cells, which are the cell type compromised in many ataxias, had 
progressively degenerated. Intriguingly, the older mice also developed slight tremors and 
mild ataxia that worsened with age (Schaefer et al. 2007). Disruption of Dicer in spinal 
motor neurons mimics clinical and pathological features of ALS, a disease associated 
with loss of motor neurons, indicating a possible impact of the miRNA pathway in the 
pathogenesis of this disease (Haramati et al. 2010). Interestingly, some key proteins 
associated with this disease have been shown to modulate miRNA biogenesis or function 
(see below). Deletion of Dicer from glial cells such as astrocytes and oligodendrocytes 
can cause neural degeneration in the mouse (Shin et al. 2009; Tao et al. 2011). In addition, 
conditional loss of Dicer in Schwann cells in the mouse revealed its importance for 
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axonal integrity (Pereira et al. 2010). In humans, Dicer protein levels have been found to 
be decreased in temporal lobe epilepsy patients with hippocampal cell loss (sclerosis), 
with about half of the miRNAs in the tissue reduced in levels (McKiernan et al. 2012). 
 
In Drosophila, knockdown of Dicer-1 is also associated with dopaminergic neural loss 
and climbing defects (Gehrke et al. 2010). Loss of Dicer-1 also enhances the toxicity of 
human pathogenic neurodegenerative disease proteins Ataxin-3 (associated with 
spinocerebellar ataxia type 3) and Tau (associated with AD and frontotemporal dementia 
[FTD]) (Bilen et al. 2006). Intriguingly, depleting Dicer from human HeLa cells also 
enhances the toxicity of disease-associated pathogenic Ataxin-3 protein and is rescued by 
adding back the small RNA fraction indicating a role for miRNAs. This study identified a 
specific miRNA, bantam, that modulates Ataxin-3 and Tau toxicity. Supporting the role 
of miRNAs in polyQ disease pathogenesis, a study of Drosophila miR-34 revealed a 
potent neuroprotective function in mitigating the toxicity of pathogenic forms of Ataxin-
3 (Liu et al. 2012). Beyond Dicer, haploinsufficiency of DGCR8, a component of the 
microprocessor complex that cleaves pri-miRNAs to generate pre-miRNAs, leads to 
neuronal dysfunction in the mouse (Stark et al. 2008; Fenelon et al. 2011; Schofield et al. 
2011). 
 
These studies, which target disruption of components of the miRNA biogenesis pathway, 
strongly suggest that miRNA activity impacts long-term brain integrity. Note, however, 
that the identification of the individual miRNAs involved is a crucial component of such 
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work. One reason for this is the potential effect of disrupting miRNA biogenesis on the 
proper expression of many related or unrelated proteins. Another reason is that disrupting 
the major components of miRNA biogenesis may cause dysfunction or degeneration 
independent of an effect on miRNAs. For example, Drosha, another component of the 
microprocessor, is reported to regulate neurogenesis by controlling Neurogenin 2 
expression independent of its role in miRNA processing (Knuckles et al. 2012). This 
function entails Drosha binding and cleavage of a hairpin structure in the 3’ untranslated 
region (UTR) of Neurogenin 2 mRNA. Recent studies have also shown that DGCR8 has 
a much broader impact on RNA processing beyond just miRNAs (Macias et al. 2012). 
 
Individual miRNAs target disease genes* 
Efforts to profile miRNAs in tissue from patients with neurodegenerative disease has 
identified miRNAs that are misregulated in the brain, some of which have been shown 
directly to target transcripts of familial disease genes. Recent reviews discuss the roles of 
individual miRNAs on the common neurodegenerative diseases (Delay et al. 2012; 
Gascon and Gao 2012; Mouradian 2012). In general, discovering specific miRNAs that 
target the 3’UTR of key disease genes, then assessing the expression pattern and level of 
those miRNAs, can uncover the extent to which they may impact the level of the disease 
protein and thus pathogenesis. Here, we highlight a few examples to illustrate the effect 
of specific miRNAs on select diseases. 
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AD is the most common neurodegenerative disease and, although it is predominantly 
sporadic, analysis of familial situations has identified critical genes for its 
etiology (Ballard et al. 2011). The pathological features of AD are the deposition of 
intracellular neurofibrillary tangles containing Tau protein and extracellular plaques 
containing amyloid-beta (Aβ) peptides in the brain. Increased production and impaired 
clearance of Aβ is a likely cause of Aβ accumulation. Various Aβ peptides are produced 
on the cleavage of amyloid precursor protein (APP) by β-site APP-cleaving enzyme 1 
(BACE1) and γ-secretase. Some of these processing events promote amyloid formation 
whereas others do not (O'Brien and Wong 2011). 
 
Studies in AD highlight the intricate and complex loops of miRNA regulation that can 
occur. miR-29a/b are downregulated in a subset of AD patients that show elevated 
BACE1 protein expression, which is predicted to promote amyloidogenic peptide 
formation (Hebert et al. 2008). The 3’UTR of BACE1 contains a miR-29a/b target site 
and miR-29 targets BACE1. The BACE1 3’UTR also contains sites for other miRNAs, 
including miR-107, miR-124, and miR-195 (Wang et al. 2008; Fang et al. 2012; Zhu et al. 
2012). miR-107 is downregulated in AD and targets cofilin, a component of rod-like 
actin structures in the AD brain. miR-15a, which belongs to the miR-107/103 family, is 
also downregulated in AD patients (Wang et al. 2011). Interestingly, the miR-15 family 
can target extracellular signal-regulated kinase 1 (ERK1), which is a Tau kinase, and this 
could potentially lead to abnormal Tau phosphorylation in vivo, another pathological 
hallmark of AD (Hebert et al. 2010). Other miRNAs implicated in AD pathology include 
  
21
miR-16, miR-101, miR-106a, miR-520c, and miR-153, which target APP (Long and 
Lahiri 2011; Liang et al. 2012; Long et al. 2012). Overall, these findings highlight the 
critical impact of select miRNAs on regulation of the expression of central proteins in 
AD pathogenesis and progression. 
 
ALS is characterized by the degeneration of motor neurons in the brain and spinal cord, 
sharing a clinical and pathological spectrum with FTD, the second most common 
dementia (Ferraiuolo et al. 2011). The RNA-binding proteins TDP-43 and FUS are both 
implicated in the pathogenesis of ALS and FTD. TDP-43 is mutated in a subset of ALS 
patients and TDP-43 knockdown in human cells leads to aberrant expression of some 
miRNAs (Buratti et al. 2010). In the mouse, miR-206 deficiency accelerates disease 
progression in a model of ALS (Williams et al. 2009), which, together with the effect of 
Dicer loss in mimicking ALS pathogenesis (Haramati et al. 2010), reinforces the 
importance of proper regulation of miRNAs and the miRNA pathway in ALS 
pathogenesis. 
 
An example of discovering a miRNA–target loop that is conserved in flies and humans 
was revealed in studies of the miR-8 miRNA and one of its targets (Atrophin 1) in flies 
(Karres et al. 2007). The Atrophin-1/Dentatorubral-pallidoluysian atrophy (DRPLA) 
protein is mutated and accumulates in the polyQ disease DRPLA. The DRPLA protein 
binds an orthologous protein RERE in vitro and RERE overexpression causes 
mislocalization of the DRPLA protein (Yanagisawa et al. 2000). miR-200b and miR-429 
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in humans potentially target the RERE transcript (Karres et al. 2007). 
Intriguingly, Drosophila miR-8, which has the same seed sequence as miR-200b and 
miR-429 in humans, targets the Drosophila Atrophin 1 mRNA. Further, miR-8 deletion 
in flies (which would lead to increased Atrophin 1 protein levels) causes a mild increase 
of apoptosis in larval brains and climbing defects in adults with age, reminiscent of 
disease features. These findings indicate a potentially conserved role of the miR-8/miR-
200 family in neurodegeneration, contributing to the pathogenesis of DRPLA. 
 
miRNAs can target pathways that impact brain integrity and disease* 
Many miRNAs may become misregulated in neurodegenerative disease, some of which 
may have a causal role in pathogenesis. However, it is often unclear what causes miRNA 
misregulation. One example of a miRNA with a suggested known mechanism is miR-
133b. miR-133b is downregulated in the midbrain of PD patients and in a dopaminergic 
neuron deficiency model mouse (Aphakia strain) (Kim et al. 2007). The Aphakia mouse 
has a mutation in Pitx3, a transcription factor in which single nucleotide polymorphisms 
(SNPs) are associated with PD in some reports (Fuchs et al. 2009; Le et al. 2011; Gui et 
al. 2012). Pitx3 overexpression leads to upregulation of pre-miR-133b in differentiating 
ES cells, whereas miR-133b directly inhibits Pitx3 through its 3’UTR (Kim et al. 2007). 
This suggests a negative feedback loop in which Pitx3 activates miR-133b expression and 
miR-133b in turn represses Pitx3 expression. This study raises the possibility that an 
observed misregulation of miR-133b in PD may be related to the SNPs linked to PD in 
Pitx3 in at least some PD situations, although there are reports of a negative association 
  
23
(de Mena et al. 2010; Cai et al. 2011a; Cai et al. 2011b). Although the miR-133b 
knockout mouse showed no obvious defects in midbrain dopaminergic neurons during 
development or aging, or in the expression of neuronal genes, including Pitx3 (Heyer et 
al. 2012), the existence of the other miRNAs in the miR-133 family could explain the 
lack of effects. 
 
miR-34 defines a miRNA family that is highly conserved in humans, the fly 
and Caenorhabditis elegans. In humans, the miR-34 family (miR-34a, miR-34b, miR-
34c) is misregulated in many cancer types and regulation of expression of these miRNA 
by p53 to impact apoptosis and cell cycle control has been well studied (He et al. 2007b; 
Wong et al. 2011). miRNA profiling in the adult mouse nervous system revealed 
enrichment of miR-34a in spinal cord and brainstem regions (medulla oblongata and 
pons) (Bak et al. 2008) and miR-34a increases with age in the cortex and hippocampus 
by in situ hybridization (Khanna et al. 2011; Li et al. 2011). miR-34a is also enriched in 
the cerebral cortex of an Alzheimer's mouse model (Wang et al. 2009) and miR-34c 
increases with age in mouse and human hippocampus, AD patients, and mouse AD 
models (Zovoilis et al. 2011). Targets include SIRT1, whose regulation by miR-34c is 
associated with memory impairment in mice (Zovoilis et al. 2011), and is inversely 
correlated with miR-34a expression in cortex and hippocampus with age (Li et al. 2011). 
In cell studies, miR-34c also functionally inhibits translation of Bcl-2, an antiapoptotic 
protein whose function may also include modulating the processing of APP (Rohn et al. 
2008; Wang et al. 2009). Further, miR-34b is elevated in the plasma of HD patients 
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(Gaughwin et al. 2011). By contrast, in PD patients, miR-34b/c is downregulated at early 
(pre-motor) stages in brain samples (Minones-Moyano et al. 2011). This study suggests 
that deficiency in miR-34b/c may promote mitochondrial dysfunction, concomitant with 
a decrease in Parkin and DJ1, two genetic loci associated with recessive parkinsonism. 
Overall, these studies highlight misregulation of the miR-34 family in neurodegenerative 
disease, although it is unclear whether misregulation is a cause or consequence of disease 
pathogenesis. 
 
In Drosophila, miR-34 is a brain-enriched, adult-onset miRNA. Deleting miR-34 causes 
early-onset loss of motor behavior, susceptibility to stress, brain degeneration, and a 
shorter lifespan (Liu et al. 2012). In addition, miR-34 upregulation mitigates polyQ 
degeneration. One miR-34 target is E74A, a critical gene for the development of the 
animal (Liu et al. 2012). This miRNA–target loop supports the idea of antagonistic 
pleiotropy; the target gene is beneficial in early life, but deleterious in later life, thus 
down regulation of the gene in the adult may protect the animal against its deleterious 
functions in the adult stage (Hughes and Reynolds 2005; Curran and Ruvkun 2007). Here, 
a single miRNA couples the age-associated physiology of the animal (climbing, stress) 
with age-associated brain gene expression and long-term maintenance of the brain (Liu et 
al. 2012). In C. elegans, miR-34 loss of function leads to extended lifespan through 
regulation of autophagy genes (Yang et al. 2011). Given that alterations of miR-34 in 
mouse and human brain are associated with age and disease, although the precise role (to 
protect or alternatively promote loss of brain integrity and age-related functions) may be 
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distinct or depend on precise targets, miR-34 is an intriguing molecular link that may 
coordinate these age-associated biological processes in multiple organisms. 
 
Disease proteins themselves may impact miRNA biogenesis and/or function* 
Beyond miRNAs affecting the level of key disease proteins or pathways, disease proteins 
themselves may directly affect miRNA biogenesis or mRNA target silencing. The human 
Huntingtin (Htt) protein, whose CAG repeat expansion causes HD, interacts with Ago2 
protein in cellular P-bodies (sites of mRNA decay) (Savas et al. 2008). Htt depletion 
impairs miRNA target silencing (Savas et al. 2008) and, in HD animal models, many 
miRNAs are misregulated (Lee et al. 2011). This may be due, at least in part, to 
upregulation of Repressor Element 1 Silencing factor (REST), a transcription factor that 
is upregulated in HD neurons and can repress hundreds of neural genes (Zuccato et al. 
2007; Johnson et al. 2008a). Interestingly, REST-binding motifs are found in close 
proximity to a subset of miRNA genes in the human genome, including miR-9/miR-9*, 
miR-29a/b, miR-124, and miR-132 (Conaco et al. 2006; Wu and Xie 2006; Johnson et al. 
2008b; Johnson and Buckley 2009). In addition, REST and its cofactor coREST have 
functional miR-9 and miR-9* target sites, respectively (Packer et al. 2008), and miR-9 is 
misregulated in HD patients (Marti et al. 2010). Thus, REST may be required for the 
expression of many miRNA genes, although the response may depend on context, such as 
the differentiation state of the cells (Gao et al. 2012). 
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TDP-43 mislocalization and mutation is associated with ALS, and TDP-43 loss-of-
function as well as gain-of-function activities may contribute to disease (Cohen et al. 
2011; Ferraiuolo et al. 2011). In human cells, expression of some miRNAs is affected by 
TDP-43 knockdown (Buratti et al. 2010). Interestingly, TDP-43 interacts with Drosha 
and Dicer complexes (which function in the generation of pri-miRNAs and pre-miRNAs, 
respectively) and binds select pri-miRNAs and pre-miRNAs in the nucleus and the 
cytoplasm, respectively, through the terminal hairpin loops (Kawahara and Mieda-Sato 
2012). Furthermore, nuclear TDP-43 facilitates Drosha-dependent cleavage of select pri-
miRNAs, whereas cytoplasmic TDP-43 promotes Dicer-dependent cleavage of select pre-
miRNAs (Kawahara and Mieda-Sato 2012). Interesting questions for the future include 
the mechanisms by which TDP-43 affects the processing of only a subset of pri- and pre- 
miRNAs, and the precise impact of these processing defects on disease pathogenesis. 
 
PolyQ expansions in Ataxin-2 (Atx2) are associated with spinocerebellar ataxia-2 
(SCA2), parkinsonism, and ALS (Lastres-Becker et al. 2008; Bonini and Gitler 2011). As 
with other disease situations, it is possible that aspects of loss of function as well as gain 
of function contribute to disease. In flies, Atx2 is required for the silencing activity of 
select miRNAs; in Atx2-deficient cells, several miRNA reporters (although not all) 
become upregulated (McCann et al. 2011). The detailed mechanisms by which the Atx2 
protein impacts miRNA silencing and whether a role of Atx2 in miRNA silencing is 
relevant to diseases associated with altered Atx2 remain to be addressed. 
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These findings suggest roles of disease-relevant proteins in miRNA biogenesis or 
miRNA target silencing. Given the potential of these proteins to affect these general 
aspects of miRNAs and the predicted large number of mRNA targets of miRNAs, it is 
readily conceivable that disruption of these processes might lead to misregulated 
expression of many proteins. Such gross disruption has the potential to profoundly impact 
long-term neural function and integrity. 
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CONCLUSIONS AND REMAINING QUESTIONS:  
miRNAs in organismal and brain aging*  
Recent technological advances in high-throughput small RNA profiling in vivo have 
identified changes in the small RNA population in neurodegenerative disease or with age. 
So far, functions of only a handful of these miRNAs have been revealed, and an 
important question will be identifying the roles of the many other miRNAs that change in 
disease or in an age-associated manner. In addressing this question, studies of C. 
elegans have provided crucial insights into miRNA function; not all miRNAs that change 
with age lead to modulated lifespan upon altered activity (de Lencastre et al. 2010) and 
many miRNAs are not required for development or viability (Miska et al. 2007; Alvarez-
Saavedra and Horvitz 2010). Redundancy among different miRNAs is one possibility. 
Alternatively, the changes of such miRNAs could be a result, rather than cause, of age-
associated physiological events. Another possibility is that such miRNAs might be 
required only in a perturbed environment or genetic background to confer ‘robustness’ on 
gene expression (Bartel and Chen 2004; Ebert and Sharp 2012; Kato and Slack 2013). 
Considering this, sensitizing the background when studying loss of function of 
miRNAs (Brenner et al. 2010; Kato and Slack 2013) or examining stressful conditions 
might uncover novel roles. Another important question is what initiates misregulation of 
miRNAs in age or disease, especially for those miRNAs that impact age-associated 
events or the onset or progression of neurodegeneration. We have only limited examples 
of such mechanisms, such as where the disease-relevant genes themselves seem to trigger 
the misregulation of miRNAs. 
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MIRNA HETEROGENEITY AT THE ENDS AND IN SEQUENCE 
Canonically, each miRNA was initially annotated as a single sequence of defined length. 
However, the development of small RNA deep-sequencing techniques has led to the 
identification of sequence and length variations of each miRNA across species. These so-
called isomiRs were originally seen as enigmatic sequences that might result from mere 
technical issues (Sdassi et al. 2009; Reese et al. 2010; Neilsen et al. 2012). However, 
accumulating evidence suggests that such heterogeneity varies depending on the specific 
cell type, the biological context such as disease, and stimuli (Ruby et al. 2006; Landgraf 
et al. 2007; Ruby et al. 2007; Wu et al. 2007; Kuchenbauer et al. 2008; Morin et al. 2008; 
Sdassi et al. 2009; Burroughs et al. 2010; Marti et al. 2010; Reese et al. 2010; Wyman et 
al. 2011; Westholm et al. 2012), and that at least some of such variation can be generated 
by specific gene activities (described below). This suggests that miRNA heterogeneity 
might be regulated and also potentially biologically relevant. As the last part of the 
introduction, we will summarize the known mechanisms and potential functional 
consequences of the heterogeneity of miRNAs across species. 
 
According to the canonical biogenesis pathway of miRNAs, the 5' and 3' ends of 
miRNAs are defined by Drosha- and Dicer-mediated cleavages. However, Drosha and 
Dicer cleavage can be imprecise so that they generate different 5' and 3' ends of miRNAs 
(Calabrese et al. 2007; Azuma-Mukai et al. 2008; Wyman et al. 2011). The impact of the 
5' end heterogeneity of miRNAs has been clearly shown in several studies, reflecting a 
change in the seed sequence (2-8th nucleotide from the 5' end of the miRNA) (Azuma-
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Mukai et al. 2008; Seitz et al. 2008; Fukunaga et al. 2012; Lee and Doudna 2012). In 
addition to the imprecise nature of Drosha and Dicer cleavages, the partner protein of 
Dicer, Loqs-PB in Drosophila or TRBP in mammals, affects the position of Dicer 
cleavage in some pre-miRNAs, resulting in the production of miRNA isoforms that are 
overlapping, but differ at the 5' end, thus have distinct seed sequences (Fukunaga et al. 
2012; Lee and Doudna 2012). This leads to distinct target specificity and potential 
differences in guide strand selection, supporting the biological impact of this 
phenomenon (Fukunaga et al. 2012; Lee and Doudna 2012).  
 
The heterogeneity of miRNAs at the 3' end is also mediated by nucleotide addition by 
nucleotidyl transferases. Deep-sequencing analyses identified 3' end nucleotide additions 
across species, from C. elegans, Drosophila, to mouse and human (Ruby et al. 2006; 
Landgraf et al. 2007; Burroughs et al. 2010; Wyman et al. 2011). Among twelve known 
nucleotidyl transferases in humans, seven are implicated in 3' end adenylation and/or 
uridylation (Neilsen et al. 2012). These polymerases add ribonucleotides to the end of 
RNA, independent of the existence of a template (Martin and Keller 2007). In one 
example, a ribonucleotidyltransferase, PAPD4/GLD-2, adenylates the 3' end of miR-122 
in human and mouse, which leads to increased stability of this miRNA (Katoh et al. 
2009). Consistent with this, the knockout of PAPD4 (resulting in no adenylation) in 
mouse increases miR-122 mRNA target expression (Katoh et al. 2009). This indicates 
that the adenylation of miR-122 at the 3' end positively affects target gene silencing 
(Katoh et al. 2009). In another example, however, the adenylation at the 3' end of miR-
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27a and miR-26a led to increased mRNA target expression, indicating that 3' end 
adenylation of these miRNAs negatively affects miRNA target silencing (Burroughs et al. 
2010). Taken together, these data indicate that the functional consequence of adenylation 
at the 3' end of miRNAs might vary for each miRNA. In addition, human Ago2 and Ago3 
are bound to reduced levels of 3' end adenylated miRNAs compared to Ago1 or the 
normal population of miRNAs from the same cell line (Burroughs et al. 2010). This 
finding raises the possibility that 3' end adenylation of miRNAs might also play a role in 
sorting specific miRNA isoforms into different Ago complexes.  
 
In addition to adenylation, uridylation of the 3' end of miRNAs may impact the target 
silencing in animals. Zcchc11 (PAPD3/TUT4) is a uridyltransferase that uridylates the 3' 
end of mature miRNAs (Jones et al. 2009; Jones et al. 2012). IGF-1 is a predicted target 
of several uridylated miRNAs, such as miR-126-5p, miR-194-2-3p, and miR-379 (Jones 
et al. 2012). When the 3' ends of these miRNAs are uridylated, silencing efficiency of the 
IGF-1 3’UTR reporter diminishes for miR-126-5p and miR-379 (Jones et al. 2012). This 
suggests that 3' end uridylation of these miRNAs negatively affects target silencing.  
 
In plants, the 3' ends of small RNAs, including miRNAs and siRNAs, are protected by 2'-
O-methylation (Yu et al. 2005). In the absence of Hen1, the methyltransferase 
responsible for 2'-O-methylation of the small RNAs, the 3' ends of these small RNAs are 
uridylated by HESO1, which leads to degradation of the small RNAs (Li et al. 2005; Ren 
et al. 2012; Zhao et al. 2012b). This suggests that, in plants, the 3' end uridylation affects 
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the stability of the small RNAs. Based on these results across species, it is clear that 3' 
end adenylation and uridylation of miRNAs affect the stability and/or the silencing of the 
target mRNAs. Important future questions include how 3' end adenylated or uridylated 
miRNAs mechanistically modulate miRNA target silencing, and what is the biological 
significance of such phenomenon in vivo. 
 
Another type of modification that occurs in miRNAs is adenosine-to-inosine (A-to-I) 
RNA editing. RNA editing is performed by Adenosine Deaminase that Acts on RNA 
(ADAR), and occurs co-transcriptionally or post-transcriptionally to convert adenosine to 
inosine in dsRNAs (Nishikura 2010). As is the case for the other types of miRNA 
heterogeneity discussed so far, RNA editing events on miRNAs is likely regulated 
biologically: RNA editing on miRNAs increases during development in the mouse brain 
(Ekdahl et al. 2012). Although RNA editing events on miRNAs are rare in general (de 
Hoon et al. 2010), studies have identified clear RNA editing events for a subset of human 
and mouse miRNAs (Kawahara et al. 2007; Alon et al. 2012). The functional 
consequence of most of these RNA editing events in miRNAs is unclear. However the 
study of miR-376 in mouse, harboring RNA editing in the seed region, showed that the 
RNA editing changes the target specificity of miR-376 (Kawahara et al. 2007). Given 
that the lack of RNA editing activity in ADAR2-null mice leads to an increased uric acid 
level, it is likely that RNA editing in general has profound biological consequences 
(Kawahara et al. 2007). Still, further studies are required to understand the impact of 
RNA editing events on individual miRNAs mechanistically and biologically. 
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CONCLUSIONS 
As discussed here, increasing evidence suggests that miRNAs are actually heterogenous, 
with variations in 3' end, 5' end and editing sequences, which appears controlled in 
different biological contexts and by specific enzymatic activities. Despite this, an 
understanding of how such heterogeneity is generated and whether it is functionally 
significant is just beginning. In line with this, previous study in our lab identified miR-34 
as an age-associated miRNA critical for regulating organismal and brain aging in 
Drosophila (Liu et al. 2012). Intriguingly, the increase of miR-34 with age is the result of 
the specific accumulation of only the short isoforms with age, and not the long isoforms 
(Liu et al. 2012). This initial finding led to a RNAi-screening to discover the enzyme that 
generates such a pattern of miR-34, described in Chapter 2. This work lead to the 
identification of a novel 3'-to-5' exonuclease, Nibber (Nbr), that generates 3' end 
heterogeneity of a subset of miRNAs in Drosophila. In Chapter 3, we set out to assess the 
biological significance of nbr in vivo, by assessing the Nbr protein expression pattern and 
the loss-of-function effects on animals. These two chapters reveal a population of 
miRNAs that are targeted by Nbr, as well as the in vivo significance of nbr gene. 
Furthermore, given that miR-34, a representative Nbr-dependent miRNA, showed a 
change in isoform pattern with age, we queried whether other Nbr-dependent miRNAs 
show changes in their isoform pattern with age. This led us to test other Nbr-dependent 
miRNAs for isoform pattern changes with age, detailed in Chapter 4. This not only 
revealed distinct isoform pattern changes of different miRNAs with age, but also led to 
the finding that 2'-O-methylation of specific miRNA isoforms increases with age. This is 
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correlated with differential Ago1 vs Ago2-loading of specific miRNA isoforms with age, 
suggesting a mechanism to control differential partitioning of small RNAs into different 
Ago complexes with age. Taken together, these studies reveal new insight into a 
mechanistic and biological understanding the small RNA heterogeneity in organismal 
aging.  
 
 
 
 
  
Figure 1.1. The miRNA biogenesis pathway.* 
 
The biogenesis of a miRNA starts with the transcription of the primary transcript, the pri
miRNA, by RNA polymerase II. The pri
complex (Drosha/DGCR8 in vertebrates, Drosha/Pasha in 
precursor miRNA (pre-miRNA). The pre
cleaved by the Dicer/TRBP (Dicer
miRNA duplex. After incorporation into miRNA
and strand selection, the mature miRNA strand induces translational repression and/or 
mRNA cleavage, leading to reduction of the protein. 
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Figure 1.2. Ways by which miRNA pathways impact neurodegenerative disease.*
 
(a) miRNAs, which can be altered in disease, may di
transcripts, to alter their translation or level. 
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rectly target disease-
(b) Evidence also suggests that some 
 
  
related 
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disease-related proteins, such as Huntingtin (Htt) and TDP-43, may directly affect 
miRNA biogenesis or miRNA target silencing activity.  
 
 
 38
CHAPTER 2 
THE EXORIBONUCLEASE NIBBLER CONTROLS  
3' END PROCESSING OF MICRORNAS IN DROSOPHILA  
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The exoribonuclease Nibbler controls 3' end processing of microRNAs in Drosophila.  
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3These authors contributed equally to this work  
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The manuscript is included with permission.  
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Note 
The format of the figure and table numbers, and references have been modified from that 
published to conform with the format of the dissertation. 
 
My contributions to this work include: 
• Identification of Nbr-dependent miRNAs globally by small RNA deep-
sequencing, in collaboration with Ammar Naqvi for data analyses (Table 2.2, 2.3, 
2.4, Figure 2.4F, and Figure 2.7).  
• Confirmation of Nbr-dependent miRNAs identified by small RNA deep-
sequencing by northern blots (Fig.2.7C,D). 
• Identification of potential biological targets of nbr in DL1 cells by microarray 
(Fig.2.4G,H).  
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Summary 
       MicroRNAs (miRNAs) are endogenous noncoding small RNAs with important roles 
in many biological pathways; their generation and activity are under precise regulation 
(Ambros 2004; Bartel 2004; O'Connell et al. 2010). Emerging evidence suggests that 
miRNA pathways are precisely modulated with controls at the level of transcription 
(Johnson et al. 2003; Bommer et al. 2007; Chang et al. 2007; He et al. 2007a; Raver-
Shapira et al. 2007), processing (Hagan et al. 2009; Heo et al. 2009; Newman and 
Hammond 2010), and stability (Ramachandran and Chen 2008; Chatterjee and Grosshans 
2009), with miRNA deregulation linked with diseases (Chang and Mendell 2007) and 
neurodegenerative disorders (Bilen et al. 2006). In the Drosophila miRNA biogenesis 
pathway, long primary miRNA transcripts undergo sequential cleavage (Bernstein et al. 
2001; Denli et al. 2004; Lee et al. 2004b) to release the embedded miRNAs. Mature 
miRNAs are then loaded into Argonaute1 (Ago1) within the RNA-induced silencing 
complex (RISC) (Hammond et al. 2001; Okamura et al. 2004). Intriguingly, we found 
that Drosophila miR-34 displays multiple isoforms that differ at the 3′ end, suggesting a 
novel biogenesis mechanism involving 3′ end processing. To define the cellular factors 
responsible, we performed an RNA interference (RNAi) screen and identified a putative 
3'→5' exoribonuclease CG9247/nibbler essential for the generation of the smaller 
isoforms of miR-34. Nibbler (Nbr) interacts with Ago1 and processes miR-34 within 
RISC. Deep sequencing analysis revealed a larger set of multi-isoform miRNAs that are 
controlled by nibbler. These findings suggest that Nbr-mediated 3′ end processing 
represents a critical step in miRNA maturation that impacts miRNA diversity. 
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Results and Discussion 
       Although miRNAs are typically annotated and observed as a single species, we 
found that miR-34 showed a pattern of three major isoforms of 24, 22, and 21 nucleotides 
(nts) in northern blots from adult Drosophila (Figure 2.1A). Deep sequencing analysis 
(Zhou et al. 2009) also showed that miR-34 is present in multiple forms that all bear the 
same 5′ terminus but differ at their 3′ ends, presenting a nested series (Figure 2.1B). To 
assess the relationship among these, we designed a pulse-chase experiment to 
follow miR-34 biogenesis. Heat-shock driven primary miR-34 was tightly induced for 
30 min and then monitored over time in adult flies. The longest isoform, isoform a (24 
nt), was predominant initially, whereas the accumulation of the shorter isoforms was 
delayed, but then increased over time (Figure 2.1C). Moreover, as the 21 nt isoform 
accumulated, the 24 nt form was lost in a seemingly reciprocal manner, suggesting that 
the 24-mer may be converted into the 21-mer. 
 
To define the mechanism, we treated cells with double-stranded RNA (dsRNA) targeting 
specific genes within the small RNA biogenesis pathways and assessed the miR-
34 pattern by northern blot. Imprecise cleavage of the precursor transcript could result in 
the production of the multiple forms. However, reduction of either Drosha or Dcr-1, or 
their binding partners Pasha and Loquacious, or Dicer-2 (Dcr-2), responsible for small 
interfering RNA (siRNA) generation, did not alter the pattern (Figure 2.2A). Therefore, 
we reasoned that the smaller isoforms may instead be generated by an exonuclease that 
sequentially processes the longest isoform into the nested series observed. To test this 
hypothesis, we performed an RNAi screen against the predicted 3'→5' exonucleases 
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in Drosophila, including components of the RNA exosome (see Table 2.1). This 
identified one gene, CG9247 (which we named nibbler/nbr), with a striking effect: 
depletion of nbr led to a dramatic accumulation of the miR-34 large isoform with a 
concomitant loss of the shorter isoforms (Figure 2.2B; Figure 2.5A,B). In contrast, loss 
of nbr did not appear to alter the sizes or levels of miRNAs that normally show a single 
isoform by northern blot, such as miR-14 and miR-277 (Figure 2.2C). We also examined 
whether nbr knockdown had an effect on endogenous siRNAs but saw no impact on esi-
2.1 (Figure 2.2C). These data suggested that the novel putative exoribonuclease Nbr is 
required to generate the shorter isoforms of the multi-isoform miRNA miR-34 but is not 
required for general small RNA biogenesis. 
 
The Nbr exoribonuclease domain shows closest sequence homology to human EXD3, 
falling within the E. coli RNase D protein family; this includes the Werner 
exoribonuclease and C. elegans Mut-7 involved in transposon silencing (Figure 2.5D; 
(Ketting et al. 1999)). Nbr, however, showed no predicted RNA binding domain, 
suggesting that it may function with a partner with RNA binding capacity, to bring Nbr 
activity to RNA substrates. To define these, we then performed a second RNAi screen for 
genes known to bind RNA or associate with small RNA silencing pathways, including 
the two somatic RISC-associated Argonautes (Table 2.1). Strikingly, loss of Ago1 
phenocopied nbr depletion: accumulation of the 24 nt isoform occurred, with reduction of 
the shorter isoforms (Figure 2.3A). Controls indicated that knockdown of Ago1 had no 
effect on nbr expression, and nbr knockdown had no effect on Ago1 expression. These 
data suggested that Ago1 is also required for trimming and that Nbr and Ago1 may act in 
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a complex. Coimmunoprecipitation (coIP) studies indicated that hemagglutinin (HA)-
tagged Nbr associates with Flag-tagged Ago1, but not with a control protein (Flag-Ran) 
(Figure 2.3B). RNase treatment indicated that the association was not RNA dependent 
(Figure 2.6). Proteomic studies have identified both Ago1 and Nbr as small RNA 
associated proteins (Gerbasi et al. 2010), underscoring the specificity of the interaction. 
Because Nbr associates with Ago1, we hypothesized that miR-34 3′ end processing may 
occur in the context of RISC. Indeed, immunoprecipitation of Ago1 revealed that all miR-
34 isoforms were bound (Figure 2.3C). Furthermore, when Nbr was depleted, the 
longest miR-34 isoform remained bound to Ago1 (Figure 2.3C). Altogether, these data 
suggest that the 24 nt miR-34 isoform is first generated by Dcr-1 then loaded into RISC. 
Next, Nbr, in association with Ago1, processes the long 24 nt isoform into shorter 
isoforms that remain loaded in RISC. 
 
To assess the in vivo role of Nbr, we analyzed the expression and function of nbr in flies. 
Northern blots revealed that nbr is expressed during development and in the adult, with 
peaks during the late larval, early pupal stage and in adults (data not shown). Analysis 
of nbr messenger RNA (mRNA) levels in animals with a transposon insertion in the 
coding region (nbrf02257) showed that homozygous mutants (nbr−/−) lacked nbr expression 
(Figure 2.4A,B). nbr−/− flies were semilethal and sterile, indicating that nbr function is 
critical. Given the homology to Mut-7, we examined levels of transposons but found no 
evidence linking nbr to transposon silencing (data not shown). Assessment of miR-
34 expression in nbr−/− flies phenocopied cells treated with dsRNA: the shorter isoforms 
were abolished, whereas the 24 nt form accumulated (Figure 2.4C). As in cells, there was 
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no striking effect on single-form miRNAs like miR-277 (Figure 2.4D). Furthermore, miR-
34* levels and isoform distribution appeared unaffected (Figure 2.5C). These data 
indicated that nbr modulates the isoform abundance of miR-34 in the animal in vivo. 
 
To assess the broader impact of Nbr function, we screened 65 miRNAs by northern blot 
of RNA isolated from cultured cells and flies. We identified nine additional miRNAs 
with multiple isoforms: mir-2, miR-3, miR-12, miR-79, miR-263a/b, miR-274, miR-
279, miR-281-1/2, and miR-305. The expression patterns of five of these were altered 
in nbr−/− mutants, exhibiting accumulation of the longest isoforms with concomitant loss 
of the shorter isoforms (Figure 2.4E; miR-2 family was not studied further as a result of 
cross hybridization between members). Analysis of small RNA profiling data from cells 
(Zhou et al. 2009) confirmed that two of these (miR-263a and miR-305) had significant 
levels of multiple forms that differed at the 3' end (Table 2.2); miR-3, miR-12, miR-281, 
and miR-274 levels were too low for analysis. Three multiple-isoform miRNAs (miR-
79, miR-274, and miR-279) did not show an altered pattern in nbr−/− flies (Figure 2.4E). 
The deep sequencing data set revealed that miR-279 displays a series of isoforms that do 
differ at the 3' end; because miR-279 processing is nbr-independent, nbr may be one 
member of a larger set of genes or mechanisms responsible for 3' end diversity. miR-
79 isoforms differed at the 5' end, suggesting that mechanisms also exist for 5' end 
diversity of miRNAs. 
 
We further investigated the extent to which trimming is involved in miRNA processing 
by deep sequencing the small RNAs from flies, comparing nbr mutants to controls. There 
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was no major impact on the size distribution of small RNAs as a whole or miRNAs in 
particular (Figure 2.7A,B). To more carefully assess isoforms, we mapped reads to the 
miRNA stem-loop sequences and analyzed for length. For each miRNA, we calculated a 
ratio of the most frequent length in wild-type to the sum of all other lengths and 
compared this ratio between nbr and control. The distribution of the length ratios 
highlighted a cohort of miRNAs with extreme differences between nbr−/− and control. At 
the two ends of the plot were miRNAs where the most common length isoform of the 
miRNA was present at a much higher or much lower level in nbr−/−than in wild-type, 
reflecting an altered pattern of isoform distribution or relative abundance for these 
miRNAs in the absence of nbr. These included miRNAs we had defined as trimmed and 
modulated by nbr (miR-34, miR-263a, miR-263b), along with additional candidates 
(Figure 2.4F, red boxes). Northern blots were performed on the top and bottom eight 
miRNAs that we had not tested; we confirmed seven new nbr-dependent miRNAs (miR-
7, miR-10, miR-11, miR-31b, miR-100,  miR-190, miR-317; (Figure 2.7; Table 2.3 and 
Table 2.4). Northern blotting revealed some miRNAs that were trimmed were not 
detected as so by deep sequencing and the reverse: for any given miRNA, the extent of 
trimming had to be greater than ~10% in isoform level to detect a consistent change by 
northern blot, whereas deep sequencing analysis suggested that not all isoforms were 
cloned with equal efficiency. 
 
Trimming exerts a profound and diverse impact on miRNA sequence 
profiles: nbr promotes the diversity of some miRNAs (miR-34, miR-7, miR-317) and 
alters the relative abundance of the most prominent isoform of others (miR-190 and miR-
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10; (Figure 2.7C and Figure 2.7B; Table 2.3). To identify potential Nbr-dependent 
miRNA targets, we performed transcriptional profiling of Nbr-deficient cells. This would 
allow identification of target mRNAs whose stability was altered by miRNA trimming, 
but not targets primarily controlled by translational repression (Bagga et al. 2005). This 
identified 12 genes whose levels were affected by nbr depletion by >1.5-fold (Figure 
2.4G; Table 2.5); of these, one was reduced (nbr) and the others were upregulated. 
Assessing the levels of eight of these by real-time PCR confirmed increased expression 
of 6/8 mRNAs (75%) in nbr-depleted cells (Table 2.5). Next, we assessed expression of 
nine of these genes in nbr−/− flies, compared to wild-type andloquacious mutant 
flies. loqsf00791 mutants are viable and show deficiency in miRNA maturation and 
function, thus allowing assessment of miRNA function in adults (Jiang et al. 2005). We 
reasoned that genes regulated by miRNAs that are impacted by nbr-processing would 
also show dependence on loqs. We validated 5/9 genes (55%) as upregulated in 
both nbr−/− and loqsf00791 (two additional genes were upregulated, although did not reach 
statistical significance in nbr−/−) (Figure 2.4H; Table 2.5). Sequence analysis of these 
mRNA targets revealed that 4/7 genes (57%) have potential sites for the miRNAs that 
showed nbr-dependent processing (Table 2.5). It is unclear, however, whether existing 
algorithms for miRNA targeting efficiently predict binding sites for miRNAs with 3' end 
diversity; targets for trimmed miRNAs may use noncanonical recognition motifs that are 
more dependent on 3' end pairing than seed complementarity. 
 
These data provide evidence for a novel step in miRNA biogenesis: miRNA 3' end 
terminal trimming mediated by the 3'→5' exoribonuclease Nbr. Notably, small RNA deep 
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sequencing has unveiled a rich pattern of miRNA sequence isoforms, although miRNAs 
have routinely been annotated as a single mature form. Our findings suggest that miRNA 
processing by Nbr alters the repertoire of at least a subset of miRNAs in cells and whole 
animals, contributing to the diversity of the small RNA profile and potentially impacting 
posttranscriptional gene regulation in Drosophila. Mechanistically, our data indicate that, 
upon nbr knockdown, miR-34 is still associated with RISC; thus, trimming is not a 
prerequisite to miR-34 loading and likely occurs after loading. 
 
The impact and biological consequences of trimming may be complex. Nbr may impact 
strand selection within RISC because strand selection is influenced by the extent of 3' 
overhang and degree of pairing for any miRNA-miRNA* duplex (Khvorova et al. 2003; 
Schwarz et al. 2003). Nbr may impact miRNA stability, because previous studies have 
demonstrated that tailing and trimming of mature Drosophila miRNAs influence their 
turnover (Ameres et al. 2010). Trimming may also impact mRNA silencing by favoring 
alterative miRNA sites within mRNA targets. Although canonical miRNA-target 
specificity is thought to be driven largely by complementarity within the seed, 
noncanonical interactions can depend more heavily on 3' compensatory sites (Brennecke 
et al. 2005; Bartel 2009). Therefore, differences in the length of the 3' end of miRNAs 
may influence both target selection and silencing efficiency of targets that require 
extensive 3' end pairing. Future analysis of trimmed miRNAs and their range of targets 
will reveal rules governing miRNA-mRNA pairing specificity that may be impacted by 3' 
end heterogeneity. Given that some mammalian miRNAs also display multiple isoforms 
(Cheloufi et al. 2010; Cifuentes et al. 2010), miRNA 3' end processing may be conserved. 
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Our studies focused on the role of nbr in miRNA pathway function; whether nbr plays a 
role in additional small RNA pathways remains an open question, although we did not 
observe effects on transposons, suggesting that it does not globally impact endogenous 
small RNA pathways. The modification of mature miRNAs and their precursors is an 
emerging facet of miRNA-mediated gene regulation (Berezikov et al. 2011). Nbr may 
represent a central player in a larger spectrum of factors that shape miRNA repertoire and 
miRNA function, through the generation of multi-isoform miRNAs. 
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Supplemental Experimental Procedures 
Fly Stocks and Culture 
Flies were grown in standard cornmeal molasses agar medium with dry yeast, at 25°C 
unless otherwise specified. General stock lines and GAL4 driver lines were obtained 
from the Drosophila Stock center at Bloomington. nbrf02257 was obtained from the 
Exelixis collection (Harvard University). Fly transgenics were generated by standard 
procedures (Genetic Services, Inc). 
 
Constructs 
Fly genomic DNA was prepared from whole flies with the Puregene DNA purification kit 
(Qiagen). Using genomic DNA as the template, a 286bp of miR-34 genomic sequence 
was amplified by PCR (primers: 5’-CCG TTA CAC ACG ACTA TTC TCA AT-3’/5’-
CCA TCT GAT ACA GGT CCT ACA TTT TCT AAA A-3’), and used to generate a 
miR-34 pUAST construct. To generate Nbr constructs, PCR amplification was conducted 
using single stranded cDNA as the template, with primer pairs of HA-Nbr (5’- GAA TTC 
ATG TAC CCA TAC GAT GTT CCA GAT TAC GCT GCA CGC AAG AGC CAC 
ATG-3’/5’- GGT ACC TCA CTT AAC ATG GGC ACC CCG). PCR products were then 
cloned into the pRmHa3 vector. 
 
mRNA Northern and Small RNA Northerns 
Total RNA was isolated from cells or flies using Trizol reagent (Invitrogen) according to 
manufacturer’s protocol. For mRNA Northern, 5µg RNA was run on a 1% 
MOPS/formaldehyde gel, and transferred onto nylon plus (Northernmax, Ambion). The 
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RNA blots were then hybridized following standard procedures at 68°C, with 
prehybridization (~ 1 hr), hybridization (~ 12 hr or overnight) with P32 labeled probe, 
washed and exposed to Phosphoimager (Amersham). RNA probes were used that were 
made by in vitro transcription of cDNA templates using Maxiscript-T7 in vitro 
transcription kit (Ambion), supplemented with P32-labled UTP. The cDNA templates 
were prepared from total RNA of DL1 cells by one-step RT-PCR (SuperScript One-Step 
RT-PCR with Platinum Taq, Invitrogen, CA), with primers: T7-nbr (5’-
GAATTCATGGCACGCAAGAGCCACATG-3’/ 5’-GAT AAT ACG ACT CAC TAT 
AGG GAG AGG CTT CAG AAT GAG CTC CAG-3’) and18S rRNA loading control 
(5’-GAT AAT ACG ACT CAC TAT AGG GAG A-3’/ 5'-AGG GAG CCT GAG AAA 
CGG CTA CCA CAT CTA AGG AAT CTC CCT ATA GTG AGT CGT ATT ATC -3’). 
For small RNA Northerns, 3-15ug of RNA was fractionated on a 15% Tris-UREA gel 
(NuPage) with 1XTBE buffer. The transfer was performed with 0.5X TBE buffer. Prior 
to hybridization, the RNA blots were first prehybridized with Oligohyb (Ambion), and 
then incubated with radioactive labeled RNA probes for ~12 hr to overnight at 50°C. 
RNA probes were used, and made by in vitro transcription of oligo templates using 
Maxiscript-T7 in vitro transcription kit (Ambion), supplemented with P32-labeled UTP. 
Oligo DNA templates were prepared by annealing two single stranded DNA oligos into 
duplex (99°C 5min and cool down to room temperature). Oligos used were miR-2b-1 (5’-
GAT AAT ACG ACT CAC TAT AGG GAG A-3’/5'-AAA AAA TAT CAC AGC CAG 
CTT TGA GGA GCT CTC CCT ATA GTG AGT CGT ATT ATC-3’); miR-3 (5’-GAT 
AAT ACG ACT CAC TAT AGG GAG A-3’/5'-AAA AAA TCA CTG GGC AAA GTG 
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TGT CTC ATC TCC CTA TAG TGA GTC GTA TTA TC-3’); miR-7 (5’-GAT AAT 
ACG ACT CAC TAT AGG GAG A-3’/5'-AAA 
AAA ATG GAA GAC TAG TGA TTT TGT TGT TCT CCC TAT AGT GAG TCG 
TAT TAT C-3’); miR-10 (5’-GAT AAT ACG ACT CAC TAT AGG GAG A-3’/5'-AAA 
AAA ACC CTG TAG ATC CGA ATT TGT TTC TCC CTA TAG TGA GTC GTA TTA 
TC-3’); miR-11 (5’-GAT AAT ACG ACT CAC TAT AGG GAG A-3’/5'-AAA AAA 
ACA TCA CAG TCT GAG TTC TTG CTC TCC CTA TAG TGA GTC GTA TTA TC-
3’); miR-12 (5’-GAT AAT ACG ACT CAC TAT AGG GAG A-3’/5'-AAA AAA TGA 
GTA TTA CAT CAG GTA CTG GTT CTC CCT ATA GTG AGT CGT ATT ATC); 
miR-31b (5’-GAT AAT ACG ACT CAC TAT AGG GAG A-3’/5'-AAA AAA TGG 
CAA GAT GTC GGA ATA GCT GTC TCC CTA TAG TGA GTC GTA TTA TC-3’); 
miR-34 (5’-GAT AAT ACG ACT CAC TAT AGG GAG A-3’/5’-AAA AAA TGG CAG 
TGT GGT TAG CTG GTT GTG TCT CCC TAT AGT GAG TCG TAT TAT C-3’); 
miR-34* (GAT AAT ACG ACT CAC TAT AGG GAG A-3’/5'- AAA AAA CAG CCA 
CTA TCT TCA CTG CCG CCT CTC CCT ATA GTG AGT CGT ATT ATC-3'); miR-
100 (5’-GAT AAT ACG ACT CAC TAT AGG GAG A-3’/5’-AAA AAA AAC CCG 
TAA ATC CGA ACT TGT GTC TCC CTA TAG TGA GTC GTA TTA TC-3’); miR-
190 (5’-GAT AAT ACG ACT CAC TAT AGG GAG A-3’/5’-AAA AAA AGA TAT 
GTT TGA TAT TCT TGG TTG TCT CCC TAT AGT GAG TCG TAT TAT C-3’); 
miR-210 (5’-GAT AAT ACG ACT CAC TAT AGG GAG A-3’/5’-AAA AAA ATT 
GTG CGT GTG ACA GCG GCT ATC TCC CTA TAG TGA GTC GTA TTA TC-3’); 
miR-263 (5’-GAT AAT ACG ACT CAC TAT AGG GAG A-3’/5'-GTT AAT GGC ACT 
GGA AGA ATT CAC TCT CCC TAT AGT GAG TCG TAT TAT C-3’); miR-277 (5’-
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GAT AAT ACG ACT CAC TAT AGG GAG A-3’/5’-TAA ATG CAC TAT CTG GTA 
CGA CAT AAA TGC ACTATCTGGTACGACA TCT CCC TAT AGT GAG TCG TAT 
TAT C-3’); miR-274 (5’-GAT AAT ACG ACT CAC TAT AGG GAG A-3’/5'-AAA 
AAA TTT TGT GAC CGA CAC TAA CGG GTA ATT CTC CCT ATA GTG AGT 
CGT ATT ATC-3’); miR-281rev (5’-GAT AAT ACG ACT CAC TAT AGG GAG A-
3’/5'-TGT CAT GGA ATT GCT CTC TTT GTT GTC ATG GAA TTG CTC TCT TTG 
TTC TCC CTA TAG TGA GTC GTA TTA TC-3’); miR-283 (5’-GAT AAT ACG ACT 
CAC TAT AGG GAG A-3’/5'AAA AAA TAA ATA TCA GCT GGT AAT TCT TCT 
CCC TAT AGT GAG TCG TAT TAT C-3’); miR-305 (5’-GAT AAT ACG ACT CAC 
TAT AGG GAG A-3’/5'-AAA AAA ATT GTA CTT CAT CAG GTG CTC TGT CTC 
CCT ATA GTG AGT CGT ATT ATC-3’); miR-307 (5’-GAT AAT ACG ACT CAC 
TAT AGG GAG A-3’/5'-AAA AAA TCA CAA CCT CCT TGA GTG AGT CTC CCT 
ATA GTG AGT CGT ATT ATC-3’); miR-307rev (5’-GAT AAT ACG ACT CAC TAT 
AGG GAG A-3’/5'- AAA AAA TCA CAC CCA GGT TGA GTG AGT CTC TCC CTA 
TAG TGA GTC GTA TTA TC-3’); miR-315 (5’-GAT AAT ACG ACT CAC TAT AGG 
GAG A-3’/5'- AAA AAA TTT TGA TTG TTG CTC AGA AAG CTC TCC CTA TAG 
TGA GTC GTA TTA TC-3’); miR-317 (5’-GAT AAT ACG ACT CAC TAT AGG GAG 
A-3’/5'- AAA AAA ATG AAC ACA GCT GGT GGT ATC CAG TTC TCC CTA TAG 
TGA GTC GTA TTA TC-3’); miR-986 (5’-GAT AAT ACG ACT CAC TAT AGG GAG 
A-3’/5'- AAA AAA ATC TCG AAT AGC GTT GTG ACT GAT CTC CCT ATA GTG 
AGT CGT ATT ATC-3’); miR-1010 (5’-GAT AAT ACG ACT CAC TAT AGG GAG 
A-3’/5'- AAA AAA TTT CAC CTA TCG TTC CAT TTG CAG TCT CCC TAT AGT 
GAG TCG TAT TAT C-3’); esi2.1 (5’-GAT AAT ACG ACT CAC TAT AGG GAG A-
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3’/5'-TTG ACT CCA ACA AGT TCG CTC CTC TCC CTA TAG TGA GTC GTA TTA 
TC-3’) and 2S rRNA (5’- GAT AAT ACG ACT CAC TAT AGG GAG A-3’/5'-TGC 
TTG GAC TAC ATA TGG TTG AGG GTT GTA TCT CCC TAT AGT GAG TCG 
TAT TAT C-3’). 
 
Cell culture, dsRNA Synthesis, and RNAi 
Drosophila DL1 cells were grown and maintained in Schneider’s media supplemented 
with 10% FBS, penicillin/streptomycin and glutamine as described (Cherry and Perrimon 
2004). dsRNAs for RNAi were generated as described (Boutros et al. 2004). Briefly, 
gene-specific primers containing T7 polymerase binding sites were used to amplify ~500 
nucleotide regions within genes of interest by PCR. PCR products were used as templates 
for in vitro transcription using MEGAscript T7 (Ambion), and dsRNA products were 
purified using RNeasy columns (Qiagen). For RNAi knockdowns, cells were bathed into 
serum free media containing dsRNA for 45min-1h. Complete media was then added and 
cells were incubated for three more days. 
 
Protein and RNA Immunoprecipitations 
pMT-FLAG-Ran (Sabin et al. 2009) and pMT-FLAG-Ago1 are as described (Zhou et al. 
2008). For protein immunoprecipitations, 8x106 cells were seeded into 10 cm plates and 
transfected the next day with 4 µg pMT-HA-Nbr and 4 µg of either pMT-Flag-Ran or 
pMT-Flag-Ago1 using Effectene (Qiagen). Plasmid expression was induced 24 hours 
later with 500 µM CuSO4, and cells were collected 36 hours post-induction. Cells were 
processed as described (Saito et al. 2005). Briefly, cells were lysed into Buffer A+KOAc: 
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150mM KOAc, 30mM Hepes pH 7.4, 2mM MgOAc, 0.1% NP40, 5mM DTT, PMSF, 
and a complete protease inhibitor cocktail (Roche). FLAG-tagged proteins were 
immunoprecipitated overnight at 4°C using anti-FLAG M2 agarose beads (Sigma). Beads 
were washed six times in Buffer A+KOAc, and bound proteins were separated by SDS-
PAGE and immunoblotted with monoclonal anti-FLAG M2 antibody diluted 1:2,500 
(Sigma #F3165) and HRP-conjugated anti-HA antibody diluted 1:2,000 (Roche 
#12013819001) as described  (Cherry and Perrimon 2004). 
For RNA immunoprecipitation, 1.2x107 DL1 cells were seeded into 10 cm plates in 
serum-free media with 12 µg dsRNA. One hour later, complete media was added and 
cells were incubated for 5 days. Endogenous Ago1 was immunoprecipitated as described 
(Czech et al. 2008). Cells were lysed in lysis buffer: 20mM HEPES pH 7.0, 150mM 
NaCl, 2.5mM MgCl2, 0.3% Triton-X, 30% glycerol, PMSF, and a complete protease 
inhibitor cocktail (Roche). Pre-cleared lysates were incubated with rabbit polyclonal 
AGO1 antibody (1:20; Abcam #ab5070) or control rabbit polyclonal GFP antibody (1:20; 
Invitrogen #A-6455) overnight at 4°C. AGO1 and control antibodies were isolated using 
protein A/G beads (1:10; Pierce #20421) for 1 hour at 4°C. Beads were then washed 6 
times, 10 minutes each in wash buffer: 30mM HEPES pH 7.4, 800mM NaCl, 2mM 
MgCl2, 0.1% NP-40, PMSF and a complete protease inhibitor cocktail (Roche). 1 mL 
Trizol (Invitrogen) was added to beads following the final wash. RNA was extracted and 
analyzed by small RNA northern blotting. 
 
Small RNA Deep Sequence Analysis 
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To make small RNA sequencing libraries, total RNA was extracted using Trizol Reagent 
(Invitrogen) from ~3d old nbr mutants and control 5905 flies (1:1 ratio between males 
and females). 40ug RNA was fractioned in a 15% TBE-Urea gel (Novex, Invitrogen), 
followed by gel-purification of small RNA ranging between 18 nt and 30 nt. The library 
was then prepared following Small RNA v1.5 Sample Preparation Guide (Illumina) with 
some modifications. To perform sequence analysis, adaptor sequences (5’ adapter- 5’-
GTT CAGA GTT CTA CAG TCC GAC GAT C-3’; 3’ adapter 5’-ATC TCG TAT GCC 
GTC TTC TGC TTG AA-3’) were removed from the raw reads in the Illumina fastQ 
generated files using the FASTQ/A Clipper program in the fastx-toolkit 
(http://hannonlab.cshl.edu/fastx_toolkit/). Reads less than 16 bp or 
more than 30 bp were discarded. Remaining reads were then mapped to the Drosophila 
genome (Flybase v5.34), and to the microRNA stemloop sequences (BDGP5.0, 
http://www.mirbase.org/) using Bowtie. Mapped files generated from Bowtie were 
formatted and analyzed by customized Perl scripts. To enrich for miRNAs affected by 
nbr function, the length distribution for all reads corresponding to individual miRNAs 
was analyzed. To be included in the analysis the miRNA had to have more than 70 reads. 
The ratio of the most frequent length to the sum of all other lengths in wild type was 
calculated, and compared to the ratio of that same most frequent form divided by the sum 
of all other lengths in nbr (ratio nbr/control), and ratios plotted (Fig. 4F). miRNAs whose 
trimming is impacted by nbr presented at either end of the ratio graph. At one end of the 
graph were miRNAs with exceptionally high ratios of nbr/control and at the other end of 
the graph were miRNAs with exceptionally low ratios of nbr/control. The ratio equals 
[(the number in nbr of most common form in wild type/sum all forms in nbr) divided by 
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(the most common form in wild type/sum of all forms in wild type)]. Thus, the ratio is 
excessively large or excessively low when the most common length in nbr is either much 
greater or much lower than the percentage of reads of that length isoform for the miRNA 
in wild type. In addition, another deep sequencing dataset from Drosophila S2 cells 
GSM430030 was also used (Zhou et al. 2009). Reads were mapped to the miRNA 
stemloop, delineated by read length and sequence, and analyzed. 
 
Transcriptional Profiling 
For microarray analysis, DL1 cells were treated with dsRNAs (Renilla control or nbr). 
Total RNA was extracted from 2.5 million DL1 cells per replicate with Trizol Reagent 
(Invitrogen). Microarray hybridization and reading was performed at the Penn 
Microarray Core Facility. For mRNA microarrays, total RNA was reverse-transcribed to 
ss-cDNA, followed by two PCR cycles using the Ovation RNA amplification system V2 
(Ovation). Quality control on both RNA and ss-cDNA was performed using 2100 Agilent 
Bioanalyzer (Quantum Analytics). The cDNA was labeled using the FL-Ovation™ 
cDNA Biotin Module V2 (Ovation), hybridized to GeneChip Drosophila Genome 2.0 
Arrays (Affymetrix) and scanned with an Axon Instruments 4000B Scanner using 
GenePix Pro 6.0 image acquisition software (Molecular Devices). 
Five biological replicates of each set of cells, and each genotype of flies were used. 
Affymetrix .cel (probe intensity) files were exported from GeneChip Operating Software 
(Affymetrix). The .cel files were imported to ArrayAssist Lite (Agilent) in which 
GCRMA probeset expression levels and Affymetrix absent/present/marginal flags were 
calculated. Statistical analysis for those genes passing the flag filter was performed using 
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Partek Genomics Suite v6.6 (Partek). The signal values were log2 transformed and a 2-
way ANOVA was performed. DataGraph 2.3.2 was used to generate the scatterplot 
(http://www.visualdatatools.com/DataGraph/). 
 
Real-time RT-PCR Analysis 
Total RNA was prepared from DL-1 cells treated with dsRNAs (Renilla control or Nbr), 
and flies, control, nbr-/-, loqsf00791. cDNA was synthesized by High-Capacity cDNA 
Reverse Transcription kit (Applied Biosystems). The realtime-PCR reaction was 
performed by Power SYBR Green PCR Master Mix (Applied Biosystems) in 7500 Fast 
Realtime PCR System (Applied Biosystems). Each target gene was normalized to 
endogenous control (Rp49), followed by calculation of relative fold change compared to 
control. 500 Fast System SDS Software (Applied Biosystems) 
 Table 2.1. dsRNA Amplicons Used in This Study
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 Table 2.2. miRNA Reads from Deep Sequencing Data, Related to Figure 
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 Table 2.3. Sequence Counts of miRNAs from Ends of the Ratio Plot in Control (WT) 
and Nbr Mutants, Related to Figure 
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 Table 2.4. Summary of Results on miRNAs from the Two Ends of the Length Ratio 
Plot, Related to Figure 2
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.4.
  Table 2.5. Genes Identified by Microarray that Changed in Cells upon Nbr 
Knockdown, related to Figure 
List of all of the genes with a change of 1.5
20% false discovery rate or less (see Figure 2.4G).  One probe (1629669_x_at) does 
not correspond to a unique gene and was not pursued.
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Figure 2.1. Drosophila miR-34 Shows Multiple Isoforms Whose Generation Appears 
Dependent on 3' End Trimming. 
(A) miR-34 has multiple forms in adult flies. Left is the miR-34 precursor, with the 
mature 24 nucleotide (nt) sequence in red, and right is a northern blot for miR-34. 
Isoforms of 24, 22, and 21 nt are labeled a, b, and c, respectively. (B) miR-34 isoforms 
from a deep sequencing Drosophila S2 cell data set (Zhou et al. 2009). In red is the 24 nt 
isoform a, and in blue are isoforms b and c. These reads are 99.1% of the total miR-
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34 reads. (C) Northern blot analysis of miR-34 isoform accumulation in vivo. Transient 
induction of pri-miR-34 by hs-GAL4 in adult flies leads to initial accumulation of isoform 
a, which is lost over time while the shorter isoforms accumulate. Arrowhead notes pre-
miR-34. (D) Quantification of miR-34 isoforms from pulse-chase in (C). Values 
normalized to 2S ribosomal RNA. 
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Figure 2.2. nbr Is Required to Generate the Isoforms of miR-34. 
(A) Depletion of known factors in the small RNA biogenesis pathways has no effect 
on miR-34. (B) Depletion of candidate exoribonucleases shows that loss of CG9247/Nbr 
(red) leads to an accumulation of the 24 nt isoform, with dramatic reduction of the shorter 
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isoforms. (C) Cells depleted of Nbr are not altered in single isoform microRNAs 
(miRNAs) or endogenous small interfering RNA (siRNA) esi-2.1. 
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Figure 2.3. Nbr Interacts with Ago1-RNA-Induced Silencing Complex. 
(A) Small RNA northern blot analysis of mir-34 isoforms. Depletion of Ago1 
phenocopies Nbr knockdown. (B) Ago1 and Nbr interact by coimmunoprecipitation 
(coIP). Cells were untreated or transfected with hemagglutinin (HA)-Nbr and Flag-Ago1 
or Flag-Ran (control). Following immunoprecipitation (IP), interacting proteins were 
probed by immunoblot. Input is 10% of Flag-IP. (C) All miR-34 isoforms 
coimmunoprecipitated with Ago1. Cells were treated with double-stranded (dsRNA) to 
control (LacZ), Nbr, or Ago1, and IPs were performed with anti-GFP (control) or Ago1 
antibodies. Input and coimmunoprecipitated RNA were analyzed by northern blotting 
for miR-34. 
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Figure 2.4. nbr Is Required In Vivo to Process Select miRNAs and Silence Target 
Messenger RNAs. 
(A) Genomic map of the nbr locus. Coding region is shown in red, with transposon 
insertion highlighted. (B) Northern blot for nbr. The nbrf02257 mutant shows complete 
messenger RNA (mRNA) loss. (C) Shorter isoforms of miR-34 are abolished in 
the nbrmutant. Arrowhead notes isoform a. (D) Northern blot of single-isoform miR-277, 
which is not altered in nbr−/−. (E) Comparison of multiple-isoform miRNAs from control 
and nbrf02257 flies. Some miRNA isoforms require nbr (red arrowheads), whereas others 
are nbr independent. (F) The ratio of the most frequent form of the miRNA in wild-type, 
compared to the sum of all other forms, was generated for nbr and control. The ratios 
were compared (nbr ratio/control ratio) and plotted. The ratio was excessively high or 
low when isoform biogenesis is defective. Red boxes highlight miRNAs with extreme 
ratios that were further analyzed. Red symbols are confirmed Nbr targets (Table 2.4). (G) 
Scatterplot of microarray data from cells treated with dsRNA against Nbr or Renilla 
control. Highlighted are all of the genes >1.5 fold changed in either direction. (H) Real-
time PCR for mRNAs from nbr and loqs mutant flies (Mean ± standard error of the 
mean, 4–6 experiments; *p < 0.05, **p < 0.01, ***p < 0.001). 
 Figure 2.5. Reduction of 
to Figure 2.2. 
(A) mRNA Northern shows that treating cells with t
different regions of the nbr gene depleted nbr mRNA levels. Loading control, 18S rRNA.
(B) Upon reduction of nbr, biogenesis of miR
control, 2S rRNA. 
(C) Loss of nbr has minimal ef
of miR-34* in wild type versus 
(D) Neighbor joining homology tree showing the relatedness of the 3'
exoribonuclease domains of Nbr and other exoribonucleases, rooted to the 
D exonuclease domain. 
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nbr Affects Biogenesis of miR-34 Shorter Isoforms, Related 
wo independent dsRNAs directed to 
-34 shorter isoforms was affected. Loading 
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nbrf00257 mutant flies. 
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 Figure 2.6.   The Interaction between Nbr and Ago1 Is Not Dependent on RNA, 
Related to Figure 2.3.  
Ago1 and Nbr interact by co
Cells were either left untreated or were transfected with HA
Flag-Ran (control), in the presence or absence of added RNase. Flag
then immunoprecipitated, and interacting
Protein input is 10% of Flag
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-immunoprecipitation in a manner that is RNA
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 proteins were probed by Western immunoblot. 
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-independent. 
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Figure 2.7.  New nbr-Dependent Candidate miRNAs, Related to Figure 2.4. 
(A and B) Distribution of (A) overall reads and (B) reads mapping to the miRNA 
stemloops in control and 
lengths between control and mutant. 
(C and D) The left panels are the distribution plots of
from which the ratio plot in Fig
75
nbrf02257 mutants. These show no overall difference in read 
 
 read lengths for these miRNAs, 
ure 2.4F was generated. The right panels are small RNA 
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Northerns from adult flies of control and nbr-/-mutants. In C are candidate miRNAs from 
the low ratio end of the plot in Figure 2.4F where the most abundant isoform in wild type 
is trimmed. The mutant shift in the distribution is observed by Northern blot analysis. In 
D, are two miRNAs are from the high ratio side of the plot in Figure 2.4F. For these 
miRNAs, only one major isoform is detectable by Northern in controls, but the level of 
this isoform becomes more abundant in nbr-/- (a 2.6-fold increase for miR-190, a 1.8-fold 
increase for miR-10). Deep sequencing analysis confirmed an impact on isoform 
distribution in the nbr-/- mutant (Table 2.3). 
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Additional data  
Luciferase reporter assays in DL1 cells with nbr RNAi. 
The identification of potential targets of Nbr in DL1 cells (Figure 2.4G) raised the 
question of whether Nbr regulates these genes through an effect on miRNA target 
silencing. Given that miRNAs tend to target 3’UTRs of mRNAs, we cloned the 3’UTRs 
from mRpS25, Fas3, CG3328, CG30359, and GluRIIA, as well as E74A (a confirmed 
miR-34 target (see (Liu et al. 2012)) downstream of the Renilla luciferase gene. nub has a 
potential miR-34 target site in the 5’UTR with high complementarity at the 3' end of 
miR-34. Therefore we cloned the 5’UTR of nub upstream of Renilla luciferase gene. The 
reporter assays revealed that, even though E74A reporter was upregulated upon ago1 
knockdown, it was not affected by nbr knockdown (Figure 2.8B). In addition, nbr 
knockdown did not affect the level of any of the other Renilla luciferase reporters (Figure 
2.8D to I). This indicates that, even though Nbr affects the trimming pattern of a subset of 
miRNAs, the loss of trimming does not have a dramatic impact on the target silencing of 
the affected miRNAs.  
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Figure 2.8. Luciferase assays in DL1 cells for E74A (confirmed miR-34 target) and 
the genes identified by DL1 microarray (Figure 2.4).  
(A)~(C) are the averages of triplicates. (D)~(I) are the averages of duplicates. 
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Method: Luciferase assays in DL1 cells 
8×104 DL1 cells were plated and bathed in 30 µl of serum-free medium with 60 ng of 
dsRNA in each well of a 96-well plate. The next day, the following amount of plasmids 
were transfected by Effectene (Qiagen): 
(A) 1.6ng of pMT-Firefly, 400ng of pMT-miR-34, and 400ng of pMT-Renilla. 
(B) 1.6ng of pMT-Firefly, 400ng of pMT-miR-34, and 400ng of pMT-Renilla-E74A-
3'UTR. 
(C) 1.6ng of pMT-Firefly, 400ng of pMT-miR-277, and 400ng of pMT-Renilla-miR-277-
4xbulged targets. 
(D) 1.6ng of pMT-Firefly and 800ng of pMT-Renilla-mRpS25-3'UTR. 
(E) 1.6ng of pMT-Firefly and 800ng of pMT-Renilla-Fas3 3'UTR. 
(F) 1.6ng of pMT-Firefly and 800ng of pMT-Renilla-CG3328-3'UTR. 
(G) 1.6ng of pMT-Firefly and 800ng of pMT-Renilla-CG30359 3'UTR. 
(H) 1.6ng of pMT-Firefly and 800ng of pMT-Renilla-GluRIIA 3'UTR. 
(I) 1.6ng of pMT-Firefly and 800ng of pMT-Renilla-nub 5'UTR. 
 Two days after transfection, the expression of the reporters and miR-34 was induced by 
CuSO4. Twenty-four hours after induction, luminescence assays were performed by the 
Dual-Glo Luciferase Assay System (#E2920, Promega, Fitchburg, WI).  
 
  
 80
Cloning 3'UTRs and 5'UTR into pMT-Renilla vector 
mRpS25 
Two DNA oligonucleotides with BamHI site at the 5' end and SalI site at the 3' end were 
annealed, digested with BamHI and SalI, and inserted to BamHI and SalI sites of pMT-
Renilla vector. 
 5'-GATCCACGTTCGCTCTGATTGTACCTTTTTTTTTAATAAATT 
AATTGTAAATTG-3' 
5'-TCGACAATTTACAATTAATTTATTAAAAAAAAAGGTACAAT 
CAGAGCGAACGTG-3' 
 
Fas3 
The following primers were used to amplify the 3'UTR of Fas3 (FBtr0112804, one of the 
several isoforms of Fas3) with BamHI site at the 5' end and SalI site at the 3' end, from 
5905 cDNA. The insert was digested with BamHI and SalI, and cloned into BamHI and 
SalI sites of pMT-Renilla vector. 
5'-AGCTggatccGCCGTTTAGGCCATTTAGGC-3' 
5'-AGCTgtcgacCATGTTTTCGTTTATTTGTTTCGTC-3' 
 
CG3328 
BamHI site (5' end) and SalI site (3' end) were added to the 5' and 3' end primers, and the 
following 3'UTR was amplified from 5905 cDNA. The insert was digested with BamHI 
and SalI, and cloned into BamHI and SalI sites of pMT-Renilla vector. 
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5'- GATCCTATTCAGCTTAATTTATGGCACGGACCGAATCTGAACTCTAAAA 
CCATGTGCGTGTGCAGCACGTTTCGGTGTTGCGGATGTGTCCTGGCACCTGGC
GCGGAAAAATCGTTTGAATTAGGAAAATTCAAAAATTAAATAATCAAAAACT
GTTGATCAGCGAGAGGAAGTTGAAAATGCATACATTTATACGTATACACAAC
AAATCATCAATAAATGCAAAAAAAAAAAAAG-3' 
 
CG30359 
BamHI site (5' end) and SalI site (3' end) were added to the 5' and 3' end primers, and the 
following 3'UTR was amplified from 5905 cDNA. The insert was digested with BamHI 
and SalI, and cloned into BamHI and SalI sites of pMT-Renilla vector. 
5'-GATCCGTTCCCACCATATGCTAGTTAATAATAAAATACTCACAATAAAGTC 
ATTCAAAGCACTCGG-3' 
 
GluRIIA 
BamHI site (5' end) and SalI site (3' end) were added to the 5' and 3' end primers, and the 
following 3'UTR was amplified from 5905 cDNA. The insert was digested with BamHI 
and SalI, and cloned into BamHI and SalI sites of pMT-Renilla vector. 
5'-GATCCGTGGTCGGAATATTGGACGATTGGCGTCTTCTACTTTGGCATTT 
CATTAGAGAGTCGCATTGGAAATGAGGCACTCCATGGTGTCCACATTGTATA
TTGTGAGCTATATTTGTAGAATTATTTTAGAACACAGATAGCGCATTTGGGTA
TATTGAATGTTCTGAAGATTTAACGAAACTTTCAATGAAATAATTTGGATAAC
TAATTTTAGTAAACTTTTCTGTTGGCTCTAATGTTTTAATAGTTGACAATAATT
GATTTTCCTTACAAAGATTTAATAAATAAACATTAAAATATG-3' 
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nub 
5'UTR of nub (FBtr0112642), which contains a potential miR-34 target site, was 
amplified with the following steps. First, the first part (182bp) and the second part 
(373bp) of the nub 5'UTR were amplified separately from 5905 genomic DNA using the 
primers (5'-AGTCGACGCGCAAAAGTGG-3' and 5'-
CTCAATTGTTGAGTTTTTCAG-3') and (5'-ACCAGCCTTCGTCCACTT-3' and 5'-
TTTCACAACTCAATGGTGCA-3'), respectively. Next, the first amplicon was extended 
at the 3' end by PCR using the primers (5'-AGTCGACGCGCAAAAGTGG-3' and 5'-
AAGTGGACGAAGGCTGGTCTCAATTGTTGAGTTTTTCAG-3'), and the second 
amplicon was extended at the 5' end by PCR using the primers (5'-
AAACTCAACAATTG 
AGACCAGCCTTCGTCCACTT-3' and 5'-TTTCACAACTCAATGGTGCA-3'). These 
two fragments contain overlapping region with each other. Then two extended PCR 
products were mixed, and the whole sequence of nub 5'UTR was amplified using the 
primers (5'-AGTCGACGCGCAAAAGTGG-3' and 5'-TTTCACAACTCAATGGTGCA-
3'). Finally, EcoRI sites were added to the full sequence of nub 5'UTR using the primers 
(5'-GAATTCAGTCGACGCGCAAAAGTGG-3' and 5'-GAATTCTTTCACAACTCAA 
TGGTGCA-3'). The PCR product was digested with EcoRI, and inserted into the EcoRI 
site upstream of the Renilla luciferase gene in pMT-Renilla vector. 
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CHAPTER 3 
THE EXONUCLEASE NIBBLER REGULATES  
AGE-ASSOCIATED TRAITS,  
AS WELL AS PIRNA AND ENDO-SIRNA LENGTH 
 IN DROSOPHILA 
 
 
 
This chapter forms the basis of a manuscript, to be submitted. Additional authors include 
Gert-jan Hendriks, Dr. Mugdha Khaladkar1, and Dr. Junhyong Kim1.  
 
1Department of Biology, Penn Genome Frontiers Institute, University of Pennsylvania 
 
Note 
• Gert-jan Hendriks, a visiting student of the Bonini lab, contributed to Nbr western 
blots (Fig. 3.1. A,B). 
• Dr. Mugdha Khaladkar, of the laboratory of Dr. Junhyong Kim, contributed to the 
bioinformatic data analysis of the ovary small RNA deep-sequencing (Fig. 3.6 to 
Fig. 3.13.).  
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Abstract 
Nibbler (Nbr) is a 3'-to-5' exonuclease that trims the 3' end of microRNAs (miRNAs) to 
generate different length patterns of miRNAs in Drosophila. Despite its effect on 
miRNAs, we lack knowledge of its biological significance and whether Nbr affects other 
classes of small RNAs such as piRNAs and endo-siRNAs. Here, we characterized the in 
vivo function of nbr by defining the Nbr protein expression pattern and loss-of-function 
effects. Nbr protein is enriched in the ovary and heads. Analysis of nbr null animals 
reveals adult-stage defects, including held-up wings, decreased locomotion, and 
accelerated brain degeneration, indicative of accelerated age-associated processes upon 
nbr loss. Importantly, these effects depend on catalytic residues in the Nbr exonuclease 
domain, indicating that the catalytic activity is responsible for these effects. Lastly, we 
analyzed the effect of nbr on piRNA and endo-siRNA lengths. As with miRNAs, nbr 
mutation lead to longer length piRNAs and endo-siRNAs; an effect which was also 
dependent on the catalytic residues of the exonuclease domain. Together, these analyses 
reveal the role of nbr on age-associated processes, as well as the length of multiple 
classes of small RNAs including miRNAs, endo-siRNAs, and piRNAs in Drosophila.  
 
Introduction 
microRNAs (miRNAs) are 20~24nt small RNAs that regulate diverse biological 
processes, such as development and age-associated diseases (Esquela-Kerscher and Slack 
2006; Kosik 2006; Krichevsky et al. 2006; Ambros 2011). Since the discovery of the first 
miRNA lin-4 (Lee et al. 1993; Wightman et al. 1993) and the second miRNA let-7 
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(Reinhart et al. 2000) as developmental timing genes, hundreds of miRNAs have been 
identified across species. The canonical biogenesis pathway of animal miRNAs starts 
with the transcription of the primary miRNA (pri-miRNA) from the miRNA-coding 
genes by RNA polymerase II in the nucleus (Bracht et al. 2004; Cai et al. 2004; Lee et al. 
2004a). Pri-miRNAs are then cleaved by two distinct RNase III/RNA-binding protein 
complexes. Drosha/Pasha (Drosha/DGCR8 in mammals) cleaves pri-miRNAs to generate 
precursor-miRNAs (pre-miRNAs) in the nucleus (Bracht et al. 2004; Cai et al. 2004; Lee 
et al. 2004a). After the export of pre-miRNAs to the cytoplasm by Exportin-5 (Yi et al. 
2003; Bohnsack et al. 2004; Lund et al. 2004), Dcr-1/Loqs-PB (Dcr/TRBP in mammals) 
cleaves the pre-miRNAs to generate miRNA/miRNA* duplexes (Bernstein et al. 2001; 
Chendrimada et al. 2005; Forstemann et al. 2005; Jiang et al. 2005; Saito et al. 2005; 
Miyoshi et al. 2010a). One of the strands of the miRNA duplex is preferentially retained 
in miRISC containing Ago1 (Ago2 in mammals), which targets mRNAs through the 
partial complementarity between the seed sequence (2~8th nucleotide at the 5' end of 
miRNA) and the mRNAs to induce translational repression and mRNA decay (Brennecke 
et al. 2005; Bartel 2009; Fabian and Sonenberg 2012).  
 
Initial efforts to identify novel miRNAs relied on computational prediction of miRNA 
genes followed by northern blots (Lai et al. 2003). However, recent developments in 
high-throughput sequencing techniques enabled discovery of small RNA species across 
different biological contexts (Ruby et al. 2006; Landgraf et al. 2007; Ruby et al. 2007; 
Wu et al. 2007; Kuchenbauer et al. 2008; Morin et al. 2008; Sdassi et al. 2009; Burroughs 
et al. 2010; Marti et al. 2010; Reese et al. 2010; Wyman et al. 2011; Westholm et al. 
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2012). The general conclusion from these profiling studies is that miRNAs are 
heterogenous at the 5' end, 3' end, and even in internal sequence (Neilsen et al. 2012).  In 
addition, the 3' end of miRNAs is relatively more variable compared to the 5' end of 
miRNAs (Neilsen et al. 2012). There are a few known mechanisms by which such 
heterogeneity is generated. For example, Drosha and Dicer cleavages define the 5' end 
and 3' end of miRNAs (Bernstein et al. 2001; Bracht et al. 2004; Cai et al. 2004; Lee et al. 
2004a; Chendrimada et al. 2005; Forstemann et al. 2005; Jiang et al. 2005; Saito et al. 
2005; Miyoshi et al. 2010a). However, the cleavages could be imprecise such that they 
generate 5' end and 3' end variations (Calabrese et al. 2007; Azuma-Mukai et al. 2008; 
Wyman et al. 2011). In line with this, recent reports show that the cleavage position by 
Dicer is controlled by its partner protein (Loqs-PB in Drosophila and TRBP in mammals) 
to generate miRNAs isoforms that are overlapping, but with distinct seed sequences due 
to a differential 5' end (Fukunaga et al. 2012; Lee and Doudna 2012). Importantly, the 
distinct seed sequences affect target specificity and guide strand selection, highlighting 
the importance of controlling 5' end heterogeneity of miRNAs in animals (Fukunaga et al. 
2012; Lee and Doudna 2012).  
 
In addition to Drosha and Dicer cleavages, the 3' end heterogeneity of miRNAs is subject 
to nucleotide addition. For example, PAPD4/GLD-2, a ribonucleotidyltransferase, 
adenylates the 3' end of human and mouse miR-122 (Katoh et al. 2009). This increases 
stability of miR-122, and the loss of PAPD4/GLD-2 (no adenylation of miR-122) leads to 
the upregulation of miR-122 mRNA targets (Katoh et al. 2009). By contrast, the 3' end 
adenylation of miR-26a and miR-27a leads to increased mRNA target expression 
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(Burroughs et al. 2010).  Together, these data indicate that, depending on the miRNAs, 3' 
end adenylation can negatively or positively affect target mRNA expression.  
 
Uridylation is another type of nucleotide addition that impacts stability or target silencing 
of miRNAs. In Arabidopsis, the 3' ends of miRNAs are 2’-O-methylated by a 
methyltransferase, Hen1 (Yu et al. 2005). Lack of 2’-O-methylation of miRNA 3' ends 
leads to HESO1-mediated uridylation and degradation of the miRNAs (Li et al. 2005; 
Ren et al. 2012; Zhao et al. 2012b), suggesting that uridylation affects the stability of 
miRNAs in plants. In mammals, Zcchc11 (PAPD3/TUT4) uridylates the 3' end of mature 
miRNAs (Jones et al. 2009; Jones et al. 2012). The uridylation of miR-126-5p and miR-
379 by Zcchc11 causes decreased silencing efficiency of a 3’UTR reporter of IGF-1, a 
potential target of these miRNAs (Jones et al. 2012). This indicates that uridylation of 
miRNAs in animals causes less efficient target silencing. In sum, despite the 
accumulating evidence of miRNA heterogeneity and the identification of the enzymes to 
generate such heterogeneity, we still lack clear knowledge of the biological impact of 
such heterogeneity at the organismal level.  
 
Previous study of Drosophila miR-34-5p show that miR-34-5p displays a pattern of 
different length isoforms due to 3' end heterogeneity, and that levels increase with age: 
however, the increase reflects accumulation of only the short isoforms and not the long 
isoform with age (Liu et al. 2012). Pursuing this pattern, RNAi screening identified a 
factor that generates the pattern of isoforms of miR-34-5p in Drosophila (Chapter 2, Liu 
et al., 2011). The screening defined a 3’-to-5’ exonuclease, Nibbler (Nbr), which is 
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responsible for the pattern of miR-34-5p: upon knockdown of the nbr gene, the long 
isoform of miR-34-5p accumulates, while the short isoforms decrease (Han et al. 2011; 
Liu et al. 2011). Even though a subset of Drosophila miRNAs are subject to the length 
pattern control by Nbr, the in vivo significance of nbr has remained unclear. In addition, 
it is unclear whether Nbr impacts the length of other classes of small RNAs such as 
piRNAs and endo-siRNAs. Here, we characterize loss of function effects of the nbr gene, 
as well as assess the effects of nbr on piRNAs and endo-siRNAs. These analyses reveal 
that nbr loss results in accelerated age-associated defects, as well as longer piRNAs and 
endo-siRNAs. Importantly, these effects depend on the catalytic residues of the Nbr 
exonuclease domain, suggesting that the processing of RNA substrates by Nbr is critical 
for these effects. Together, this study reveals new insight into the importance of 
controlling length heterogeneity of small RNAs to age-associated processes in animals. 
 
Results 
Expression pattern of Nbr in vivo 
Nibbler (Nbr) is a 3'-to-5' exonuclease identified as a factor that trims the 3' end of miR-
34-5p in Drosophila (Han et al. 2011; Liu et al. 2011). Upon nbr loss, a subset of 
Drosophila miRNAs show accumulation of long isoforms (Han et al. 2011; Liu et al. 
2011). However the biological significance of nbr has not been well defined. Therefore, 
to understand the in vivo role of nbr in more detail, we first assessed the expression 
pattern of the Nbr protein. We developed a rabbit polyclonal antibody against the N-
terminus of Nbr (see methods). By western immunoblot, Nbr was enriched in ovary, then 
heads, followed by the body (Figure 3.1A). Temporally, Nbr showed little change in level 
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with age in the adult head (Figure 3.1B). This was intriguing, given that the age-
associated increase of the lower isoforms of miR-34-5p suggest a change in Nbr 
trimming activity with age (Liu et al. 2012). In addition, nuclear/cytoplasmic 
fractionations revealed that Nbr was enriched in the cytoplasm (Figure 3.1C), consistent 
with its role in a complex with Ago1 to process the 3' end of miRNAs (Liu et al. 2011). 
To understand the spatial expression pattern of Nbr, we made a transgene of the genomic 
region of nbr, with ~650bp upstream and ~150bp downstream of the nbr open reading 
frame, with 1xHA tag inserted at the C terminus. Immunohistochemistry of the ovary 
with anti-HA antibody revealed that Nbr is expressed from germarium to later stages of 
egg chamber development (Figure 3.1D). Consistent with biochemical 
nuclear/cytoplasmic fractionations, Nbr was enriched in the cytoplasm of nurse cells, 
follicle cells as well as the cells of the germarium at lower level (Figure 3.1D). Nbr 
expression remained in nurse cells until stage 11, after the nurse cells have dumped their 
contents into the ooctye (Figure 3.1E). In the oocyte and mature eggs, Nbr expression 
was low (Figure 3.1E,F). Together, these results suggest a potential importance of nbr in 
ovary as well as in adult tissues. 
 
Generation of nbr loss-of-function mutants 
Previously, we observed lethality and sterility of the nbrf02257 allele, harboring a Piggybac 
insertion in the first exon of nbr ((Liu et al. 2011), Figure 3.2A). To examine if the 
lethality and sterility of nbrf02257 allele are indeed caused by the loss-of-function of nbr, 
we crossed nbrf02257 allele with a nbr deficiency line (Df (2L) BSC312) that deletes a ~60 
kb region including the nbr gene (Figure 3.2B). Surprisingly, we found that 
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nbrf02257/Df(2L)BSC312 heterozygotes (hereafter referred to as nbr null) were viable and 
fertile, indicating that these two effects are independent of nbr function. miR-34-5p 
trimming was compromised in nbr null (Figure 3.2C), and the Nbr protein level and miR-
34-5p trimming pattern were fully rescued by introducing the genomic nbr transgene 
(Figure 3.2C). Importantly, rescue of miRNA trimming activity was dependent on the 
catalytic residues of the Nbr exonuclease domain, since mutating the catalytic residues 
(D435A,E437A) within the genomic transgene failed to rescue miR-34-5p trimming 
(Figure 3.2C).  
 
Nbr mutants show accelerated age-associated effects 
Using the nbr null chromosomal combination (nbrf02257/Df(2L)BSC312), we assessed the 
effect of the loss of nbr function in the animal. Although Nbr was highly expressed in 
ovaries, we saw no effect on ovary development in nbr null animals (Figure 3.3); we 
were able to obtain viable eggs from nbr null females. We then examined the adult 
animal. Intriguingly, nbr null aminals showed an age-associated held-up wing phenotype 
(Figure 3.4). At the time of emergence of the adult (eclosion), nbr null animals showed 
normal wing posture (Figure 3.4E). However, by 20d, > 90% of nbr mutants showed 
held-up wings (Figure 3.4E). This effect was fully rescued by wild-type, but not the 
catalytically-mutated (D435A,E437A) (hereafter referred to as "cat-dead nbr") nbr 
genomic transgenes, indicating that the exonuclease activity of Nbr was required for 
normal wing posture.  Examination of nbr null animals for other effects revealed 
additional age-associated deleterious effects, including brain degeneration, and loss of 
climbing ability. Nbr mutants showed no brain vacuolization in young animals (3d), but a 
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high level of brain vacuolization by 30d (Figure 3.5A,B). This effect was rescued by 
expression of normal nbr transgene, but not by the cat-dead genomic transgene. In 
addition, nbr mutants show dramatic loss of climbing ability: while wild-type animals 
show little change in the climbing ability even at 30d (> 90% of wild-type flies 
successfully climbed at 30d), nbr null animals showed a dramatic decline already by 20d 
(~50% of flies failed to climb at 20d) (Figure 3.5C). This effect was also fully rescued by 
wild-type, but not cat-dead, nbr transgene (Figure 3.5C). Together, these results suggest 
that nbr loss is associated with advancement of several age-associated effects in 
Drosophila.  
 
Nbr affects the length of piRNAs and endo-siRNAs 
Nbr has been shown to impact the length of a subset of miRNAs in Drosophila (Han et al. 
2011; Liu et al. 2011). However, it is unknown if other classes of small RNAs, such as 
Piwi-interacting RNAs (piRNAs) (Aravin et al. 2007; Brennecke et al. 2007; Guzzardo et 
al. 2013) and endogenous siRNAs (endo-siRNAs) (Czech et al. 2008; Ghildiyal et al. 
2008; Kawamura et al. 2008; Okamura et al. 2008) are also affected by nbr. piRNAs are 
~24-30nt small RNAs that are bound to Piwi-clade proteins of the Argonaute family 
(Brennecke et al. 2007; Malone et al. 2009; Guzzardo et al. 2013), and are derived from 
heterochromatin, 3'UTRs of protein-coding genes, and euchromatic transposable 
elements (Brennecke et al. 2007; Robine et al. 2009; Saito et al. 2009). Endo-siRNAs are 
~21nt small RNAs identified in Drosophila (Czech et al. 2008; Ghildiyal et al. 2008; 
Kawamura et al. 2008; Okamura et al. 2008), C. elegans (Ruby et al. 2006; Pak and Fire 
2007; Sijen et al. 2007), and mammals (Tam et al. 2008; Watanabe et al. 2008). In 
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Drosophila, endo-siRNAs are bound to Ago2, a siRISC component (Czech et al. 2008; 
Ghildiyal et al. 2008; Kawamura et al. 2008; Okamura et al. 2008). Like piRNAs, endo-
siRNAs are also derived from transposable elements, as well as other overlapping and 
hairpin RNA sources (Czech et al. 2008; Ghildiyal et al. 2008; Kawamura et al. 2008; 
Okamura et al. 2008). Both piRNAs and endo-siRNAs are suggested to silence 
transposable elements (Aravin et al. 2007; Brennecke et al. 2007; Czech et al. 2008; 
Ghildiyal et al. 2008; Kawamura et al. 2008; Okamura et al. 2008; Guzzardo et al. 2013), 
indicating the importance of these two classes of small RNAs to maintain genome 
integrity in the animal. Given the high expression level of Nbr in the ovary, we examined 
the effect of nbr on piRNAs and endo-siRNAs in ovary libraries. We deep sequenced and 
analyzed small RNA libraries from ovaries of wild-type, nbr def/+ (Df(2L)BSC312/+), 
nbr null, nbr null with pCaSper-nbr (WT) (referred to as “rescue (WT nbr)”), and nbr 
null with pCaSper-nbr (D435A,E437A) (referred to as “rescue (cat-dead nbr)”). Because 
none of these genotypes had defects in ovary development (see Figure 3.3 and data not 
shown), none of the effects we observed on the length of endo-siRNAs and piRNAs were 
caused by the loss of specific tissue or cell types in the ovaries. We first confirmed the 
effects of Nbr on miRNAs, such as miR-34-5p, miR-305-5p, and miR-263a-5p (Han et al. 
2011; Liu et al. 2011), in these ovary libraries. As expected, these three miRNAs showed 
a higher portion of longer isoforms in the nbr null, which was rescued by wild-type, but 
not by the cat-dead nbr transgene (Figure 3.6). We then mapped non-miRNA reads onto 
identified piRNA (Brennecke et al. 2007) and endo-siRNA (Czech et al. 2008) loci. The 
total length distribution of piRNAs and endo-siRNAs revealed that the ratio of longer 
piRNAs (> 26nt) and endo-siRNAs (22nt) increased in nbr null animals, while the ratio 
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of the shorter piRNAs (~24nt) and endo-siRNAs (21nt) decreased (Figure 3.7 and 3.8). 
This pattern was similar between nbr null and rescue (cat-dead nbr), suggesting that the 
Nbr catalytic activity regulates the length of these two classes of small RNAs.  
     
   We next examined individual piRNA loci. Among the 142 piRNA clusters (Brennecke 
et al. 2007), 138 loci were expressed in all of our genotypes. Among them, 106 loci were 
similarly affected by nbr loss: longer piRNAs (> 26nt) accumulated, while short piRNAs 
(~24nt) decreased (Figure 3.7 and 3.9). This trend was rescued by wild-type, but not by 
the cat-dead nbr transgene (Figure 3.7 and 3.9). Among the rest of the loci, four loci were 
affected in unique ways: piRNA cluster #10, #14, and #82 showed low raw read number 
compared to the other genotypes, while piRNA cluster #11 showed extremely low read 
numbers only in rescue (cat-dead nbr), but not in any of the other genotypes (Figure 3.10). 
Together, these 110 piRNA loci accounted for ~90% of piRNAs in the libraries (92.5% in 
wild-type, 88.7% in nbr def/+, 88.1% in nbr null, 90.3% in rescue (WT nbr), and 90.1% 
in rescue (cat-dead nbr)). This suggests that most of the piRNAs generated in Drosophila 
ovaries are subject to regulation in length by Nbr.  
 
    We next examined individual endo-siRNA loci. Among the 49 endo-siRNA loci 
identified in Drosophila ovaries (Czech et al. 2008), only 4 loci were affected by nbr 
mutation: an increase of 22nt, and decrease of 21nt of endo-siRNAs upon nbr loss 
(Figure 3.12). Importantly, this trend for all four loci was rescued by wild-type, but not 
by the cat-dead nbr transgene. These four loci accounted for more than 60% of the endo-
siRNAs generated from each genotype (60.6% in wild-type, 66.6% in nbr def/+, 74.6% 
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in nbr null, 60.2% in rescue (WT nbr), and 74.3% in rescue (cat-dead nbr)). This 
suggests that more than a half of endo-siRNAs generated in Drosophila ovaries are 
subject to the regulation in length by Nbr.   
 
Discussion    
Ours and others' previous studies raise a model on how Nbr impacts the length of 
miRNAs (Han et al. 2011; Liu et al. 2011). In this model, Nbr makes a complex with 
Ago1 (miRISC) to trim the 3' end of miRNAs. Our current findings indicate that Nbr also 
impacts the length of select piRNAs and endo-siRNAs.  How could Nbr affect the length 
of piRNAs and endo-siRNAs? The current model suggests that the primary biogenesis of 
piRNAs starts with the transcription of the piRNA clusters (Guzzardo et al. 2013). The 5' 
end of piRNAs is thought to be defined by an endonuclease Zucchini (Zuc) (Ipsaro et al. 
2012; Nishimasu et al. 2012). Following the loading of the piRNA intermediates into 
Piwi proteins, a Mg2+ -dependent 3' trimming acitivity is required to generate mature 
lengths of piRNAs in Silkworm in vitro assay (Kawaoka et al. 2011). Based on this 
model, one possibility is that Nbr, a predicted Mg2+ -dependent 3'-to-5' exonuclease (Han 
et al. 2011), might trim the end of piRNA intermediates to generate different length 
piRNAs. In considering this model, it is of note that both piRNAs and endo-siRNAs are 
protected at the 3' end by 2'-O-methylation (Horwich et al. 2007; Kirino and Mourelatos 
2007a; Kirino and Mourelatos 2007b; Kirino and Mourelatos 2007c; Czech et al. 2008; 
Kawamura et al. 2008; Okamura et al. 2008), in contrast to miRNAs which are mostly 
unmodified at the 3' end (Hutvagner et al. 2001; Okamura et al. 2004; Vagin et al. 2006). 
Given that 2'-O-methylation of small RNAs at the 3' end is protective from the 
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destabilization of potential 3' end trimming (Horwich et al. 2007; Ameres et al. 2010; 
Kamminga et al. 2010), Nbr likely trims the 3' end of piRNAs and endo-siRNAs prior to 
the protection by 2'-O-methylation at the 3' end.  
 
Alternatively, nbr might affect the length of piRNAs in a more indirect manner. It is 
intriguing that the three Drosophila Piwi-clade proteins, Piwi, Aub, and Ago3, are loaded 
with slightly different length piRNAs: Piwi is bound by the longest piRNAs, followed by 
Aub  and Ago3 (Brennecke et al. 2007). Given this observation, the change in the length 
of piRNAs upon nbr loss might reflect a change in the loading pattern of piRNAs among 
these different Piwi-clade proteins. Further studies are required to reveal in greater 
mechanistic detail how nbr impacts the length of piRNAs in vivo.  
 
Despite the effect of nbr on the length of piRNAs, nbr loss did not lead to an obvious 
developmental defect in the ovary, in contrast with other mutations affecting piRNA 
biogenesis (Lin and Spradling 1997; Cox et al. 1998; Harris and Macdonald 2001). This 
indicates Nbr has a more subtle impact that affects the essential function of piRNAs to 
silence transposons during ovary development. The more fine-tuned role of nbr could be 
the reason why the recent screenings for components of the primary piRNA biogenesis 
pathway did not identify nbr as a candidate (Czech et al. 2013; Handler et al. 2013; 
Muerdter et al. 2013).  
 
In this study, we have characterized biological function of Nbr in Drosophila. It is 
intriguing that the loss of function of nbr leads to age-associated defects, such as brain 
 96
degeneration and declined locomotion, plus wing postural defects. We also observed that 
the nbr null animals rescued with the catalytically mutated genomic-nbr transgene 
showed a consistent and striking lifespan reduction of ~50% (Abe and Bonini, 
unpublished). Some of these effects overlap those of miR-34 (brain degeneration, loss of 
climbing ability), however whether these phenotypes depend on the loss of 3' end 
trimming of miRNAs (notably miR-34-5p) or other functions of Nbr on small RNAs, 
awaits further study. Moreover, given that Nbr affects the length of not only miRNAs, 
but also endo-siRNAs and piRNAs, Nbr could potentially trim the 3' ends of a much 
broader species of RNA substrates, including other long and short non-coding RNAs and 
mRNAs. It is worth noting that the potential homologues of Nbr in mammals include 
Exd3 and Werner Syndrome Protein (WRN) (Liu et al. 2011), which causes Werner 
syndrome, a premature aging disorder. Even though it is not yet clear whether 
mammalian WRN impacts 3' end heterogeneity of small RNAs, future studies in 
mammalian system might reveal an intriguing link between the control of 3' end 
heterogeneity of small RNAs and aging processes across species. 
 
 
Materials and methods 
Fly stocks 
Flies were grown in standard cornmeal molasses agar medium at 25°C. nbrf02257 (FlyBase 
ID: FBti0050491) and nbr deficiency line (Df(2L)BSC312/CyO) (FlyBase ID: 
FBst0024338) were  obtained from the Bloomington Stock Center. nbrf02257 line was 
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backcrossed into a homogenous wild-type background (Bloomington Stock Line 5905 
(BL5905), FlyBaseID: FBst0005905, w1118) for 5 generations.  
 
Genomic nbr transgenic flies 
Wild-type, HA-tagged (C-terminus of Nbr), and the catalytically mutated 
((D435A,E437A) nbr transgenes, which include ~650bp upstream and ~150bp 
downstream of nbr ORF, were generated by PCR and cloned into pCaSpeR4 vector. 
Because of unanticipated difficulties on amplifying the entire region of nbr locus with a 
single PCR reaction, we amplified the genomic nbr region with the combination of 
regular PCR from genomic DNA (5905) and overlapping PCR to eventually amplify the 
whole nbr genomic region (~3.2kb) using the primers, 5'-
TAAGAAGCGATCTGCGGAAT-3' and 5'-TGCGGTTTCGTCTTCCTGAT-3'. The 
concept of overlapping PCR is described in (Young and Dong 2004; Xiong et al. 2006). 
Based on this wild-type genomic nbr sequence, we inserted 1 x HA tag sequence at the 
C-terminus, as well as inserted mutations (D435A,E437A) in the exonuclease domain by 
additional PCRs. The genes were then subcloned into pCaSpeR4. Constructs were 
sequence verified.  Genomic constructs were prepared by maxi-prep (Qiagen), and 
injected into BL5905 (w1118) (Genetic Services, Cambridge, MA), and transgenic flies 
were selected and maintained over the TM6C,Sb balancer chromosome.  
 
Nbr antibody  
A rabbit polyclonal antibody against the Nbr protein was developed using a synthetic 
peptide of residues 10-23 (C-AIPAGFESDEENME) (ProSci Incorporated, Poway, CA). 
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The serum was affinity-purified to enrich for IgG directed to the Nbr peptide antigen. For 
western immunoblots, the purified antibody was used at 1/2000. 
 
Western immunoblots 
Fly tissues were resuspended in RIPA buffer, followed by grinding and centrifugation to 
remove debris. The supernatant was measured by Bradford assay, and 25~50ug of protein 
in NuPAGE LDS-Sample buffer (4x) (NP0007, Life Technologies) was loaded each lane.  
NuPAGE Novex 4-12% Bis-Tris gel (#NP0321BOX, Life Technologies, Carlsbad, CA) 
were loaded and run in 1xNuPAGE MES SDS Running Buffer (#NP0002, Life 
Technologies, Carlsbad, CA). Western transfer was performed on PVDF membrane, 
followed by blocking in 5% milk/TBST for 1h at 4°C. The membrane was incubated with 
primary antibody (anti-Nbr, 1/2000) at 4°C overnight. After washing the membrane in 
TBST buffer 3 times (5 min each), the membrane was incubated with secondary antibody 
(goat anti-rabbit IgG-HRP, #sc-2030, Santa Cruz Biotechnology, Inc., Dallas, Texas) at 
4°C for 2h. The membrane was washed in TBST 3 times (5 min each), followed by signal 
development by Pierce ECL plus Western Blotting Substrate (#32132, Thermo Fisher 
Scientific, Waltham, MA). The image was scanned by Fujifilm LAS-3000 Imager 
(Fujifilm, Tokyo, Japan). 
 
Immunohistochemistry 
Ovaries were dissected in PBS, followed by fixation in 4% paraformaldehyde in PBS for 
20min at room temperature. After washing with PBST (PBS + 0.2% Triton X-100) twice, 
the ovaries were permealized in PBST-5 (PBS + 0.5% Triton X-100 with 5% goat serum). 
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After washing once with PBST-B (PBS + 0.2% Triton X-100 + 1% BSA), the ovaries 
were incubated with the primary antibody (1:150, rat monoclonal anti-HA: 3F10, 
Roche#11867423001) in PBST-B at 4°C overnight. Washing was performed in PBST 3 
times, 2 min each at room temperature, followed by 20min wash in PBST 3 times and 
2min wash in PBST-B once at room temperature. The ovaries were incubated with 
secondary antibody Alexa Fluor 488 Goat Anti-Rat IgG (H+L) (1:100, #A-11006, Life 
Technologies, Carlsbad, CA) in PBST for 2h at 4°C. After secondary antibody incubation, 
washing was performed in PBST 3 times, 2 min each at room temperature, followed by 
20min wash in PBST 3 times and 2min wash in PBST-B once at room temperature. After 
washing, the ovaries were carefully separated on slides by fine forceps, and mounted with 
Vectashield Mounting medium with DAPI (#H-1200, Vector laboratories, Burlingame, 
CA). 
 
Small RNA northern hybridization 
Total RNA was extracted from fly tissues using Trizol Reagent (#15596-018, Life 
Technologies, Carlsbad, CA), following the manufacturer's protocol. 3~10ug of total 
RNA was loaded/lane onto 15% TBE-urea gels (#EC6885BOX, Life Technologies, 
Carlsbad, CA), followed by the transferring to nylon membrane (Hybond N+, GE 
Healthcare, Piscataway, NJ). After UV crosslinking and pre-hybridization (50°C, 1h), the 
membranes were hybridized with P32-labeled probes overnight at 50°C. Two DNA 
oligonucleotides were annealed to obtain the template for each RNA probe. The DNA 
oligonucleotides used to make probe templates were: miR-34-5p (5’-GAT AAT ACG 
ACT CAC TAT AGG GAG A-3’/5’-AAA AAA TGG CAG TGT GGT TAG CTG GTT 
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GTG TCT CCC TAT AGT GAG TCG TAT TAT C-3’) and 2S rRNA (5’- GAT AAT 
ACG ACT CAC TAT AGG GAG A-3’/5'-TGC TTG GAC TAC ATA TGG TTG AGG 
GTT GTA TCT CCC TAT AGT GAG TCG TAT TAT C-3’).  Probe syntheses were 
performed by in vitro transcription using MAXIscript T7 Kit (#AM1312, Life 
Technologies, Burlingame, CA), supplemented with P32-α-UTP. 
  
Small RNA deep-sequencing 
Ovaries were dissected in PBS, and 40ug total RNA was prepared from 4-7d ovaries of 
wild-type, Df(2L)BSC312/+, nbr null (nbrf02257/Df(2L)BSC312), (nbr null; pCaSper-nbr 
(WT)), and (nbr null; pCaSper-nbr (D435A,E437A)), using Trizol Reagent (#15596-018, 
Life Technologies, Carlsbad, CA) following the manufacturer's protocol. The small 
RNAs between ~16 to ~29 nt in size were purified from 15% TBE-urea gel 
(#EC6885BOX, Life Technologies, Carlsbad, CA). Small RNA libraries were prepared 
using Illumina's TruSeq small RNA sample preparation kit (#RS-200-0012, Illumina, Inc. 
San Diego, CA), following the manufacturer's protocol. The libraries were sequenced on 
HiSeq2000 platform (Illumina). 
 
Held-up wing analysis 
Adult male flies were collected on the day of eclosion, aged at 25°C with 15 flies per vial, 
and transferred to new fly food vials every other day. At each time point, the number of 
flies with held-up wings was scored. 30 flies were used for each genotype/time point, and 
the average of three independent experiments was calculated. 
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Climbing assay 
Adult male flies were collected on the day of eclosion, aged at 25°C with 15 flies per vial, 
and transferred to new fly food vials every other day. For the climbing assay, flies aged to 
specific time points were incubated in the dark at room temperature for 30min, followed 
by transferring into 14-ml polystyrene round-bottom vial (Falcon). Under red light, flies 
were gently banged to the bottom,, and the percentage of flies that successfully climbed 
higher than 2.5 cm from the bottom of the vial in 10 sec was recorded. Three scorings 
were performed for each genotype/time point in each biological replicate, and the average 
was calculated. Approximately 30 flies for each genotype/time point were used for each 
experiment. Three independent experiments were performed in total.  
 
Brain paraffin sections 
Adult female heads (3d and 30d) were used for paraffin sections as described (Li et al. 
2008). Brain vacuoles were counted in the whole area of each brain section except retina, 
through 5 continuous frontal sections, starting from the center section (defined as the 
section in which brain occupies the largest region, and oesophagus is obvious) toward 
posterior direction.  
 
 
Computational analyses (Mugdha Khaladkar1) 
Alignment 
Trimming of the adapter sequences from the obtained reads were performed by an in-
house script (developed by Stephen Fisher from Junhyong’s lab). The trimmed reads 
were then aligned to the dm3 (BDGP Release 5) genome assembly of Drosophila 
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Melanogaster using the RUM pipeline. We set RUM to use 0 mismatches while aligning 
using Bowtie and 100% identity for Blat.  
 
Mapping to small RNAs 
miRNA stem-loop sequences were obtained from miRBase. piRNA loci in Drosophila 
ovaries were obtained from (Brennecke et al. 2007). endo-siRNA loci in Drosophila 
ovaries were obtained from (Czech et al. 2008). The unique reads with no mismatches 
that mapped to each small RNA locus, ranging from 16 to 35nt, were counted. For 
normalization, the reads were normalized by dividing with the total small RNA read 
number in each library after trimming. 
 
Length distribution and density plot of piRNAs and endo-siRNAs 
For length distribution of each small RNA locus, we obtained the fraction of reads 
corresponding to each length for each genotype, and plotted on graph. For density plot, 
the fraction of reads starting at specific 5’nt positions in each locus was obtained for each 
genotype and plotted. For overall length distribution of piRNAs and endo-siRNAs, all 
reads corresponding to piRNAs or endo-siRNAs were pooled for each genotype, the 
fraction of each length calculated, and plotted.  
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Figure 3.1. Expression pattern of the Nbr protein. 
(A) Nbr protein expression in head, ovary, and body (without ovary). Left panel: Nbr is 
enriched in the head relative to the body.  Right panel: Nbr protein expression is highest 
in the ovary. (B) Nbr expression shows little change with age. Mean ±SD (n=4), p= 0.76 
(Student's t-test). (C) Nbr protein is highly enriched in the cytoplasm vs nucleus. (D-F) 
Nbr expression in developing ovary, detected by anti-HA antibody in pCaSper-nbr.HA 
flies. (D) Nbr is detected throughout egg chamber development. (E) Nbr expression in 
stage 12. Nbr expression persists in the remnants of nurse cells, but is not detectably 
present in the mature oocyte. (F) Nbr is not detectable in the mature egg. The outline of 
the egg was shown by dashed lines. 
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Figure 3.2. Analysis and rescue of nbr loss-of-function mutation. 
(A) nbrf02257 null insertion mutation noting position of the Piggybac transposon (see Liu 
et al., 2012). (B) Deficiency used in trans to nbrf02257 allele to generate nbr null activity. 
Deleted region is indicated by parentheses (see Flybase GBrowse). (C) Nbr protein level 
and miR-34 pattern in various strains. Nbr protein is not detectable in nbr null 
(nbrf02257/Df(2L)BSC312) flies in heads, Nbr protein level was recovered in lines 
pCasper-nbr (WT) and pCasper-nbr.HA, and catalytically dead pCaSper-nbr 
(D435A,E437A). The miR-34 pattern was compromised in nbr null. However the miR-34 
pattern was rescued by pCasper-nbr (WT) or pCasper-nbr.HA transgenes.  A genomic 
rescue construct expressing catalytically dead Nbr failed to rescue the miR-34 pattern, 
despite robust levels of the Nbr protein.  
  
 105
 
Figure 3.3. Hoechst staining of wild-type and nbr null ovaries from 2~3d female flies 
(in the same scale). 
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Figure 3.4. nbr null (nbrf02257/Df(3L)BSC312) animals have held-up wings. 
 (A-D) Adult male flies at 14d.  (A) Normal flies with normal wing posture. (B) nbr null 
(nbrf02257/Df(3L)BSC312) have a held-up wing posture. (C) nbr null; pCaSper-nbr (wild-
type) is rescued to normal wing posture, (D) nbr null; pCaSper-nbr (D435A,E437A) have 
a held-up wing posture. (E) Quantification of flies with normal wing posture with age.  
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Figure 3.5. nbr null animals show age-associated defects. 
(A) Paraffin sections of wild-type, nbr def/+ (Df(3L)BSC312/+), nbr null 
(nbrf02257/Df(3L)BSC312), rescue (WT nbr) (nbr null; pCaSper-nbr (wild-type)), and 
rescue (cat-dead nbr) (nbr null; pCaSper-nbr (D435A,E437A)) heads at 3d and 30d. 
Scale bar = 0.1 mm. All pictures are in the same scale. (B) Quantification of brain 
vacuolization at 3d and 30d. (C) Climbing assay of wild-type, nbr null, nbr null; 
pCaSper-nbr (WT), and nbr null; pCaSper-nbr (D435A,E437A) at 2d, 5d, 10d, 20d, and 
30d.  
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Figure 3.6. Length distribution of select miRNAs in ovary deep-sequencing libraries.  
The red arrows indicate the increased portion of long isoforms, while the blue arrows 
indicate the decreased portion of short isoforms in nbr null and rescue (cat-dead nbr). 
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Figure 3.7. nbr affects the length of piRNAs. 
(A) Overall size distribution of piRNAs in wild-type, nbr def/+ (Df(3L)BSC312/+), nbr 
null (nbrf02257/Df(3L)BSC312), rescue (WT nbr) (nbr null; pCaSper-nbr (wild-type)), and 
rescue (cat-dead nbr) (nbr null; pCaSper-nbr (D435A,E437A)) in ovaries.  
(B) Size distribution of piRNAs from the 42AB cluster, which generated the highest 
number of piRNAs in the libraries.  
In (A) and (B), the red arrows indicate the increased portion of long piRNAs, while the 
blue arrows indicate the decreased portion of short piRNAs, in nbr null and rescue (cat-
dead nbr) libraries.  
(C) Density plots of piRNAs in 42AB cluster. 
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Figure 3.8. nbr affects the length of endo-siRNAs. 
(A) Overall size distribution of endo-siRNAs in wild-type, nbr def/+ (Df(3L)BSC312/+), 
nbr null (nbrf02257/Df(3L)BSC312), rescue (WT nbr) (nbr null; pCaSper-nbr (wild-type)), 
and rescue (cat-dead nbr) (nbr null; pCaSper-nbr (D435A,E437A)) in ovaries. (B) Size 
distribution of eiRNAs from the esi-1 cluster, which generated the highest number of 
endo-siRNAs in the libraries. In (A) and (B), the red arrows indicate the increased portion 
of 22nt endo-siRNAs, while the blue arrows indicate the decreased portion of 21nt endo-
siRNAs in nbr null and rescue (cat-dead nbr) libraries. (C) Density plots of piRNAs in 
esi-1 cluster. 
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Figure 3.9. Length distribution of individual piRNA loci that are affected by nbr 
loss. (continued to the next pages) 
MA1: wild-type, MA2: nbr def/+, MA3: nbr null, MA4: rescue (WT nbr), and MA5: 
rescue (cat-dead nbr). The raw read number is shown for each genotype in the box.   
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Figure 3.9. Length distribution of individual piRNA loci that are affected by nbr 
loss. (continued to the next pages) 
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Figure 3.9. Length distribution of individual piRNA loci that are affected by nbr 
loss. (continued to the next pages) 
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Figure 3.9. Length distribution of individual piRNA loci that are affected by nbr 
loss. (continued to the next pages) 
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Figure 3.9. Length distribution of individual piRNA loci that are affected by nbr 
loss. (continued to the next pages) 
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Figure 3.9. Length distribution of individual piRNA loci that are affected by nbr 
loss. (continued to the next pages) 
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Figure 3.9. Length distribution of individual piRNA loci that are affected by nbr 
loss. (continued to the next pages) 
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Figure 3.9. Length distribution of individual piRNA loci that are affected by nbr 
loss. (continued to the next pages) 
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Figure 3.9. Length distribution of individual piRNA loci that are affected by nbr 
loss. (continued to the next pages) 
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Figure 3.9. Length distribution of individual piRNA loci that are affected by nbr 
loss. (continued to the next pages) 
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Figure 3.9. Length distribution of individual piRNA loci that are affected by nbr 
loss. (continued to the next pages) 
 
  
 122
 
Figure 3.9. Length distribution of individual piRNA loci that are affected by nbr 
loss. (continued to the next pages) 
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Figure 3.9. Length distribution of individual piRNA loci that are affected by nbr 
loss. (continued to the next pages) 
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Figure 3.9. Length distribution of individual piRNA loci that are affected by nbr 
loss. (continued to the next pages) 
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Figure 3.9. Length distribution of individual piRNA loci that are affected by nbr 
loss. (continued to the next pages) 
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Figure 3.9. Length distribution of individual piRNA loci that are affected by nbr 
loss. (continued to the next pages) 
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Figure 3.9. Length distribution of individual piRNA loci that are affected by nbr 
loss. (continued to the next page) 
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Figure 3.9. Length distribution of individual piRNA loci that are affected by nbr 
loss. 
MA1: wild-type, MA2: nbr def/+, MA3: nbr null, MA4: rescue (WT nbr), and MA5: 
rescue (cat-dead nbr). The raw read number is shown for each genotype in the box.   
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Figure 3.10. Length distribution of individual piRNA loci that are uniquely affected 
by nbr loss. 
MA1: wild-type, MA2: nbr def/+, MA3: nbr null, MA4: rescue (WT nbr), and MA5: 
rescue (cat-dead nbr). The raw read number is shown for each genotype in the box.  
piRNA loci #10, #14, and #82 show extremely low read number in nbr null (MA3) 
compared to the other genotypes, while piRNA locus #11 shows extremely low read 
number in rescue (cat-dead nbr) (MA5). This suggests that Nbr may affect these four loci 
in distinct mechanisms compared to the other affected loci. 
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Figure 3.11. Length distribution of individual piRNA loci that are not affected or do 
not show clear trend by nbr loss. (continued to the next pages) 
 
 
 131
 
Figure 3.11. Length distribution of individual piRNA loci that are not affected or do 
not show clear trend by nbr loss. (continued to the next pages) 
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Figure 3.11. Length distribution of individual piRNA loci that are not affected or do 
not show clear trend by nbr loss. (continued to the next pages) 
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Figure 3.11. Length distribution of individual piRNA loci that are not affected or do 
not show clear trend by nbr loss. (continued to the next page) 
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Figure 3.11. Length distribution of individual piRNA loci that are not affected or do 
not show clear trend by nbr loss. 
MA1: wild-type, MA2: nbr def/+, MA3: nbr null, MA4: rescue (WT nbr), and MA5: 
rescue (cat-dead nbr). The raw read number is shown for each genotype in the box.   
  
 135
 
Figure 3.12. Length distribution of individual endo-siRNA loci that are affected by 
nbr loss.  
MA1: wild-type, MA2: nbr def/+, MA3: nbr null, MA4: rescue (WT nbr), and MA5: 
rescue (cat-dead nbr). The raw read number is shown for each genotype in the box.   
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Figure 3.13. Length distribution of individual endo-siRNA loci that are not affected 
by nbr loss. (continued to the next pages) 
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Figure 3.13. Length distribution of individual endo-siRNA loci that are not affected 
by nbr loss. (continued to the next pages) 
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Figure 3.13. Length distribution of individual endo-siRNA loci that are not affected 
by nbr loss. (continued to the next pages) 
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Figure 3.13. Length distribution of individual endo-siRNA loci that are not affected 
by nbr loss. (continued to the next pages) 
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Figure 3.13. Length distribution of individual endo-siRNA loci that are not affected 
by nbr loss. (continued to the next pages) 
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Figure 3.13. Length distribution of individual endo-siRNA loci that are not affected 
by nbr loss. (continued to the next pages) 
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Figure 3.13. Length distribution of individual endo-siRNA loci that are not affected 
by nbr loss. (continued to the next page) 
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Figure 3.13. Length distribution of individual endo-siRNA loci that are not affected 
by nbr loss. 
MA1: wild-type, MA2: nbr def/+, MA3: nbr null, MA4: rescue (WT nbr), and MA5: 
rescue (cat-dead nbr). The raw read number is shown for each genotype in the box.   
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CHAPTER 4 
IMPACT OF AGE-ASSOCIATED INCREASE  
IN 2'-O-METHYLATION OF MIRNAS  
ON AGING AND NEURODEGENERATION IN DROSOPHILA 
 
 
This chapter forms the basis of a manuscript, to be submitted. Additional authors include 
Ammar Naqvi1 and Dr. Andrey Grigoriev1. 
 
1Biology Department, Center for Computational and Integrative Biology, Rutgers 
University, Camden, NJ 
 
Note 
• Ammar Naqvi, of the laboratory of Dr. Andrey Grigoriev, contributed to the 
bioinformatic data analysis of the Ago1 vs Ago2-IP small RNA deep-sequencing 
(Table 4.2 and 4.3, Figure 4.6 to 4.8). 
• Gert-jan Hendriks, of the Bonini lab, provided initial insight into distinct age-
associated miRNA pattern changes by northern blots (Figure 4.1). 
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Abstract 
microRNAs (miRNAs) are approximately 20~24nt small RNAs that impact a variety of 
biological processes, from development to age-associated processes. To study the role of 
miRNAs in aging, many studies profiled changes in the level of miRNAs with age. 
However, evidence suggests that miRNAs show heterogeneity in length and sequences in 
different biological contexts. Here by examining the age-associated pattern of miRNAs, 
we discovered that Drosophila miRNAs show distinct isoform pattern changes with age. 
Surprisingly, the increase of some miRNAs reflected increased 2'-O-methylation of 
specific isoforms. Small RNA deep-sequencing revealed a global increase of miRNAs 
loaded into Ago2, but not into Ago1 with age. In addition, only specific isoforms showed 
increased loading in Ago2, but not in Ago1, indicating a mechanism that regulates 
differential loading of miRNAs between Ago1 and Ago2 with age. Mutations in hen1 and 
ago2, which lack 2'-O-methylation of miRNAs, resulted in accelerated neurodegeneration 
and shorter lifespan, indicating the involvement of the age-associated increase of 2'-O-
methylation of small RNAs on age-associated processes. Together, our study highlights 
that miRNA 2'-O-methylation at the 3' end is regulated through differential partitioning 
of miRNAs between Ago1 and Ago2 with age, and that this process might impact the 
aging process in Drosophila.  
  
 
Introduction 
miRNAs are ~20-24nt small RNAs that regulate gene expression post-transcriptionally 
through translational repression and/or mRNA cleavage. Starting from the discovery of 
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the first miRNA lin-4 in C. elegans, hundreds of miRNAs have now been identified in 
various species. miRNAs were classically studied for their role on developmental timing 
in C. elegans (Lee et al. 1993; Reinhart et al. 2000; Bartel 2004). However, some studies 
have addressed miRNA function in age-associated events. Functional analyses have 
identified some miRNAs, such as lin-4 in C. elegans (Boehm and Slack 2005; Kenyon 
2010a; Smith-Vikos and Slack 2012) and miR-34 in Drosophila (Liu et al. 2012) as 
miRNAs with critical roles in organismal and brain aging, respectively. Although most 
studies have focused on changes in the abundance of miRNAs with age (Ibanez-Ventoso 
et al. 2006; de Lencastre et al. 2010; Kato et al. 2011), evidence suggests that miRNAs 
also show heterogeneity in length and sequence in different cell types and biological 
contexts (Burroughs et al. 2010; Marti et al. 2010; Li et al. 2012; Westholm et al. 2012; 
Llorens et al. 2013). Studies indicate that such heterogeneity is mediated by imprecise 
Drosha and Dicer cleavages (Calabrese et al. 2007; Azuma-Mukai et al. 2008; Wyman et 
al. 2011), 3' end adenylation/uridylation (Ruby et al. 2006; Landgraf et al. 2007; 
Burroughs et al. 2010; Wyman et al. 2011), and RNA editing events (Kawahara et al. 
2007; Nishikura 2010; Alon et al. 2012; Ekdahl et al. 2012). Importantly, effects of such 
heterogeneity on miRNA target silencing are also reported (Azuma-Mukai et al. 2008; 
Seitz et al. 2008; Fukunaga et al. 2012; Lee and Doudna 2012), suggesting a functional 
importance of regulating miRNA heterogeneity in animals. Intriguingly, our recent study 
on the role of miR-34 on aging and age-associated neurodegeneration in Drosophila 
revealed an intriguing pattern of miR-34 isoforms: although multiple length isoforms of 
miR-34 are generated, only the short isoform accumulates with age (Liu et al. 2012). 
Importantly, the generation of isoforms of miR-34 requires 3' end trimming by a novel 3'-
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to-5' exonuclease, Nibbler (Nbr) (Han et al. 2011; Liu et al. 2011), highlighting the 
potential importance of regulation of miRNA length on age-associated processes.  
 
     In addition to length and sequence heterogeneity of miRNAs, the 2'-OH of the 3' 
terminal ribose of miRNAs can be modified by 2'-O-methylation (Zhao et al. 2012a). In 
plants, this modification occurs on nearly all miRNAs, as well as siRNAs (Yu et al. 2005; 
Zhao et al. 2012a; Zhao et al. 2012b), and protects the small RNAs from HESO1-
mediated uridylation and degradation (Li et al. 2005; Yu et al. 2005; Ren et al. 2012; 
Zhao et al. 2012b). In Drosophila, most miRNAs are loaded into Ago1 and remain 
unmodified (Hutvagner et al. 2001; Okamura et al. 2004; Vagin et al. 2006). However, a 
subset of miRNAs are found to be 2'-O-methylated (Forstemann et al. 2007; Horwich et 
al. 2007; Ghildiyal et al. 2008; Czech et al. 2009; Okamura et al. 2009). Importantly, this 
modification is also protective in animals: loss of 2'-O-methylation of small RNAs leads 
to destabilization, and tailing and trimming of the small RNAs (Kurth and Mochizuki 
2009; Ameres et al. 2010; Kamminga et al. 2010).  
 
    In Drosophila, 2'-O-methylation of small RNAs is associated with loading of the 
miRNAs into different Ago complexes: while most miRNAs are loaded into Ago1 
(miRISC) and remain unmodified, those loaded into Ago2 (siRISC) are 2'-O-methylated 
(Czech et al. 2009; Okamura et al. 2009; Ghildiyal et al. 2010). The miRNA/miRNA* 
duplex structure and 5' nucleotide preference are two suggested mechanisms by which 
miRNAs are directed into the two distinct Ago complexes (Forstemann et al. 2007; 
Tomari et al. 2007; Okamura et al. 2009; Ghildiyal et al. 2010). However, the exact 
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mechanism of miRNA-loading into these different Ago complexes in Drosophila, 
especially in vivo, remains unclear. Recent findings that the miR-34 loop miRNA is 
loaded into Ago1, despite being single-stranded (Okamura et al. 2013), suggests the 
existence of bulge-independent mechanisms for loading of small RNAs into the Ago 
complexes in vivo (Okamura et al. 2013).   
 
miRNAs loaded into Ago2 are also active on translational silencing of the target 
genes, like miRNAs loaded into Ago1, but by a potentially different mechanism (Czech 
et al. 2009; Iwasaki et al. 2009; Okamura et al. 2009). Biochemically, while Ago1-loaded 
let-7 represses translation by removal of the poly A tail from the target mRNA, Ago2-
loaded let-7 does this without removal of the poly A tail, indicating that Ago1 and Ago2 
in Drosophila can employ distinct mechanisms to induce translational repression of the 
associated miRNA species (Iwasaki et al. 2009). Intriguingly, such mechanistic 
difference seems to contribute to the difference in silencing efficiency of the target 
reporters: Ago1-loaded let-7 is more efficient than Ago2-loaded let-7 to silence the target 
reporters in vitro (Iwasaki et al. 2009). Despite the discovery of functional Ago2-loaded 
and 2'-O-methylated miRNAs in Drosophila, whether such loading of miRNAs to Ago2 
is biologically regulated, or biologically important in vivo is not yet known.  
 
    Here, we pursued study of several Nbr-dependent miRNAs that show multiple 
isoforms, like miR-34, and examined their isoform pattern with age.  Unexpectedly, we 
found that these miRNAs show a diversity of patterns with age.  The age-associated 
increase of some Drosophila miRNAs reflects increased 2'-O-methylation of select 
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isoforms with age. Associated with this increase, we found increased loading of specific 
miRNA isoforms into Ago2, but not Ago1, with age. Importantly, lack of 2'-O-
methylation by hen1 and ago2 mutations resulted in reduced lifespan and brain 
degeneration, suggesting that the increased protection of small RNAs with age may be of 
critical importance to age-associated events.  
 
Results 
Distinct age-associated isoform patterns of nbr-trimmed miRNAs 
Drosophila miR-34-5p, which is a target of Nibbler (Nbr)-dependent 3' end trimming 
(Han et al. 2011; Liu et al. 2011), shows an increase in the short isoform with age (Liu et 
al. 2012) (Figure 4.1A, B). This observation led us to examine the age-associated pattern 
of other Nbr-trimmed miRNAs. We focused on several miRNAs that could readily be 
detected by northern analysis. Northern blots of these miRNAs at 3d and 30d in heads 
revealed intriguing changes in isoform patterns with age. One Nbr-trimmed miRNA, 
miR-317-3p increased with age like miR-34-5p (Figure 4.1B). The increase in both of 
these miRNAs reflected an increase in their short isoforms with age (Figure 4.1A,B). By 
contrast, although both miR-305-5p and miR-263a-5p increased in total amount with age, 
their isoform pattern was opposite: these miRNAs showed an increase in the longer 
isoforms with age (Figure 4.1C,D). miR-11-3p showed a single isoform by northern, and 
showed a slight increase with age (Figure 4.1E,F). These observations raised the 
possibility that multiple mechanisms are used to generate distinct miRNA isoform 
patterns with age. 
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Age-associated increase in 2'-O-methylation of Nbr-trimmed miRNAs 
One mechanism to explain an increase in long isoforms with age could be an increased 
protection of these specific isoforms with age. Almost all plant miRNAs and siRNAs (Li 
et al. 2005; Yu et al. 2005; Ren et al. 2012; Zhao et al. 2012b), and animal siRNAs and 
piRNAs are 2'-O-methylated (Horwich et al. 2007; Kirino and Mourelatos 2007a; Kirino 
and Mourelatos 2007b; Kirino and Mourelatos 2007c). However, recently studies also 
suggest that a subset of Drosophila miRNAs are 2'-O-methylated (Forstemann et al. 
2007; Horwich et al. 2007; Czech et al. 2009; Okamura et al. 2009; Ghildiyal et al. 2010). 
Importantly, 2'-O-methylation of animal small RNAs is also protective such that loss of 
2'-O-methylation leads to their destabilization (Ameres et al. 2010; Kamminga et al. 
2010). Therefore, we hypothesized that the increase of the long isoforms of miR-305-5p, 
miR-263a-5p, and miR-11-3p may result from increased protection at the 3' end of 
specific isoforms by 2’-O-methylation. To address this, we performed oxidation/β-
elimination assays on total RNA from 3d and 30d wild-type head and body. If the 3' end 
ribose of small RNAs is protected by 2'-O-methylation, as for piRNAs and siRNAs, those 
small RNAs cannot react with sodium periodate in the oxidation/β-elimination assay 
(Horwich et al. 2007) and will not decrease in size. However if the 3' end ribose is 
unmodified, they react with sodium periodate, will be β-eliminated, and will shift down 
in size (Horwich et al. 2007). Therefore a change in the mobility of the small RNAs by 
northern indicates the presence or absence of a protective modification at the 3' end.  We 
performed this assay, and found that miR-34-5p shifts in size, thus is not protected at the 
3' end (Figure 4.2A, left panel). By contrast, miR-305-5p, miR-263a-5p, and miR-11-3p 
 151
showed an increase in protection of the long isoforms with age (Figure 4.2A, arrows, 
right panel).  
 
We quantified the ratio of protected to unprotected isoforms of miR-305-5p, miR-263a-
5p, and miR-11-3p. This analysis revealed an increase of the ratio of protected to 
unprotected isoforms with age. If the increase of the protected isoforms simply reflected 
the increase of the overall level of these miRNAs, the ratio of protected to unprotected 
isoforms after oxidation/ β-elimination would not change. However the ratio increased 
for these three miRNAs (Figure 4.2B). These data indicate a mechanism to increase the 
protection of the long isoforms of these miRNAs with age.  
 
     We next asked whether the protection of specific miRNA isoforms is due to 2'-O-
methylation at the 3' end. 2'-O-methylation of small RNAs depends on the 
methyltransferase Hen1. In addition, 2'-O-methylation of small RNAs requires loading 
into Ago2: loss of Ago2 and Ago2-loading machinery (Dcr2 and R2D2) leads to loss of 
modification (Horwich et al. 2007). Therefore to confirm that the miRNAs were 2’-O-
methylated and loaded into Ago2, we tested the effect of loss of hen1 and ago2 on the 
pattern of miR-305-5p, miR-263a-5p, and miR-11-3p with age. hen1f00810 and ago2BL16608 
mutant flies were aged to 3d or 30d, RNA isolated and oxidation/β-elimination performed. 
This revealed that miR-305-5p, miR-263a-5p, and miR-11-3p were no longer protected, 
but rather depend on hen1 and ago2 for protection at both 3d and 30d (Figure 4.3, 
arrowheads). This finding suggests that the increase of the long isoforms of these 
miRNAs is dependent on hen1, thus due to 2'-O-methylation at the 3' end. These data also 
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indicate that these miRNA isoforms are loaded into Ago2 for 2'-O-methylation. We note 
that miR-317-3p is an exceptional miRNA in that it showed protection of the long 
isoform from oxidation/β-elimination in both young and old flies (Figure 4.2A, 
arrowheads). However, to our surprise, protection persisted even after the loss of hen1 
and ago2 (Figure 4.3, arrowheads). This suggests that miR-317-3p is protected in a 
manner independent of Hen1 and Ago2. 
 
An age-associated increase in Ago2-loading of 2'-O-methylated isoforms of miRNAs 
         In Drosophila, while most miRNAs are loaded into Ago1 and thus are unmodified, 
a subset of miRNAs have been observed to be loaded into Ago2 (siRISC) and are 2'-O-
methylated (Czech et al. 2009; Okamura et al. 2009; Ghildiyal et al. 2010). Therefore, 
based on our observations, we determined whether the specific isoforms of miR-305-5p, 
miR-263a-5p, and miR-11-3p were increased in loading into Ago2, but not Ago1, with 
age. To address this, we immunoprecipitated Ago1 and Ago2 from whole flies, then 
performed northerns on the precipitated small RNAs, comparing 3d and 30d. Ago1 could 
be immunoprecipitated with an antibody; for Ago2, we used flies bearing a genomically-
tagged FLAG-HA-ago2 (Czech et al. 2008). This approach revealed a specific loading 
pattern for each small RNA with age in Ago1 vs Ago2. miR-34-5p, which was not 
protected at the 3' end (see Figure 4.2A), was predominantly loaded into Ago1, and not 
detectably present in Ago2 (Figure 4.4A). Consistent with the age-associated pattern of 
miR-34-5p by northern from total RNA (see Fig.1A, Liu et al., 2012), the short isoforms 
of miR-34-5p accumulated in Ago1 with age (Figure 4.4A). esi-2.1, an abundant 
endogenous siRNA in flies (Czech et al. 2008; Ghildiyal et al. 2008; Kawamura et al. 
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2008; Okamura et al. 2008), was selectively loaded into Ago2, and not detectable in 
Ago1 (Figure 4.4A). By contrast, miR-305-5p and miR-263a-5p showed an intriguing 
loading pattern: while multiple isoforms were present in Ago1 at both 3d and 30d, only 
the long isoforms (24nt) were present in northerns of Ago2 IP material (Figure 4.4A). 
The single isoform of miR-11-3p was present in Ago1, however, a small portion was 
loaded into Ago2 (Figure 4.4A). In addition to the loading of specific length of isoforms 
into Ago2, there was also a trend of increased levels of the loaded isoforms of miR-305-
5p, miR-263a-5p, and miR-11-3p into Ago2 with age. To quantify this, we normalized 
the level of the Ago2-loaded miRNAs to Ago2-loaded esi-2.1 at the corresponding age. 
The total level of esi-2.1 did not change with age (Figure 4.4B). Therefore, given that esi-
2.1 is loaded into Ago2, but not into Ago1 (Figure 4.4A), we normalized the levels of 
miRNAs in Ago2 to the loaded level of esi-2.1 with age. After normalizing, we 
confirmed a significant increase of Ago2-loaded miR-305-5p, miR-263a-5p, and miR-11-
3p with age (Figure 4.4C,D,E). These findings suggest that the age-associated increase of 
2'-O-methylation of miRNAs reflects increased loading of selective isoforms into Ago2 
with age.  
 
These results suggest the existence of a mechanism to selectively increase Ago2-loading 
of specific miRNA isoforms with age. One possibility for increased loading could be an 
increase in the level of Hen1, Ago2 and/or the Ago2-loading machinery (Dcr2 and R2D2) 
with age (Liu et al. 2003; Tomari et al. 2004; Marques et al. 2010; Okamura et al. 2011; 
Nishida et al. 2013). To address this possibility, we performed western blots on Ago2 
(FLAG-HA-ago2 flies), R2D2, and Dcr2 with age (no antibody is available for Hen1). 
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Both Ago2 and R2D2 were unchanged with age (Figure 4.4F,G,H), and Dcr2 was not 
detectable in adult flies (Figure 4.5). To further confirm these results, we examined 
microarray data from aged Drosophila brains (3d, 30d, and 60d) (Liu et al. 2012). 
Analysis revealed no significant increase in Hen1, Ago2, Dcr-2, or R2D2 RNA levels 
with age (Table 4.1). In addition, the level of Ago1 mRNA was unchanged, suggesting 
that a decrease in Ago1 levels would not explain the relative increase in Ago2-loading of 
miRNAs with age (Table 4.1). We observed a potential increase in mRNA levels for 
Hsp70 (Table 4.1), a component of RISC-loading machinery in a complex with Hsp90 
(Iki et al. 2010; Iwasaki et al. 2010; Miyoshi et al. 2010b). However, since the Hsp90 
level is unchanged, there is likely no increase in the Hsp90/Hsp70 complex with age. 
Together, these results suggest that the increase of Ago2-loading of miRNAs with age 
occurs independent of  a change in the level of Ago2 or Ago2-loading machinery.  
 
A global shift of Ago1 vs Ago2-loaded miRNAs with age 
To confirm the increase in miRNA loading into Ago2 with age, we immunopurified 
Ago1 and Ago2 from flies aged 3d and 30d, and performed deep sequencing of small 
RNAs. We normalized the number of observed reads to the total number of non-miRNA 
reads in Ago1, and to the esi-2.1 reads in Ago2. In this analysis, we found that the total 
read number of miRNAs in Ago1 was largely unchanged, while that of Ago2 increased 
with age (Figure 4.6A). In addition, the share of miRNAs among total RNA occupying 
Ago1 showed little change with age, while in Ago2 the miRNA reads increased 
dramatically with age (Figure 4.6B, 30.7% at 3d to 69.6% at 30d). During the analyses, 
we noticed that miR-263a-5p was the most abundant miRNA in the 3d and 30d Ago2 
 155
libraries. Therefore, to rule out that the increased trend of total miRNA reads and 
percentage in Ago2 with age simply reflected a change in miR-263a-5p, we removed 
miR-263a-5p reads from 3d and 30d Ago2-IP libraries, and re-calculated the total 
miRNA read number (normalized to esi-2.1) and the % of total miRNAs in 3d and 30d 
Ago2 libraries (Figure 4.7). This confirmed that, even after removing miR-263a-5p, the 
trend persisted: the read number and percentage of the total miRNAs in Ago2 increased 
with age (Figure 4.7). These results, together with the increased ratio of protected to 
unprotected isoforms of miRNAs with age (see Figure 4.2), support the idea that more 
miRNA molecules are loaded into Ago2, but not Ago1, with age.  
 
         We analyzed in detail the three miRNAs, which were the focus of northern analysis, 
miR-305-5p, miR-263a-5p, and miR-11-3p. Supporting our earlier observations, miR-
305-5p, miR-263a-5p, and miR-11-3p showed increased association in Ago2 with age 
(Figure 4.6C, bottom panels). By contrast, the amount of these miRNAs in Ago1 
decreased with age (Figure 4.6C, top panels). Together, these data support the idea that 
the loading pattern of miRNAs between Ago1 and Ago2 changes dramatically with age, 
such that Ago2-loading of selective miRNA isoforms increases, while Ago1-loading of 
the miRNA isoforms generated from the same stem-loops decreases with age.  
 
        Additional analysis of the libraries allowed identification of additional miRNAs with 
the same trend of an increase of select isoforms in Ago2 with age. We compared relative 
loading ratios (Ago2 over Ago1, R21, see Methods) of the most abundant isoform for each 
miRNA in 30d flies vs 3d flies (Figure 4.8A). This analysis revealed that the three 
 156
miRNAs of our northern focus (miR-305-5p, miR-263a-5p, and miR-11-3p) are among 
those preferentially loaded into Ago2 at both 3d and 30d (Figure 4.8A).  
 
Among 240 Drosophila miRNA genes, 135 miRNA genes were found to be present with 
at least one raw read in both Ago1- and Aog2-IP libraries at 3d, while 143 miRNA genes 
were present at 30d. Among them, 67 5p and 3p sequences had at least 1000 raw reads of 
at least one isoform at 3d or 30d. Among these 67 5p and 3p sequences, 15 mature and 9 
star sequences showed preferential loading of specific isoforms into Ago2 relative to 
Ago1 at 3d (R21> 1.2), while 16 mature and 9 star sequences showed that trend at 30d 
((R21> 1.2; Table 4.2 and 4.3). (5p and 3p sequences were classified as “mature” or “star”, 
based on their relative abundance in the Ago1-IP 3d library: those with a higher read 
number compared to the read number from the other strand of the stemloop were defined 
as “mature”. See Methods for details.). 
 
Next, we determined whether the miRNA isoforms showing preferential loading into 
Ago2 at either age (R21>1.2) in Figure 4.8A also showed an increase in loading into 
Ago2 with age. To assess this, we calculated the fold change in normalized read numbers 
of each isoform between 30d and 3d (Figure 4.8B). A change of > 1 would indicate an 
increase in specific miRNA loading into Ago2 with age. Consistent with the previous 
analysis (see Figure 4.4A-E), miR-305-5p, miR-263a-5p, and miR-11-3p showed 
increased loading into Ago2 with age (Figure 4.8B, red bars). Together, these data 
indicate 11 mature and 8 star sequences out of 67 (5p and 3p) total sequences (analysis 
was limited to those miRNAs with > 1000 raw reads of at least one isoform at 3d or 30d) 
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show preferential loading of specific isoforms into Ago2 relative to Ago1, and increase 
with age. 
 
 Loss of Hen1 and Ago2 is associated with shortened lifespan and neurodegeneration. 
     To address the biological significance of the global shift in the population of Ago2-
loaded miRNAs, we examined the impact of loss of 2’-O-methylation of small RNAs by 
analyzing hen1 and ago2 mutant animals. Ago2 loss has been shown to cause defects in 
synaptic structure in third instar larvae (Pepper et al. 2009), indicating the importance of 
ago2 on neuronal development. Here we focused on adult-specific age-associated effects 
in hen1f00810, ago2414 and ago2BL16608 mutants. Lifespan analysis indicated that both 
hen1f00810 and ago2BL16608 mutants showed a shorter lifespan compared to genetic 
background-matched controls (Figure 4.9D). Detailed analysis of these animals also 
showed that both hen1f00810 and ago2 (ago2414 and ago2BL16608) mutants have increased 
brain vacuolization, indicative of brain degeneration with age (Figure 4.9A,B,C). While 
hen1f00810 mutants showed more brain vacuolization in the optic lamina (Figure 4.9B), 
ago2 mutants had excessive vacuoles in the retina (Figure 4.9C). Both hen1 and ago2 
mutants are predicted to impact siRNAs, and the difference in phenotypes between hen1 
and ago2 mutants might reflect a broader roles of ago2 beyond its effects on siRNAs 
(Taliaferro et al. 2013). However, defects in hen1 and ago2 mutants suggest that 2’-O-
methylation of small RNAs, one class of which is miRNAs, is critical for age-associated 
processes in Drosophila.  
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Discussion 
Dynamic regulation of Ago1 vs Ago2-loading of miRNAs with age 
Increasing evidence suggests that miRNAs show heterogeneity at the 5' end, 3' end and 
even in precise sequence in different cell types and biological contexts (Neilsen et al. 
2012). Despite this, it is less understood whether and how such heterogeneity is regulated 
biologically, or the biological impact. Here, by examining the age-associated pattern of 
miRNA isoforms, we show that 2'-O-methylation of miRNAs is regulated in an age-
dependent manner in Drosophila. This regulation is correlated with a shift in partitioning 
of miRNAs into Ago2 vs Ago1 with age. These data suggest that the partitioning of 
miRNAs between Ago1 and Ago2 is dynamically regulated with age in Drosophila.  
 
What mechanism may select specific miRNAs to become partitioned into Ago2 with age? 
Previously, miR-277 was shown to be loaded into both Ago1 and Ago2 because of the 
lack of an extensive central bulge in the miR-277/miR-277* duplex (Forstemann et al. 
2007). However, our analyses of the miRNAs that are 2'-O-methylated with age failed to 
identify a consistent lack of central bulges on miRNA/miRNA* duplexes (Figure 4.10). 
Rather, our results indicate that miRNA isoforms with the same sequence and length can 
be partitioned into both Ago1 and Ago2, and that a change in this distribution is an age-
associated phenomenon. This suggests that, at least in vivo, the partitioning of miRNAs 
into Ago1 and Ago2 is regulated by a bulge-independent mechanism(s). The presence of 
a bulge-independent mechanism to partition small RNAs into different Ago complexes is 
suggested from other work as well: the loop sequence from miR-34 precursor stem-loop 
is abundant in some cells and loaded into Ago1, despite its single-stranded nature 
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(Okamura et al. 2013). An important future direction is to identify the molecular 
mechanism for loading small RNAs into different Ago complexes independent of their 
bulge structure.   
   
In vivo significance of differential partitioning of miRNAs between Ago1 and Ago2 
with age  
Our analyses of hen1 and ago2 mutants suggests that 2'-O-methylation of small RNAs 
affects age-associated traits of brain degeneration and lifespan. How could loss of 2'-O-
methylation of small RNAs affect age-associated phenotypes? It is possible that the loss 
of 2'-O-methylation of miRNAs leads to destabilization of the miRNAs, thus affecting 
the target silencing, causing accelerated age-associated defects. In this case, theoretically 
Ago2-loaded, but not Ago1-loaded miRNAs, are selectively affected. What could be the 
functional consequence of losing Ago2-loaded miRNAs? Interestingly, both Ago1 and 
Ago2 are active on silencing miRNA targets. However, Drosophila Ago1 and Ago2 
employ different mechanisms to silence their miRNA target genes, as silencing by Ago1-
let-7 RISC entails the removal of poly A tail, whereas that by Ago2-let-7 RISC entails 
retention of the poly A tail (Iwasaki et al. 2009). Such mechanistic difference might 
contribute to the different silencing efficiency of the two Ago complexes of the reporters: 
Ago1-let-7 is more efficient than Ago2-let-7 to silence the reporters (Iwasaki et al. 2009). 
An interesting possibility is that, by shifting miRNAs towards Ago2 from Ago1 with age, 
flies might be adjusting the efficiency of target gene expression for ongoing or upcoming 
age-associated stresses. Since Ago2-mediated translational silencing causes retention of 
the poly A tail (Iwasaki et al. 2009), this might make it possible to respond to age-
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associated internal or external stresses more rapidly with re-activation of targets. Another 
possibility is the effect of loss of 2'-O-methylation on other classes of small RNAs, such 
as endo-siRNAs or piRNAs (Horwich et al. 2007; Czech et al. 2008; Ghildiyal et al. 
2008; Kawamura et al. 2008; Okamura et al. 2008). Loss of ago2 leads to decreased 
production of endo-siRNAs, which is correlated with upregulation of transposons (Czech 
et al. 2008; Ghildiyal et al. 2008; Kawamura et al. 2008; Okamura et al. 2008). Recently, 
an age-associated increase of transposon expression and shorter lifespan were noted in 
ago2 mutants (Li et al. 2013). Although ago2 mutants show developmental defects, such 
as synaptic structure defects in third instar larvae (Pepper et al. 2009), given that both 
hen1f00810 and ago2 (ago2414 and ago2BL16608) mutants are maintained homozygously, and 
that the overall brain morphology and climbing activity of these mutants when young is 
normal (Figure 4.9A,B,C), the defects observed in adult hen1 and ago2 mutants likely 
reflect defects in age-associated processes. These findings support the importance of 
terminal modification of small RNAs on impacting age-associated traits. 
 
Dynamic isomiR regulation with age 
It has become evident that the pattern of miRNA isoforms (isomiRs) varies in different 
biological contexts, such as different stages of development, different tissues, and with 
disease (Fernandez-Valverde et al. 2010; Marti et al. 2010; Li et al. 2012; Neilsen et al. 
2012; Llorens et al. 2013). It is also becoming evident that such isoform distributions are 
regulated (Neilsen et al. 2012). For example, Nbr defines the 3' end of many Drosophila 
miRNAs (Han et al. 2011; Liu et al. 2011), and Loqs-PB (Drosophila homologue of 
TRBP) partnering with Dcr-1 defines the cleavage position of several Drosophila 
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miRNAs, which seems conserved in mammals as well (Fukunaga et al. 2012; Lee and 
Doudna 2012). Our study reveals another repertoire of biologically-regulated 
heterogeneity of miRNAs: differential 2'-O-methylation of miRNA with age. It is 
intriguing that the loss of such miRNA heterogeneity leads to clear biological defects 
(this study and chapter 3). These results raise the possibility that, in the aging adult, fine-
tuning of miRNA heterogeneity might be critical for combating age-associated stresses. 
Further studies will define the specific mechanistic role of this fine-tuning of miRNA 
heterogeneity on each miRNA and on specific age-associated processes. 
 
Materials and methods 
Small RNA northern hybridization 
Total RNA was extracted from Fly tissues using Trizol Reagent (#15596-018, Life 
Technologies, Carlsbad, CA), following the manufacturer's protocol. 3~10ug of total 
RNA was loaded/lane in 15% TBE-urea gel (#EC6885BOX, Life Technologies, Carlsbad, 
CA), followed by the transferring to nylon membrane (Hybond N+, GE Healthcare, 
Piscataway, NJ). After UV crosslinking and pre-hybridization (50°C, 1h), the membranes 
were hybridized with P32-labeled probes overnight at 50°C. DNA oligonucleotides were 
annealed to obtain the templates for RNA probes. The sequences of the DNA 
oligonucleotides used to make probes were: miR-34-5p (5’-GAT AAT ACG ACT CAC 
TAT AGG GAG A-3’/5’-AAA AAA TGG CAG TGT GGT TAG CTG GTT GTG TCT 
CCC TAT AGT GAG TCG TAT TAT C-3’), miR-263a-5p (5’-GAT AAT ACG ACT 
CAC TAT AGG GAG A-3’/5'-GTT AAT GGC ACT GGA AGA ATT CAC TCT CCC 
TAT AGT GAG TCG TAT TAT C-3’), miR-305-5p (5’-GAT AAT ACG ACT CAC 
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TAT AGG GAG A-3’/5'-AAA AAA ATT GTA CTT CAT CAG GTG CTC TGT CTC 
CCT ATA GTG AGT CGT ATT ATC-3’), miR-317-3p (5’-GAT AAT ACG ACT CAC 
TAT AGG GAG A-3’/5'- AAA AAA ATG AAC ACA GCT GGT GGT ATC CAG TTC 
TCC CTA TAG TGA GTC GTA TTA TC-3’), esi2.1 (5’-GAT AAT ACG ACT CAC 
TAT AGG GAG A-3’/5'-TTG ACT CCA ACA AGT TCG CTC CTC TCC CTA TAG 
TGA GTC GTA TTA TC-3’), miR-8 (), miR-100 (), miR-1000 () and 2S rRNA (5’- GAT 
AAT ACG ACT CAC TAT AGG GAG A-3’/5'-TGC TTG GAC TAC ATA TGG TTG 
AGG GTT GTA TCT CCC TAT AGT GAG TCG TAT TAT C-3’). P32-labeled probes 
were synthesized by in vitro transcription using MAXIscript T7 Kit (#AM1312, Life 
Technologies, Burlingame, CA), supplemented with P32-α-UTP. 
 
Oxidation/β-elimination of RNA 
Total RNA was extracted from fly tissues using Trizol Reagent (#15596-018, Life 
Technologies, Carlsbad, CA), following the manufacturer's protocol. Total RNA was 
resuspended in 1xborate/borax buffer with or without NaIO4 (final concentration: 25mM) 
(#311448, Sigma-Aldrich, St. Louis, MO), and incubated at room temperature in dark for 
30min. After adding 1/10 volume of 100% glycerol, the samples were incubated further 
for 10min at room temperature at dark. After purifying the RNA, the RNA samples were 
resuspended into 1xborate/borax buffer with supplemented with NaOH to the final 
concentration of 0.1 mM. The samples were incubated at 45°C for 90min, followed by 
purification and analysis by northern blots. 10~20ug of total RNA was used for each 
miRNA. 
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IP-northern 
Fly lysate was prepared from 3d and 30d male FLAG-HA-ago2 whole flies (Czech et al. 
2008). Approximately 80 flies were used for each IP (Ago1 or Ago2) followed by 
northerns (miR-34-5p, esi-2.1, miR-305-5p, miR-263a-5p, miR-11-3p, and miR-317-3p). 
Immunoprecipitation was performed as described (Kirino et al. 2011), except that 
800mM of NaCl (final concentration) was used for Ago2-IP. Anti-Ago1 (ab5070, 
Abcam) or M2 beads (#A2220, Sigma-Aldrich, St. Louis, MO) was used for Ago1 or 
Ago2-IP respectively. After extraction of RNA from beads as described in Kirino et al., 
2011, the purified RNA was loaded onto 15% TBE-urea gel, followed by northern blots.  
 
Preparation of Ago1 and Ago2-IP small RNA libraries 
40 whole male flies (FLAG-HA-ago2, 3d and 30d) were used for Ago1-IP, and 200 
whole male flies (3d and 30d) were used for Ago2 (M2)-IP. After immunoprecipitation of 
Ago1 or Ago2, the purified RNA was P32-labeled as described (Kirino et al. 2011), and 
the radiolabeled RNA was run on a 15% TBE-urea gel (#EC6885BOX, Life 
Technologies, Carlsbad, CA). The gel was exposed to phosphorimager screen, and the 
fractions corresponding to small RNAs were excised from the gel. After purifying the 
small RNAs from the gel, small RNA libraries were generated using Illumina's TruSeq 
small RNA sample prep kit (#RS-200-0012, Illumina, Inc. San Diego, CA), following the 
manufacturer's protocol. The libraries were sequenced on HiSeq2000 platform (Illumina).  
 
Western immunoblots 
 Fly tissues were resuspended in RIPA buffer, followed by grinding and centrifug
remove debris. The supernatant was measured by Bradford assay, and 25~50ug of prote
was loaded each lane. NuPAGE Novex 
Technologies, Carlsbad, CA)
Running Buffer (#NP0002, 
to PVDF membrane, and the membrane was blocked by 5% milk/TBST for 1h at 4°C. 
The membrane was incubated with primary at 4°C overnight. After washing the 
membrane in TBST buffer 3 times (5 min each), the membrane was incubated with 
secondary antibody at 4°C for 2h. The membra
each), followed by signal development by Pierce ECL plus Western Blotting Substrate 
(#32132, Thermo Fisher Scientific,
LAS-3000 Imager (Fujifilm, 
flies were used. For R2D2 and Dcr2 WB, wild
antibodies used are anti-FLAG
for Ago2. Anti-R2D2 (rabbit polyclonal)
were the kind gifts from Siomi lab.
HRP (1:2000, #7076S, Cell Signaling Technology, Inc. Danvers, MA), 
HRP (1:2000, #sc-2030, Santa Cruz Biotechnology, Inc., Dallas, Texas
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4-12% Bis-Tris gel (#NP0321BOX, Life 
 was used to run the samples in 1xNuPAGE
Life Technologies, Carlsbad, CA). Proteins were transferred 
ne was washed in TBST 3 times (5 min 
 Waltham, MA). The image was scanned by Fujifilm 
Tokyo, Japan). For Ago2 western, FLAG-HA
-type male flies were used. The 
-HRP (1:2000, #A8592, Sigma-Aldrich, St. Louis, MO
 and anit-Dcr2 (mouse monoclonal)
 The secondary antibodies used are anti
anti
). 
ation to 
in 
 MES SDS 
-ago2 male 
primary 
) 
 antibodies 
-mouse IgG-
-rabbit IgG-
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Fly stocks 
Flies were grown in standard cornmeal molasses agar medium at 25°C. hen1foo810 
(FlyBase ID: FBst1016506, The Exelixis Collection at the Harvard Medical Shool) and 
ago2414 (Flybase ID: FBst0313641, DGRC Kyoto Stock Center) flies were the kind gifts 
from Sara Cherry lab. ago2BL16608 (FlyBase ID: FBst0016608) and FLAG-HA-ago2 flies 
(FlyBase ID: FBst0033242) were obtained from the Bloomington Stock Center. hen1foo810 
and ago2BL16608 lines were backcrossed into a homogenous wild-type background 
(Bloomington Stock Line 5905 (BL5905), FlyBaseID: FBst0005905, w1118) for 5 
generations. 
 
Lifespan assay 
180~200 flies were used for each lifespan replicate. Male flies were collected on the day 
of eclosion, aged at 25°C, 15 flies per vial, and transferred to new fly food vials every 
other day while scored for the survival. The assay was repeated in triplicate, and was 
analyzed by Excel (Microsoft) for survival curves.   
 
Brain paraffin sections 
Adult female heads (3d and 30d) were used for paraffin sections as described (Li et al. 
2008). Brain vacuoles were counted for lamina or retina through 10 continuous horizontal 
sections, defining the center section with oesophagus being most prominent. 4 heads per 
genotype were used for quantification. 
 
Computational analyses  
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Mapping and Histograms:  
Adaptor sequences were removed from the 3' end of the reads in the Illumina fastQ 
generated files using the fastx-toolkit (http://hannonlab.cshl.edu/fastx_toolkit/). The 
adapter sequences are as follows: 
5' adapter = 5'- GUUCAGAGUUCUACAGUCCGACGAUC- 3' 
3' adapter = 5'- TGGAATTCTCGGGTGCCAAGG- 3’  
Reads were then collapsed and annotated with the number of times each was sequenced, 
and only unique reads were analyzed.  Reads were filtered based on bp size, such that 
reads less than 16 bp or greater than 30 bp were discarded. The remaining reads were 
than mapped using Bowtie to the Drosophila melagonaster (dm5) genome and 
microRNA stem-loop sequences obtained from mirBase (release 20). Bowtie parameters 
were restricted to only output perfectly aligned matches to the stemloop sequence.  The 
reads were aligned and mapped to entire miRNA stem-loops. After aligning, each read 
was either annotated as a 5P or a 3P. To do this, the stem-loop sequence was split in half, 
with the first half designated the 5’ arm and the second half designated the 3’ arm, as the 
start and end positions of most microRNAs are imprecise.  
 
Change in the read number and percentage of total microRNAs and other classes of 
small RNAs (see Figure 4.6A):  
All processed reads were first mapped to transposons annotated by the Flybase. The rest 
of the reads were stored and mapped to microRNA stem-loop regions, as well as known 
ncRNAs (snRNAs, snoRNAs, tRNAs, and rRNAs) and the rest of the genome (defined as 
"ncRNA" and "genome" by Flybase). 
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Identification of preferentially Ago2-loaded miRNA isoforms at 3d and 30d (Figure 
4.8):  
We identified miRNA isoforms preferentially loaded into Ago2 compared to Ago1 for 
flies of different age using a measure of “Ago2/Ago1 relative load ratio”, or R21. The 
most abundant isoform from each miRNA stem (5p or 3p) from Ago2-IP 3d library was 
selected. For all the isoforms in each library that start with the same 5'nt position, we 
denoted the share of each isoform silib, such that ∑isilib = 1 in each library, and the share 
of the most abundant isoform Slib. The age ratio for 3d flies was R3d21 = S3dAgo2/S3dAgo1 (x-
axis in Figure 4.8A) and for 30d, R30d21 = S30dAgo2/S30dAgo1 (y-axis of Figure 4.8A).  
5p and 3p miRNA stem sequences were classified as “mature” and “star”, based on their 
relative (high and low, respectively) deep sequencing read counts in the Ago1 sample at 
3d (strand with S3dAgo1 being the mature strand). If there was a discrepancy of the 
relatively more abundant stem (5p or 3p) between Ago1-3d and any of the other three 
libraries (Ago2-3d, Ago1-30d, and Ago2-30d), those cases were removed. This was 
because, in order to compare the ratio of a specific isoform between Ago1 and Ago2, 
after assigning "mature" or "star" category, the mature and star categories have to be 
consistent among all four libraries. In other words, we made sure that the same isoform is 
consistently called "mature" or "star" in all four libraries (Ago1-3d, Ago1-30d, Ago2-3d, 
Ago2-30d). We also filtered out any miRNAs that were less than a 1000 read count 
threshold.  
Note that miR-34-18nt, miR-276a-5p-17nt, miR-276b-5p-17nt, and miR-981-5p-21nt 
showed extremely high R21 ratio at 3d and/or 30d (> 16, Table 4.2 and 4.3). This suggests 
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much higher accumulation of these miRNA isoforms in Ago2-IP, compared to Ago1-IP 
at 3d and/or 30d. This could happen because of biologically relevant upregulation of 
these miRNA isoforms, or some artifacts, such as cloning bias or degradation from the 
corresponding longer isoforms. These miRNA isoforms were removed from Figure 4.8, 
because including the dots corresponding to these miRNA isoforms obscured the 
distribution of the other dots in the plot (Figure 4.8A). miR-34-18nt was undetectable by 
Ago1 vs Ago2-IP northerns. Therefore most-likely miR-34-18nt is an artifact. 
 
Change in read number of preferentially Ago2-loaded isoforms with age (Figure 
4.8B):   
After identifying preferentially loaded Ago2 isoforms we calculated a ratio of normalized 
reads at 30d and 3d for each specific isoform. The ratios (fold change) was plotted as in 
Figure 4.8B. 
  
 Table 4.1. Change of miRNA and siRNA components, and Ago2
in aging microarray (3d
Note that Ago2 and R2D2 showed little change with age by western blots (Figure 4.4). 
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-loading machinery 
, 30d, and 60d wild-type brains) (data from Liu et al., 2012). 
 
 
 Table 4.2. Ago2/Ago1 loaded ratio of each mature miRNA isoform with > 1000 raw 
reads at 3d and 30d.  
5p and 3p sequences were classified as “mature” or
abundance in the Ago1-IP 3d library: those with a higher read number compared to the 
read number from the other strand of the stemloop were defined as “mature”. 
Note that we have removed outliers with extremely large ratio
visibility of other miRNA isoforms in Figure 4.8A.
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 “star”, based on their relative
 for the purpose of 
 
 
 
 
 Table 4.3. Ago2/Ago1 loaded ratio of each star miRNA isoform with > 1000 raw 
reads at 3d and 30d. 
5p and 3p sequences were classified as “mature” or
abundance in the Ago1-IP 3d library: those with a lower read number compared to the 
read number from the other strand of the stemloop were defined as “star”.
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 “star”, based on their relative
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Figure 4.1. Nbr-dependent miRNAs show distinct isoform patterns with age. 
Northern blots of different Nbr-dependent miRNAs with age.  
(A, B) miR-34-5p and miR-317-3p showed accumulation of short isoforms with age (A, 
(B left panel)). Both miR-34-5p and miR-317-3p also increased in total amount with age 
(B, right panel).   
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(C, D) miR-305-5p and miR-263a-5p showed accumulation of long isoforms with age (C, 
D left panel). Both miR-305-5p and miR-263a-5p increased in total amount with age (D, 
right panel).   
(E, F) miR-11-3p, a single form miRNA by northern, accumulated with age.  
(B, D, F)  Left panel: Quantification of the different isoforms of each miRNA. Arrows 
indicate the isoforms increased with age.  
Right panel: Quantification of the total amount of each miRNA with age. Red arrowheads 
and arrows indicate the isoforms that increased with age.   
Mean ±SD (n=3), *p<0.05  (Student’s t-test).  
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Figure 4.2. Age-associated increase of long isoforms of miR-305, miR-263a/b, and 
miR-11 is associated with increased protection from oxidation/β-elimination.  
Northern blots of miR-305, miR-263a/b and miR-11, miR-34 and miR-317, without (left 
side of each miRNA panel) and with (right side of each miRNA panel) treatment by 
oxidation/β-elimination, with quantitation.  
(A) All isoforms of miR-34 were sensitive to oxidation/β-elimination. The longest 
isoform of miR-317 was protected (arrowheads), but there was a decrease in the ratio of 
the protected isoform with age.  miR-305, miR-263a/b, and miR-11 show accumulation 
of a protected long isoform with age (arrows). (B) Ratio of oxidation/β-elimination 
protected isoforms to unprotected isoforms with age.  Mean ±SD (n=3, *p<0.05  
(Student’s t-test)).  
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Figure 4.3. The age-associated increase of the long isoforms of miR-305, miR-263a, 
and miR-11 is eliminated upon hen1 and ago2 mutation.     
Northern blots of each miRNA with or without oxidation/β-elimination at 3d and 30d in 
wild-type, hen1foo810, and ago2BL16608 animals.  Red arrowheads indicate the isoforms that 
are protected after oxidation/β-elimination in wild-type; these forms for miR-305, miR-
263a/b, and miR-11 were no longer protected in hen1 foo810 and ago2BL16608 mutant 
animals.  The long forms of miR-317 remained protected in hen1foo810 and ago2BL16608 
animals, indicating an alternative mechanism by which the long isoform accumulates for 
this miRNA.  
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Figure 4.4. Increased Ago2 loading of long miRNA isoforms with age. 
(A) Northern blots for small RNAs on RNA isolated from (left) Ago1-IP and (right) 
Ago2-IP (FLAG-HA-Ago2). (B) Quantification of esi-2.1 level with age (mean ±SD 
(n=4), Student’s t-test confirmed no significant differences with age). There is no change 
in esi-2.1 levels with age. (C~E) Quantification of miRNA isoforms loaded into Ago2 
with age, normalized to esi-2.1 in Ago2-IP. Mean ± SD (n=3), * p<0.05 (Student's t-test). 
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For all three miRNAs, the Ago2-loaded isoforms increase with age. (F) Western 
immunoblot for Ago2 and R2D2 with age. (G) Quantification of Ago2 protein level with 
age. Mean ± SD (n=3) (Student's t-test). (H) Quantification of R2D2 protein level with 
age. Mean ± SD (n=4) (Student's t-test).  
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Figure 4.5. Western blot for Dcr-2 from flies and cell line (DL1). 
Dcr-2 is detected from flies with upregulated dcr-2 and from DL1 cells, but is not 
detectable in wild-type flies or DL1 cells treated by dcr2 RNAi. 
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Figure 4.6. Ago1 vs Ago2-IP small RNA deep-sequencing with age. 
(A) Normalized read number of total miRNAs in Ago1 or Ago2 with age. (B) Percentage 
of miRNAs and other small RNAs in Ago1 and Ago2 with age. (C) miR-305-5p, miR-
263a-5p, and miR-11-3p show the trend of a decrease in Ago1, but an increase of specific 
isoforms in Ago2 with age.  
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Figure 4.7. Total read number and percentage of miRNAs in Ago2-IP small RNA 
deep-sequencing after removing miR-263a-5p. 
Because miR-263a-5p comprised 52% (3d) to 57% (30d) of the total miRNA reads in 
Ago2-IP, we also calculated the loading in Ago2 subtracting the miR-263a-5p reads. (A) 
Normalized read number of total miRNAs in Ago2 after removing read counts of miR-
263a-5p. (B) Percentage of miRNAs and other small RNAs in Ago2 after removing miR-
263a-5p. 
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Figure 4.8. Identification of Ago2-loaded miRNA isoforms whose loading increases 
with age. 
(A) Dot plot showing the ratio of preferentially Ago2-loaded isoforms at 3d (X-axis) to 
30d (Y-axis). The line indicates equal loading at 3d and 30d; those miRNAs to the left of 
the line show increased loading at 30d compared to 3d. This plot highlighted those 
miRNAs preferentially loaded into Ago2 at 3d or 30d, respectively (miR-305-5p, miR-
263a-5p, and miR-11-3p are clearly seen, full lists in Tables 4.2 and 4.3). The R21 interval 
[0,1] on both x and y-axis contains the miRNAs with higher loading into Ago1 than 
Ago2. Note that miR-34-18nt, miR-276a-5p-17nt, miR-276b-5p-17nt, and miR-981-5p-
21nt showed extremely high R21 ratio at 3d and/or 30d (> 16, Table 4.2 and 4.3). This 
suggests much higher accumulation of these miRNA isoforms in Ago2-IP, compared to 
Ago1-IP at 3d and/or 30d. This could happen because of biologically relevant 
upregulation of these miRNA isoforms, or some artifacts, such as cloning bias and 
degradation from the corresponding longer isoforms. These miRNA isoforms were 
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removed from Figure 4.8, because including the dots corresponding to these miRNA 
isoforms obscured the distribution of the other dots in the plot (Figure 4.8A). miR-34-
18nt was undetectable by Ago1 vs Ago2-IP northerns. Therefore most-likely miR-34-
18nt is an artifact. (B) Fold change of preferentially Ago2-loaded miRNA isoforms with 
age (30d/3d).  
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Figure 4.9. Mutations in hen1 and ago2 are associated with age-dependent brain 
degeneration and shorter lifespan.  
(A) Paraffin sections of wild-type, hen1f00810 , ago2BL16608, ago2414/+, and ago2414 heads 
at 3d and 30d. Scale bar = 0.1 mm.  The abundant vacuoles that are present in 30d 
animals in the mutants are highlighted in yellow.  
(B) Quantification of brain vacuoles in lamina.  
(C) Quantification of brain vacuoles in retina.  
(C) Lifespan of wild-type, hen1f00810, and ago2BL16608 mutants.   
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Figure 4.10. Duplex structure of preferentially Ago2-loaded miRNAs (from 
miRBase). 
The stem-loop structure is shown for each miRNA (from miRBase). miRNA/miRNA* 
duplexes are highlighted by pink. The characteristics of each miRNA/miRNA* duplex is 
described on the right of each panel.  
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CHAPTER 5 
 CONCLUSIONS AND FUTURE DIRECTIONS 
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Increasing evidence suggests that miRNAs show heterogeneity in different cell types and 
biological contexts (Ruby et al. 2006; Landgraf et al. 2007; Ruby et al. 2007; Wu et al. 
2007; Kuchenbauer et al. 2008; Morin et al. 2008; Sdassi et al. 2009; Burroughs et al. 
2010; Marti et al. 2010; Reese et al. 2010; Wyman et al. 2011; Westholm et al. 2012). 
However, there has been a gap in our knowledge between the accumulating evidence of 
miRNA heterogeneity in different biological contexts, and whether such heterogeneity is 
biologically regulated or functionally significant.  
 
The research described in this thesis extends our knowledge of how such heterogeneity is 
generated, whether it could be biologically important, and whether miRNA heterogeneity 
changes in the aging context. Below I summarize the major points and significance of 
each chapter, followed by discussion on important future questions and approaches. 
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CONCLUSIONS AND SIGNIFICANCE OF THIS STUDY  
In chapter 2, we reported a characterization of a 3'-to-5' exonuclease, Nbr, which is 
responsible for generating 3' end heterogeneity of a subset of miRNAs in Drosophila. It 
has been known that the 3' ends of miRNAs are highly heterogenous, potentially subject 
to adenylation, uridylation, 2’-O-methylation and trimming (Ameres et al. 2010; Neilsen 
et al. 2012). Despite the accumulating knowledge of such heterogeneity and the 
identification of the enzymes responsible for uridylation, adenylation, and 2’-O-
methylation, there had been no report on a 3’-to-5’ exonuclease that fine-tunes the 3' end 
of miRNAs. Our study in chapter 2 is the first report to show that miRNA 3' end 
heterogeneity is fine-tuned by a specific exonuclease activity. This report raised the 
question of whether such 3' end trimming activity of miRNAs is biologically important. 
Even though my reporter assays did not clearly show the effects of loss of 3' end 
trimming by Nbr of miRNAs on the target reporter silencing (Figure 2.8), the 
experiments from Zamore’s group showed slight decline in miRNA silencing activity 
upon nbr interference (Han et al. 2011). This indicates an impact of lack of 3' end 
trimming of miRNAs on control of miRNA target silencing. Still, it remained unclear 
whether nbr has a significant biological impact in vivo. This led us to analyze the effect 
of loss of function mutation of the nbr gene in chapter 3. Although our initial work and 
that of Zamore’s lab (Han et al. 2011; Liu et al. 2011) had suggested nbr knock-down 
was lethal or semi-lethal, we subsequently revealed that this lethality is not associated 
with the nbr gene.  In chapter 3 we showed that nbr loss leads to intriguing adult defects, 
such as held-up wings, decline in climbing ability and earlier onset of brain degeneration. 
Since these phenotypes were rescued by wild-type, but not by a catalytically mutated, nbr 
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transgene, this finding suggests that Nbr’s exonuclease activity is critical for these 
effects. Given the range and severity of phenotypes, it was possible that Nbr had 
additional targets, such as other classes of small RNAs. We investigated a role in small 
RNAs in the ovary by deep-sequencing analysis, to find that Nbr affects the length of 
piRNAs and endo-siRNAs. That these RNA classes are also affected raises the possibility 
that Nbr might target an even broader range of RNA species, including long and short 
ncRNAs or even protein coding mRNAs. Therefore, the observed phenotypic effects 
upon nbr loss might reflect defects on not only miRNAs, but also other classes of RNA 
species not yet analyzed.  
 
In chapter 4, we characterized the pattern change with age of several Nbr-dependent 
miRNAs. This was driven by the finding that miR-34-5p, the representative Nbr-
dependent miRNA, accumulates only the short isoforms, but not the long isoform, with 
age (Liu et al. 2012), raising the possibility that other Nbr-dependent miRNAs might also 
show accumulation of their short isoforms with age. This led to the unexpected finding 
that Nbr-dependent miRNAs show distinct but variable age-associated patterns: some 
show the accumulation of the short isoforms, like in the case of miR-34-5p, while others 
show the accumulation of the long isoforms with age. By addressing how the long 
isoforms accumulate with age, we discovered that the increase of the long isoforms 
reflects an increase in 2’-O-methylation at the 3' end of the specific isoforms. Reflecting 
that Ago2-loaded, but not Ago1-loaded, small RNAs are 2’-O-methylated at the 3' end in 
Drosophila (Hutvagner et al. 2001; Okamura et al. 2004; Vagin et al. 2006; Forstemann 
et al. 2007; Horwich et al. 2007; Ghildiyal et al. 2008; Czech et al. 2009; Okamura et al. 
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2009), the increase of the 2’-O-methylated isoforms was correlated with the increased 
loading of those specific isoforms into Ago2 with age. This finding led us to globally 
define the loading pattern of miRNAs in Ago1 and Ago2 with age (3d vs 30d). Small 
RNA deep-sequencing of Ago1- vs Ago2-loaded small RNAs revealed that the total read 
number and percentage of miRNAs increased in Ago2, but not in Ago1, with age. This 
suggests a mechanism that selectively increases the loading of miRNAs into Ago2, but 
not Ago1,  with age. This is the first evidence showing that 2’-O-methylation of 
miRNAs, which is correlated with the change in the loading pattern between the two Ago 
complexes, dramatically change in a specific biological context, such as with age in 
animals.  
 
In the following, I will discuss additional future questions that are highlighted from our 
findings in the above chapters. 
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ADDITIONAL QUESTIONS AND POTENTIAL APPROACHES 
Nbr regulates only select miRNAs for their length control 
Our work (chapter 2 and (Liu et al. 2011)) and the study from the Zamore group (Han et 
al. 2011) revealed that Nbr affects the length of only a subset (~25% in S2 cells) of 
miRNAs in Drosophila (Han et al. 2011; Liu et al. 2011). One question is how Nbr 
selects only specific miRNAs for length modulation. One simple possibility is that, after 
the cleavage by Drosha and Dcr-1, those Nbr-dependent miRNAs might have longer 
length compared to other miRNAs that are independent of Nbr, before being incorporated 
into Ago1. This might be possible, since several representative Nbr-dependent miRNAs, 
such as miR-34-5p, miR-305-5p, and miR-263a-5p all show the accumulation of 24nt 
isoforms as well as the short isoforms in wild-type, while Nbr-independent miRNAs, 
such as miR-277 and miR-14 show main isoforms of 22nt and 20nt, respectively. Thus, it 
is possible that the slightly longer length 3' end of these miRNAs is subject to trimming 
by the exonuclease activity of Nbr. However, this is probably not the only mechanism to 
select target miRNAs of Nbr: miR-317 accumulates 20 and 21nt as the main isoforms in 
wild-type (Figure 2.7), however, upon nbr loss the short isoform (20nt) decreased, while 
the long (21nt) isoform accumulated (Figure 2.7). This suggests that there is a mechanism 
to select the miRNAs targeted by Nbr, independent of the mere absolute length of the 
miRNAs after Drosha and Dcr-1 cleavages. 
 
Another possibility is that Nbr might recognize a sequence motif present in Nbr-
dependent miRNA or miRNA precursor sequences. It has been shown that terminal loops 
of select pre-miRNAs are critical for recruiting specific RNA binding proteins to regulate 
 191
the processing by Drosha and Dicer. For example, LIN28 is an RNA binding protein that 
recognizes the loop sequence in the let-7 stem-loop (Neilsen et al. 2012). The binding of 
LIN28 to the let-7 terminal loop negatively regulates the processing by Drosha and Dicer. 
Thus, it might be that the terminal loops of Nbr-dependent miRNAs harbor unique 
structures, such that they are bound by unknown regulators of Nbr-dependent 3' end 
trimming. Such factors might be in a complex with Nbr to regulate its activity. Therefore, 
identification of Nbr-interacting proteins by an unbiased approach, followed by RNAi to 
test the effect on the miR-34-5p pattern, might give insights into whether Nbr activity is 
regulated by other factors, and how Nbr selects specific miRNAs for 3' end processing.  
 
Functional consequences of 3' end processing of miRNAs on target silencing 
Even though a previous study showed that nbr knockdown leads to less efficient 
silencing of a reporter (Han et al. 2011), our luciferase assays in DL1 cells did not reveal 
a clear effect of nbr knockdown (Figure 2.8). Residual Nbr protein after knocking down 
of the nbr gene might diminish the effect of nbr on the reporter silencing. If this is the 
case, performing reporter assays in vivo in a nbr null background might be useful. 
Further, additional targets, including the targets of additional miRNAs should be tested: 
now that we have several confirmed targets of Nbr-dependent miRNAs, such as E74A by 
miR-34-5p (Liu et al. 2012), and W (hid) by miR-263a-5p (Hilgers et al. 2010), it is 
feasible to do such experiments.   
 
Conservation of 3' end trimming of small RNAs in other species 
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Similar to Drosophila miRNAs, mammalian and C. elegans miRNAs also show 
extensive heterogeneity at the 3' end, as revealed by small RNA deep-sequencing 
analyses in different cell types and biological contexts (Ruby et al. 2006; Landgraf et al. 
2007; Burroughs et al. 2010; Wyman et al. 2011). Even though at least some of the 
enzymes responsible for adenylation, uridylation, and 2'-O-methylation have been 
identified in mammals (Horwich et al. 2007; Kirino and Mourelatos 2007b; Jones et al. 
2009; Katoh et al. 2009; Jones et al. 2012) and C. elegans (Ibrahim et al. 2010; Billi et al. 
2012), no 3'-to-5' exonuclease that trims the 3' end of mammalian and C. elegans 
miRNAs has yet been reported. From phylogenetic studies, Nbr belongs to the RNase D 
family of 3'-to-5' exonucleases. The closest homologs of Nbr include human EXD3, and 
C. elegans mut-7 (Figure 2.5D). However, whether the loss of these components leads to 
accumulation of long isoforms of miRNAs is not yet known. Testing the effects of the 
loss of these components on the length of miRNAs would expand our knowledge of how 
3' end trimming of miRNAs is conserved and regulated across species.  
 
Mechanism by which Nbr modulates the length of miRNAs, piRNAs and endo-
siRNAs 
From our studies in chapter 2 and chapter 3, Nbr affects the length of not only miRNAs, 
but also piRNAs and endo-siRNAs. Since the knockdown of ago1 led to the 
accumulation of long isoforms of miRNAs (Figure 2.3A), which phenocopied the loss of 
nbr, and since Nbr coimmunoprecipitates with Ago1 (Figure 2.3B), it is likely that Nbr is 
in a complex with Ago1 to trim the 3' end of miRNAs. How could Nbr affect the length 
of piRNAs and endo-siRNAs? Given that both piRNAs and endo-siRNAs are 2’-O-
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methylated at the 3' end, and that 2’-O-methylation at the 3' end of small RNAs is 
protective from 3' end trimming and tailing of small RNAs (Ameres et al. 2010), it is 
likely that the length of these two classes of small RNAs are regulated before Hen1-
mediated 2’-O-methylation at the 3' end. One possibility is that, analogous to Nbr-Ago1 
protein-protein interaction, Nbr might make a complex with PIWI-clade proteins (Aub, 
Piwi, and/or Ago3) or Ago2 to trim the 3' end of piRNAs or endo-siRNAs, respectively, 
prior to Hen1-mediated 2’-O-methylation. CoIPs between Nbr and PIWI-clade proteins 
or Ago2 is a potential experiment to do. Alternatively, based on the report that the three 
PIWI-clade proteins (Aub, Piwi, and/or Ago3) are loaded with slightly different length of 
piRNAs (Brennecke et al. 2007), it is possible that Nbr indirectly affects the length of 
piRNAs by affecting the loading pattern of piRNAs into different PIWI-clade proteins. 
To test this possibility, immunoprecipitation of Aub, Piwi, and Ago3 followed by 
northern blots and small RNA deep-sequencing in wild-type and nbr null background 
will reveal whether the loading pattern of piRNAs is affected by nbr loss among the 
different PIWI-clade proteins.  
 
Functional consequences of loss of nbr on piRNA and endo-siRNA targets 
Even though Nbr affects the length of piRNAs and endo-siRNAs, the functional 
consequence of the fine-tuning of the length of piRNAs and endo-siRNAs is not yet 
defined. Examining the expression level of several key endogenous targets or reporters 
(such as transposons from which abundant piRNAs and endo-siRNAs are generated) is an 
obvious experiment to do. However, it is of note that nbr loss did not lead to any obvious 
defects in ovary development (Figure 3.3), by contrast to the severe defects by the loss of 
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key components on piRNA biogenesis pathway, including Piwi, Aub, and Ago3 (Lin and 
Spradling 1997; Cox et al. 1998; Harris and Macdonald 2001) that lead to transposon 
activation. Therefore it might be unlikely that we will see such a dramatic effect on the 
expression level of the targets upon nbr loss, but rather the effect of nbr loss may be 
subtle (as with the effect on the miR-34 target reporter (Han et al. 2011)).  
 
Inconsistency between Nbr expression and the affected tissues upon nbr loss 
In line with the observation that nbr null ovaries did not show obvious morphological 
defects, it is intriguing that the Nbr expression pattern does not necessarily correlate with 
the tissues that are affected by nbr loss. Nbr is highly enriched in ovaries compared to 
other adult tissues (Figure 3.1A), in spite of the lack of any obvious defects in ovary 
development upon nbr loss. Further analysis of the ovary for markers of pattern 
formation may be appropriate. The wing posture defects of the nbr null chromosome 
combination (Figure 3.4) potentially reflect defects in either the thoracic muscles or the 
motor neurons. However Nbr is not likely enriched in thorax tissue compared to ovary 
and heads, given the very low level of Nbr in the body after removal of the head and 
ovary (Figure 3.1A). Considering that wild-type Nbr successfully rescued these 
phenotypes, and that the rescue depended on the catalytic residues of Nbr, this might 
suggest a cell specific expression pattern of Nbr or a potential cell non-autonomous role 
of Nbr to control these effects. Intrigued by these observations, we tried to define the 
critical tissues for Nbr’s function by directing Nbr expression to select tissues, using 
neuronal (elav, OK371, D42)- or muscle (24B)- specific GAL4 drivers with UASp-HA-
nbr transgene. However, we discovered that all of the UASp-HA-nbr transgenic lines 
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could rescue in the absence of directed expression, such that the phenotypes of nbr null 
were rescued without a GAL4 driver. This indicates that this phenotype is sensitive to 
low levels of Nbr expression. Even though such technical limitation hindered us from 
addressing the critical tissues for Nbr function in this effect, an alternative approach, such 
as tissue-specific RNAi against nbr in vivo, might reveal the specific cell types in which 
Nbr is critical to modulate wing posture (whether nervous system or muscle).   
 
This point leads to another question: what are the downstream targets of Nbr that cause 
such phenotypes upon nbr loss? Previously, we performed microarray in DL1 cells after 
nbr dsRNA knockdown to find targets of nbr function in cells. Some of these identified 
genes were upregulated in nbrf02257 whole flies (Figure 2.4G,H). However, because of the 
potential tissue-specific functions of Nbr, the complication of the germline in whole fly 
studies, and the background effects in nbrf02257 (Note:  homozygous nbrf02257 phenotypes 
were not rescued by the wild-type genomic-nbr transgene), it is necessary to perform 
gene expression profiling using specific tissues, such as brains and thoraces in nbr null, to 
identify biologically relevant targets of Nbr in vivo. In parallel, predicting genes that are 
potentially targeted by Nbr-dependent miRNAs, using target prediction programs such as 
miRanda, Pictar, and Target Scan, might eventually identify biologically relevant 
downstream targets of Nbr in vivo. 
 
Mechanism to control differential loading of miRNAs into Ago1 vs Ago2 with age 
Our analysis in chapter 4 revealed that the increase in 2’-O-methylation of miRNAs with 
age reflects an age-associated increase in Ago2-loading of miRNAs. What could be the 
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mechanism to selectively increase Ago2-loading of miRNAs with age? Our studies and 
the previous microarray analysis of brains with age (Liu et al. 2012) revealed that the 
level of Ago2, Ago2-loading machineries (Dcr2 and R2D2), or Hsp90/Hsp70 complex do 
not significantly change with age (Figure 4.4F,G,H, Table 4.1). Therefore it is likely that 
the increase of Ago2-loading of miRNAs with age reflects a mechanism that is 
independent of changes in levels of these components. One possibility is the existence of 
specific factors that might be in a complex with Ago2 and the Ago2-loading machineries. 
Identifying proteins interacting with Ago2 in young vs old flies might reveal the factors 
that are in a complex with Ago2 in age-associated manner. Testing the role of such 
factors on miRNA loading into Ago2 with age would reveal whether such factors are 
responsible for controlling differential loading of miRNAs into distinct Ago complexes 
with age. 
 
Functional consequence of loss of 2’-O-methylated small RNAs with age 
Since hen1 and ago2 mutations, which result in the loss of 2’-O-methyaltion of small 
RNAs, led to age-associated defects, such as accelerated brain degeneration and shorter 
lifespan, it is likely that protecting the 3' end of small RNAs is critical for regulating age-
associated processes. Does this reflect the effect of the loss of 2’-O-methylation of 
miRNAs, or an impact on other classes of 2’-O-methylated small RNAs such as piRNAs 
and endo-siRNAs? Since the loss of 2’-O-methylation of small RNAs leads to potential 
destabilization of all of these small RNAs (Kurth and Mochizuki 2009; Ameres et al. 
2010; Kamminga et al. 2010), it is possible that the phenotypic effects in hen1 and ago2 
reflect the accumulating effects of destabilized miRNAs, piRNAs, and endo-siRNAs. 
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Regarding this, it is intriguing that transposon expression, which is controlled by endo-
siRNAs and piRNAs, increases with age in C. elegans and Drosophila (Lund et al. 2002; 
Li et al. 2013). Even though these studies did not observe the level of the corresponding 
endo-siRNAs or piRNAs from the affected transposon loci with age, one possibility is 
that the increased transposon expression level with age reflects decreased endo-siRNA or 
piRNA levels from the corresponding loci with age. Based on these insights, one 
possibility is that the age-associated defects observed in hen1 and ago2 mutants reflect 
the effect of the upregulated transposons on genome integrity with age. Alternatively or 
not in a mutually exclusive manner, the defects in hen1 and ago2 mutants might reflect 
the effect of the destabilization of the 2’-O-methylated miRNAs. Loss of 2’-O-
methylation of miRNAs is expected to lead to a decreased amount of miRNAs loaded 
into Ago2. Previous studies reported that both Ago1- and Ago2-loaded miRNAs are 
active on silencing targets (Czech et al. 2009; Iwasaki et al. 2009; Okamura et al. 2009). 
Intriguingly, biochemical studies showed that Ago1 and Ago2 potentially employ distinct 
mechanisms to silence the target mRNAs: while the silencing by Ago1-loaded let-7 
entails removal of the poly A tail from the target mRNA, the silencing by Ago2-loaded 
let-7 retains the poly A tail (Iwasaki et al. 2009). The in vivo significance of this 
phenomenon is not yet revealed. However one possibility is that, by retaining the poly A 
tail, Ago2-loaded miRNAs might be able to switch on and off target gene translation in 
more rapid manner, in order to cope with internal or external stresses that accumulated 
with age. Biochemical assays to measure the rate of silencing by Ago1- and Ago2-loaded 
miRNA, as well as the rate of re-activation after inhibiting the miRNA in each Ago 
complex, might provide insights into this possibility. 
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APPENDIX 
 
DETAILED PROTOCOLS ON SELECT EXPERIMENTS 
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RNA prep by Trizol 
- Always minimize the chance of contamination of RNase.  
- Pay close attention to what is contaminated or not, and what you touch with your 
fingers in the work area.  
- When you feel you touched anything NOT RNase-free, change gloves or at least wipe 
the fingertips with RNaseZAP. 
- When pipetting, always use filter tips. 
 
1. Before starting experiments, spray bench area with Windex and/or 70% EtOH to 
remove dust and spilled buffer etc. You can NEVER remove RNase with Windex 
or 70% EtOH. This just removes dust and spills. 
 
2. Wash tube racks with water and soap (hand-soap or dish-soap), wipe with paper 
towels. This again is to remove dust and spilled buffer etc. on the tube racks. 
 
3. Put a sheet of plastic wrap on the work area of bench. Perform all procedure on 
the plastic wrap. This is based on the assumption that plastic wraps should be 
minimized with dust and RNase contamination. Still no guarantee. 
 
4. Spray tube racks and pipetters (P1000, P200, P20, and P2) with RNaseZAP, wipe 
with Kimwipes or paper towels. 
 
 200
5. Take out RNase free tubes (Ambion) without directly grabbing the tubes (just 
shake the bag a bit and drop the tubes directly on the plastic wrap). When closing 
caps, never touch inside of the cap.  
 
When prepping RNA from flies 
6. Add 300ul of Trizol in each tube, and put flies in there. I wouldn't exceed 15 flies 
in each tube. 
 
7. Grind completely: use pestles from Kimble Chase (1.5 mL Pestle, cat#749521-
1500). Make sure the tissue is in between the pestle and the side or bottom of the 
tube, not floating around. Grind by turning the pestle clockwise and counter-
clockwise, until you see as uniform a suspension as possible. You cannot grind 
the cuticle completely, so there's always some leftover chunk of tissues in there. 
Just do your best. 
 
(When prepping RNA from Drosophila cells) 
• Add 1mL of Trizol directly onto cell pellet (1.5 mL tube or 15mL tube). Lyse cells 
by pipetting until you see a uniform suspension. The pellets can be fresh or frozen 
(-80deg).  
 
 
8. In the chemical hood, add 200ul chloroform to each tube (in the hood). Do not 
directly pipet chloroform from the bottle into each tube. First transfer >the total 
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amount into a 15mL or 1.5mL tubes, then take 200ul from that aliquot. Chemical 
hood is not clean, so pay very close attention not to touch anything dirty (in terms 
of RNase) in there with your pipet or fingers.  
 
9. Vortex tubes ~15sec, leave at room temperature for ~2min. 
 
10. In cold room, in the RNase-free centrifuge, spin tubes at 12,000g for 15min. I 
usually spray the rotor of the centrifuge with RNaseZAP and wipe with 
Kimwipes. We never know who spins what. 
 
11. Put tubes on ice. The original protocol from Invitrogen says room temperature, 
but I do everything on ice from this point on to minimize potential degradation of 
RNA. It works well.  
 
12. Transfer the upper phase into new RNase-free tubes (Ambion). Keep everything 
on ice. Pipet up very slowly so you never pipet up the middle phase. 400ul is the 
most conservative. I usually stop ~500ul. If I try to pipet more than that, 
occasionally I get contamination of the mid phase.  
 
13. Add equal volume of 100% isopropanol. I prepare 50mL stock tube of 
isopropanol only for RNA. I never use this for DNA work. 
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14. Vortex tubes for a few seconds. Optionally I leave the tubes at -80deg for >30min 
to increase the yield (Gert-jan said his new lab does it this way and this increased 
the yield).  
 
15. Centrifuge tubes at 15,000rpm for 30min~1h (depending on the schedule) in cold 
room, RNase-free centrifuge.  
 
16. Remove supernatant 
 
17. Add 500ul 70~80% EtOH (RNase-free), vortex for a few seconds. 
 
18. Centrifuge at 15,000rpm for 5min in cold room, RNase-free centrifuge 
 
19. Remove supernatant 
 
20. Centrifuge tubes briefly in cold room, RNase-free centrifuge. I usually use "short" 
spin button to go up to ~10,000rpm. 
 
21. Carefully pipet up residual EtOH by P20 or P200 pipet. Do not touch the pellets. 
 
22. Dry pellets briefly (1~2min) at room temperature on your bench. When drying I 
put a piece of Kimwipe on top of the tubes to avoid dust coming into the tubes. 
The lab is full of dust. 
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23. Add appropriate amount of DEPC-water (30~50ul) (I use a bottle of DEPC-water 
only for RNA), and resuspend pellets by pipetting. You should see pellets 
dissolving completely. If you cannot dissolve pellets completely, add more DEPC 
water. 
 
24. Always keep tubes on ice.  
 
25. To assess quality of the preparation:  
 
a. Always measure concentration by Nanodrop. A260/280 ratio should be 
1.9~2.1. Pay close attention to potential RNase contamination from 
Nanodrop area. People use the area for DNA work as well. I usually do 
not touch the keyboard and mouse directly with fingers. I put a Kimwipe 
on the keyboard and mouse to avoid direct contact. 
b. When learning how to get outstanding quality RNA, run ~1 ug/lane of 
RNA on a 1% Agarose TBE gel (use RNase free water. Ideally DEPC-
treated water, but Millipore water should also work).  Below is an example 
of how a gel should look.  
c. Optional: Bioanalyzer can be used once RNA preps look good by agarose 
gel, to confirm outstanding quality – please note that this is very sensitive. 
Pay close attention to potential RNase contamination from Bioanalyzer 
area. People use the area for DNA work as well. I do not touch the 
 keyboard and mouse directly with fingers. I put a Kimwipe on the 
keyboard and mouse to avoid direct contact.
 
 
26. RNA is kept at -80C for longterm storage. 
 
 
Above shows the pattern of high quality RNA by agarose gel (1% agarose
of RNA run/lane. 
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-TBE), ~ 1ug 
  
 
Above shows pattern of high quality RNA by Bioanalyzer.  Bioanalyzer is a very 
sensitive approach.  It is expensive and RNA does not necessarily need to be outstanding 
by Bioanalyzer, depending upon final use of the RNA (real time PCR &  northern require 
outstanding agarose level RNA, microarray requires bioanalyzer). 
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Oxidation/β-elimination assay of small RNAs 
Materials 
• Total RNA extracted by Trizol reagent (Invitrogen). 
• DEPC water 
• 2xborax/borate buffer (120 mM borax (sodium tetraborate)/120 mM borate (boric 
acid)) 
• 200mM NaIO4 
• 100% glycerol 
• RNeasy mini columns (Qiagen) or NucleoSpin RNA II Columns (Macherey-
Nagel). It is cheaper to use NucleoSpin RNA II columns, and the results are just 
as good as with RNeasy mini columns. 
• Buffer RPE (RNeasy kit) or Buffer RA3 (Macherey-Nagel) 
• 80% EtOH 
• 100% EtOH 
• RNase-free 1.5ml tubes 
• 1M NaOH 
 
Oxidation of RNA 
1. Take at least 10ug of total RNA (extracted by Trizol) for each small RNA tested. 
If testing 5 different small RNAs, take 50ug of total RNA into 1.5 ml RNase-free 
tubes. 
2. Add DEPC water up to 75ul. 
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3. Add 100ul 2x borax/borate buffer to each tube. 
4.  Divide into two tubes (87.5ul each). 
5. Add 12.5ml DEPC water into one tube, and 12.5ul 200mM NaIO4 to the other 
tube, mix briefly by vortex and spin down. 
6. Incubate in dark (like in drawer) at room temperature for 30min. 
7. Add 10ul 100% glycerol in each tube. Mix by pipetting and vortex, then spin 
down. 
8. Incubate in dark at room temperature for 10min. 
9. Add 150ul 100% EtOH in each tube, mix by pipetting. 
10. Transfer each sample to RNeasy column (Qiagen) or NucleoSpin RNA II 
Column. Both types of columns work fine.  
11. Centrifuge at 15,000rpm for 30sec at 4°C. Discard the flow-through. 
12. Add 500ul Buffer RPE or Buffer RA3. 
13. Centrifuge at 15,000rpm for 30sec at 4°C. Discard the flow-through. 
14. Add 500ul 80% EtOH. 
15. Centrifuge at 15,000rpm for 30sec at 4°C. Discard the flow-through. 
16. Centrifuge at 15,000rpm for additional 2min at 4°C.  
17. Transfer columns to new 1.5ml tubes (RNase-free). 
18. Add 50ul DEPC water to each column. 
19. Centrifuge at 15,000rpm for 1min at 4°C. Discard columns. 
20. Add 50ul 2x borax/borate buffer to each tube (in total 100ul). 
 
β-elimination of RNA 
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1. Add 12.5ul 1M NaOH to each tube. Mix by briefly vortexing. 
2. Incubate at 45°C for 90min. 
3. Add 168.75ul 100% EtOH to each tube. 
4. Transfer each sample to RNeasy column (Qiagen) or NucleoSpin RNA II 
Column. Both types of columns work fine.  
5. Centrifuge at 15,000rpm for 30sec at 4°C. Discard the flow-through. 
6. Add 500ul Buffer RPE or Buffer RA3. 
7. Centrifuge at 15,000rpm for 30sec at 4°C. Discard the flow-through. 
8. Add 500ul 80% EtOH. 
9. Centrifuge at 15,000rpm for 30sec at 4°C. Discard the flow-through. 
10. Centrifuge at 15,000rpm for additional 2min at 4°C.  
11. Transfer columns to new 1.5ml tubes (RNase-free). 
12. Add 30~50ul DEPC water to each column. 
13. Centrifuge at 15,000rpm for 1min at 4°C. Discard columns. 
14. Add equal amount (30~50ul) of Gel Loading Buffer II (Ambion). The samples 
can be stored before or after denaturing (99°C for 10min) at -20°C or -80°C for up 
to ~2 weeks for northern hybridization. Follow regular protocol of small RNA 
northerns. 
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mRNA northern hybridization  
Materials 
• Total RNA extracted by Trizol reagent (invitrogen) 
• UltraPure Agarose (invitrogen#16500-100) 
• NorthernMax 10X Denaturing Gel Buffer (LifeTechnologies#AM8676) 
• NorthernMax 10x Running Buffer (MOPS) (LifeTechnologies#AM8671) 
• Size ladder if necessary  
• Formaldehyde Load dye (LifeTechnologies#AM8552) 
• Plastic wrap 
• Filter papers 
• Paper towels 
• Northern Max Transfer Buffer (LifeTechnologies#AM8672) 
• Hybond N+ nylon membrane (GE HealthCare#RPN303B) 
• Transferring pipet 
• UltraHyb hybridization buffer (LifeTechnologies#AM8670) 
• MaxiScript kit (T7 or whichever appropriate enzyme for your probe) 
• P32-alpha UTP (from EHRS) 
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Day 1 
Making RNA denaturing gel 
1. Spray with RNaseZap: gel tray, gel comb, gel running box, 50ml flask, 50ml 
cylinder. 
2. Rinse with MilliQ water twice. 
3. Measure 45ml MilliQ water by 50ml cylinder, and add to 50ml flask. 
4. Weigh 0.5g UltraPure Agarose into the 50ml flask with water. 
5. Microwave for 2min, and cool down at room temperature until touchable 
(50~60°C). 
6. Add 5ml of NorthernMax 10X Denaturing Gel Buffer to the flask, mix by gently 
swirling.  
7. Add 5ul of RNA SYBR green (cat #, co), mix by gently swirling. 
8. Set up gel tray with a comb, pour the melted agarose/Denaturing buffer mix onto 
gel tray. Solidify at room temperature or in cold room. 
 
Preparing RNA/loading buffer mix (do this while you are solidifying the gel) 
1. Take 5~10ug of total RNA into RNase free tubes (such as Ambion's 1.5ml RNase 
free tubes or 8 strip tubes). The amount of RNA to be used should be determined 
empirically for each target you are detecting.  I used 3~5ug for nbr mRNA, and 
5ug~10ug for ago2 mRNA.  
2. Add more than equal volume of Formaldehyde Load dye in each tube. For 
example, if you have 5ul of RNA sample, you should add at least 5ul of 
Formaldehyde dye and mix. 
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3. Heat the samples at 70~95°C for 5min, cool down on ice. 
 
Running RNA on gel 
1. Make 250ml of 1x Running Buffer: take 225ml MilliQ water, add 25ml of 10x 
Running Buffer (MOPS) and mix. 
2. Pour running buffer into gel running box with solidified gel.  
3. Take the gel box in cold room, load samples in each lane. 
4. Run at 100V for 1~1.5h. 
5. Take a gel picture under UV illuminater: you should see bands of 18s rRNA 
(2kb), and RNA size ladder (if available).  
 
Transferring RNA onto membrane 
1. Put a piece of plastic wrap onto bench. 
2. Stack ~10cm of paper towels (cut into a half) onto the plastic wrap. 
3. Put 2 pieces of filter papers onto the paper towels. 
4. Pour NorthernMax transferring buffer into a container (such as empty pipet tip 
box). Filling up to ~2cm from the bottom should be enough. 
5. Cut membrane to the size of the gel, and soak into the transferring buffer. (mark 
the bottom of the membrane with date, and sample/probe name etc.) 
6. Wet one piece of filter paper with transferring buffer, put onto the stack of paper 
towels/filter papers. 
7. Put the wet membrane onto the stack of paper towels/filter papers. 
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8. Put gel onto the membrane. Remove bubbles in between membrane and the gel by 
adding transferring buffer in between with a transferring pipet. 
9. Mark the membrane with a pencil at the position of 18s rRNA (2kb) or at the 
position of each size of ladder, by matching the gel picture and the position of the 
gel. 
10. Add transferring buffer onto gel with transferring pipet. 
11. Wet a filter paper with transferring buffer, put onto the gel. 
12. Cut a piece of long size of filter paper into a half width, soak one side into the 
transferring buffer, and put the other side onto the gel/filter paper stack. 
13. Put a glass plate (or anything hard and flat) onto the stack. 
14. Put a water bottle or flask filled with water onto it. Make it well-balanced so that 
it won't fall off for ~2h or so. 
15. Wait for 1~2h until the transferring is done (the gel gets completely flat by then). 
 
UV crosslinking and hybridization 
1. While transferring is ongoing, warm up the hybridization buffer to 68°C (nbr and 
ago2 mRNA). The temperature should be determined empirically for each probe. 
2. UV crosslinking: after the transferring is done, take out the membrane, and UV 
crosslink in UV Stratalinker 1800 (Press "AutoCrosslink" (1200u joules x100) 
and start). Make sure to keep the transferred side facing up. 
3. Pre-hybridization: put membrane into a hybridization bottle (transferred side 
facing inside), and add ~7 ml of pre-warmed hybridization buffer. Rotate in the 
incubator (68°C) > 30min. 
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4. While pre-hybridization is ongoing, synthesize P32-labeled probe. 
 
Synthesize P32-labeled probe 
1. Use Maxiscript kit. In the case of nbr mRNA probe (T7), mix the followings 
(20ul): 
• 2ul template  
PCR product with T7 sequence:  
In the case of nbr probe template, PCR was performed using the follwoing primers with 
T7 sequence: 
 5’-GAATTCATGGCACGCAAGAGCCACATG-3’ 
5’-GATAATACGACTCACTATAGGGAGAGGCTTCAGAATGAGCTCCAG-3’ 
using wild-type cDNA as a  template. 
• 2ul 10x transcription buffer 
• 1ul each of 10mM ATP, CTP, and GTP 
• 8ul water 
• 2ul T7 enzyme mix 
• 3ul P32-alpha UTP 
2. Incubate at 37°C for 1 hour. 
3. Add 2ul TurboDNase, incubate additional 15min at 37°C. 
4. Raise temperature to 99°C, incubate additional 15min (denaturing). 
5. Add the P32-labeled probe mix into the hybridization bottle (in pre-hybridzation). 
6. Rotate overnight at 68°C. 
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Day 2 (washing and exposure) 
1. Wash the membrane in 2xSSC/0.1% SDS for 30min at 68°C. 
2. Wash the membrane in 0.2xSSC/0.1% SDS for 1h at 68°C. 
3. Expose the membrane onto phosphor screen (4h~overnight) 
4. Scan the image with Typhoon scanner. 
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Ago1 vs Ago2-IP northern, western, and deep-sequencing. 
Materials 
• FLAG-HA-ago2 flies (FlyBase ID: FBst0033242, Bloomington Stock Center)  
• anti-Ago1 antibody (Abcam, ab5070) 
• anti-FLAG M2 beads (Sigma-Aldrich, A2220) 
• Protein A/G agarose beads (Thermo Scientific, 20421) 
• 1M Tris-HCl (pH 7.4) 
• 5M NaCl 
• 1M MgCl2 
• 10% IGEPAL CA-630 (Sigma, I18896) 
• 10% Triton X-100 
• Protease inhibitor cocktail (PIC) (EDTA-free) (Roche, 04693159001 or 
11873580001) 
• DEPC water 
• RNasin (Promega, N2511) or RNaseOUT (Life Technologies, 10777-019) 
• Trizol Reagent (Invitrogen, cat number) 
• chloroform 
• Isopropanol 
• 80% EtOH 
• glycogen, RNase-free (5mg/ml) (AM9510, Life Tehcnologies ) 
 
Lysis buffer (200mM NaCl, for Ago1-IP)  
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(Every time make fresh in DEPC water.) 
• 20mM Tris-HCl (pH 7.4) 
• 200mM NaCl  
• 2.5mM MgCl2 
• 0.5% IGEPAL CA-630 
• 0.1% Triton X-100 
• PIC (Prepare 25x solution from one tablet (good for 10ml) of PIC (EDTA-free), 
and add 1/25 volume) 
 
Lysis buffer (800mM NaCl, for Ago2-IP) 
(Every time make fresh in DEPC water.) 
• 20mM Tris-HCl (pH 7.4) 
• 800mM NaCl  
• 2.5mM MgCl2 
• 0.5% IGEPAL CA-630 
• 0.1% Triton X-100 
• PIC 
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1 bind and wash beads 
Ago1-IP 
• Use 30ul protein A/G agarose beads/IP. 
• Resuspend beads in 1mL lysis buffer (200mM NaCl), wash beads three times in 
lysis buffer (200mM NaCl). Centrifuge at 2300g for 5s and aspirate the 
supernatant. 
• Aspirate lysis buffer, add antibody (5ug for Ago1-IP) and 500ul lysis buffer per 
IP beads. 
• Rotate 45min at 4°C. 
• Wash beads three times with 1mL lysis buffer. Centrifuge at 2300g for 5s and 
aspirate. 
 
Ago2-IP 
• Use 25ul M2 beads (anti-FLAG covalently linked to agarose beads). 
• Resuspend beads in 1mL lysis buffer (200mM NaCl), was beads three times in 
lysis buffer (200mM NaCl). Centrifuge at 2300g for 5s and aspirate the 
supernatant. 
• Aspirate lysis buffer (ready for use in IP) 
 
2 Preparation of tissue lysate/IP 
• Grind tissue by pestles (~40 male flies for IP-northerns and Ago1-IP small RNA 
deep-sequencing. ~200 male flies for Ago2-IP small RNA deep-sequencing) in 
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0.5mL lysis buffer in 1.5ml tube (RNase-free). Add RNasin (or RNaseOUT) to 
0.1U/ul.  
• Sonicate three times, 10s each, 10% power in a bath sonicator (QSonica sonicator 
Q700 in cold room). 
• Centrifuge max speed for 20min. 
• Take supernatant into new tubes. Save 80ul as reference (northern and WB). 
• Add the rest of the lysate onto beads/antibody. 
• Rotate 1h at 4°C. 
• Wash beads 5 times with 1mL lysis buffer. 
• Save beads for WB control (Go to step 7 below for IP-western protocol). 
 
3 RNA extraction 
• Add 1ml Trizol to beads. Vortex 30s to 1min. Could store at -20°C. 
• Add 300ul chloroform and vortex briefly. 
• Let tubes sit at room temperature for 2min. 
• Spin at max speed for 20min, room temperature 
• Collect aqueous phase (~600ul). Add 3ul of glycogen (5ug/ul) and vortex briefly. 
• Add 700ul isopropanol, vortex briefly. Sit tubes at -20°C for 20min. 
• Spin at max for 30min, 4°C. 
• Remove supernatant. 
• Wash pellets with 80% EtOH, spin 5min. 
• Remove supernatant. 
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• Spin tubes at 10,000rpm for a few seconds to collect all residual EtOH to the 
bottom (4°C). 
• Remove all residual EtOH at the bottom by pipetting. Do not touch pellet. 
• Dry pellet on bench, room temperature for 1~2min. 
• Resuspend pellets in 21.5ul DEPC water (could store at -80°C). 
• If doing northern, add equal volume (21.5ul) of Gel loading buffer II (Ambion, 
cat no), denature, and follow regular small RNA northern protocol. 
• If preparing small RNA libraries, go on to the next section (Day2, 
Dephosphorylation of RNA). 
 
Day2 (if making small RNA libraries) 
4 Dephosphorylation of RNA 
• Mix 21.5ul RNA, 2.5ul 10xCIAP buffer, 1ul CIAP (1U/ul, Promega,M182A). 
• Incubate 37°C or 30min. 
• Add 175ul water. 
• Add 200ul (equal volume) of phenol/chloroform/isoamyl alcohol, vortex 
30s~1min. 
• Spin max for 2min, room temperature. 
• Collect aqueous phase, add 2ul glycogen (5ug/ul), 20ul of 3M NaOAC pH5.2, 
550ul cold 100% EtOH. 
• Mix and place at -80°C for 30min. 
• Spin at max for 30min, 4°C. 
• Remove supernatant and wash pellets with 500ul cold 80% EtOH. 
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• Spin at  max for 10min, 4°C. 
• Remove supernatant, dry pellets. 
• Resuspend pellets in 6ul DEPC water. 
 
 5 5' end labeling of RNA 
• Mix RNA (CIAP treated) 6ul, 10xT4PNK buffer 1ul, P32-gamma-ATP 2ul, T4 
PNK 1ul. (PNK, 10U/ul, M0201S, NEB)  
• 37°C for 1h. 
• Add 10ul Gel loading buffer II (AM8546, Life Technologies) 
• Load labeled RNA side by side with pBR322/MspI ladder (P32) onto 15% TBE-
urea gel (The protocol on making the ladder is in (Kirino et al. 2011)) 
• Run 180V 1.5h (or until the dye comes to the bottom of the gel). 
• Disassemble gel, place in between hybridization bags and expose (~5h) (check 
how hot the gel is). 
• Scan images. 
• Print out with the size of the actual gel. 
 
 
6 Gel extraction of RNA 
• Excise the gel piece corresponding to labeled small RNAs with clean razor blade, 
place in a microcentrifuge tube. 
• Add 400ul elution buffer (0.1% SDS, 0.3 M NaOAC, 100 mM EDTA), incubate 
at room temperature for 12~16h. 
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• Collect elution buffer onto Spin-X cellulose acetate columns (CLS8163-100EA, 
Sigma-Aldrich). 
• Centrifuge for 20min, max speed, room temperature. 
• Add 4ul glycogen and 1mL cold 100% EtOH, place at -80°C for 30min. 
• Spin at max or 30min, 4°C. 
• Carefully remove supernatant. 
• Wash pellets with 500ul 80% EtOH. 
• Spin at max for 10min, 4°C. 
• Remove supernatant, dry pellets. 
• Resuspend pellets in 6ul DEPC water. 
• Follow the manual of TruSeq small RNA sample prep kit (RS-200-0012, 
Illumina, San Diego, CA) for making small RNA libraries. 
 
7 IP-western 
• After washing beads in step 2 above, take 1% volume of beads into new tubes. 
For example, if you have 1ml of washing buffer/beads, take 10ul into new tubes. 
• Add water up to 20ul. 
• Add 5ul of 4 x LDS sample buffer (Life Technologies #NP0007) with 0.4ul of 
bME. 
• Mix by briefly vortexing. 
• Incubate the tubes at 70°C for 10min. Cool down on ice. 
• Load on gel. Follow regular western protocol. 
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Western Blotting  
1 Lysate preparation 
1xRIPA Buffer (50mL) 
- 250uL 1M Tris pH8.0 
- 1.5mL 5M NaCl 
- 0.5g Sodium Deoxycholic acid  
- 0.05g SDS 
- 0.5mL NP-40 (Igepal CA-630) 
- 0.01g sodium azide 
- water up to 50mL 
Filter sterilize and store at 4°C. 
Right before use, add PIC (Roche, complete) and PMSF.  
I usually make 25xPIC in water and 100xPMSF in isopropanol, and store them in -20deg. 
 
Fly lysate 
1. Add 200ul  (for 5 whole flies) of RIPA buffer in 1.5ml tubes. 
2. Collect flies on CO2, put the into the 1.5ml tubes with RIPA buffer. 
3. Grind thoroughly with pestles. 
4. Let the tubes sit on ice for 10min. 
5. Spin at 15,000 rpm at 4°C for 10min. 
6. Take supernatant into new tubes. 
 
Cell lysate 
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1. Collect cells (one well of 6 well plate) into a 1.5ml tube. 
2. Spin at 2000rpm at room temperature, and remove supernatant. 
3. Add 200ul of RIPA buffer, resuspend pellet by pipetting. 
 
Bradford assay 
1. Make 0.2, 0.4, 0.6, 0.8, and 1 mg/mL of BSA in water 
2. Add 30ul of each in 1mL of Bradford Ultra, vortex 
3. Add 5ul of lysate and 25ul of water in 1mL of Bradford Ultra, vortex (1/6 
concentration). 
4. Measure 595nm absorbance in spectrophotometer and make a standard curve. 
5. Measure 595nm absorbance for each of your samples. 
6. Based on the standard curve, calculate the concentration of protein in each 
sample. 
 
2 Running gel 
I use 4-12% Bis-Tris Gel from Invitrogen. Run in 1xMES or 1xMOPS buffer, 200V 
>30min. This depends on your experiment. 
 
3 Transferring proteins to membrane 
Transfer Buffer 
- 1x NuPAGE Transfer Buffer 
- 20% MeOH (for two membranes. For one membrane, 10% is fine) 
- water up to 250mL 
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Pre-treatment of PVDF membrane 
- Submerge PVDF membrane (cut in appropriate size) in 100% MeOH (1~2min) 
- Then submerge into transfer buffer (2~3min). 
 
- Transfer in semi-dry, 20V 1~2h . 
 
4 Blocking, incubation with antibodies, and detection 
1. Blocking in 5% milk/TBST, 4°C 1h 
2. Incubate with primary antibody in 5% milk/TBST, 4°C 2h~O/N 
3. Wash membrane in 1xTBST, 5min x 3 
4. Incubate membrane with secondary antibody in 5% milk/TBST, 4°C 2h 
5. Wash membrane in 1xTBST, 5min x 3 
6. detection by ECL (regular or plus) 
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dsRNA treatment of DL1 cells 
(Originally from Cherry lab) 
Reagents 
 Serum-free medium: Schneider's Drosophila Medium (#21720-024, Gibco) 
 
 Complete medium (mix the followings): 
• 450ml Schneider's Drosophila Medium (#21720-024, Gibco) 
• 50ml Fetal Bovine Serum  
• 5ml Penicillin-Streptomycin (5000 U/mL, #15070-063, Gibco) 
• 5ml L-glutamine (200 mM L-alanyl-L-glutamine dipeptide in 0.85% NaCl) 
(#35050-061, Gibco) 
 
Warm-up medium at room temperature (~25°C) before use. 
1. Dislodge cells from flask, count the number of cells by hemocytometer. 
2. Take desired amount containing required number of cells into 15ml tube, 
centrifugation at 1200rpm for 5min at room temperature. (2 million cells/1 well of 
6 well plate) 
3. Resuspend pellet in serum-free medium (2 million cells/ml). 
4. Spot 4ug of dsRNA/well at the bottom of each well in 6 well plate. 
5. Plate 2 million cells per well (1ml in serum-free medium). 
6. Incubate at 25°C for 45min. 
7. Add 2ml complete medium (supplemented with 10% FBS/penn streptomycin/L-
glutamate). 
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8. Incubate at 25°C for at least 3 days, 5 days maximum to achieve knockdown of 
genes. 
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Lifespan assay 
1. Collect adult male flies on the day of eclosion. Start with > 200 flies for each 
repeat. Expand each genotype in bottles so that you get > 200 flies within 3~4 
days. The number of bottles required depends on the genotype: whether all 
progenies can be used (maintained homozygously, wild-type etc.), or whether you 
need to make crosses to get the progenies (you get only 1/2 or 1/4 of the progenies 
to be used for the lifespan assay). 
2. Keep 15 flies per vial. Maintain flies at 25°C. 
3. Every other day, transfer flies into new vials. Count the number of dead flies upon 
each transfer. 
4. In excel sheets, calculate % of survived flies on the day of each transferring.   
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Climbing assay 
1. Collect adult male flies on the day of eclosion.  
2. Keep 15 flies per vial. Maintain flies at 25°C. 
3. Every other day, transfer flies into new vials, until the flies are aged to the day of 
your interest. 
4. On the day of climbing assay, first move flies into dark room at room 
temperature, leave them for 30min in Leidy 215A. 
5. Turn on a red light in the dark room. 
6. Transfer flies into empty vials (no food). The empty vial should have a line 
marking specific distance from the bottom (I used 2.5cm).  
7. Under red light, bang the vial to the gently so the flies go to the bottom. Count the 
number of flies that successfully or unsuccessfully climb to the marked line in 10 
sec. 
8. Calculate the percentage of flies that successfully climbed above the marked line 
in 10 sec. 
 
• I used 30 male flies for each genotype/time point for nbr null climbing assay, and 
repeated all studies at least three times independently.  
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Immunohistochemistry in Drosophila ovary 
Female flies should be grown on yeast-supplemented fly food vials for at least 2 days, in 
order to get fully developed ovaries. 
 
DAY 1 
Dissect ovaries 
1. Euthanize flies with CO2 
2. Dissect out ovaries in PBS 
3. Fix ovaries in fixative solution for 20 min at room temperature. 
4. Discard fixative and wash in PBST for 2 min. Repeat this one more time (in total 
two washes). 
 
Permeabilize & block  ovaries 
1. Remove buffer from last wash and add 1ml PBST-5 + 5% normal goat serum. 
Incubate for 20min. 
2. Repeat this twice more (in total three blockings) 
3. Wash one time for 5 min at RT with 1 ml PBST-B 
 
Primary Antibody 
1. Dilute primary antibody to appropriate concentration in PBST-B. 
2. Nutate overnight in the cold room. 
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DAY 2 
Washes 
1. Remove primary antibody solution. 
2. Wash with PBST for 3 times, 2 min each at room temperature. 
3. Wash 3 times for 20 min each at room temperature with PBST. 
4. Wash one time for 2 min at room temperature with 1 ml PBST-B. 
 
Secondary Antibody 
1. Dilute secondary antibody to the appropriate concentration in PBST-B (minimum 
solution in Eppendorf tube= 100ul). 
2. Nutate for 2 hours in the cold room. 
 
Washes 
1. Remove secondary antibody solution. 
2. Wash with 1ml PBST for 3 times, 2 min each at room temperature. 
3. Wash 3 times for 20 min each at room temperature with PBST. 
4. Carefully separate each ovariole on slides.  
5. Mount with Vectashield Mounting medium with DAPI (Vector laboratories #H-
1200). 
 
 
REAGENTS:   
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Buffer 
• PBST: PBS + 0.2% Triton X-100 
• PBST-5: PBS + 0.5% Triton X-100 
• PBST-B: PBS + 0.2% Triton X-100 + 1% BSA 
 
Fixative solution:  
• 4% Formaldehyde (paraformaldehyde, cat no, co) in PBS. Use fresh fixative each 
time. 
 
Antibodies:  
 
Primary antibody (for HA-tagged Nbr genomic transgenes flies) 
• anti-HA (3F10, rat monoclonal antibody Roche#11867423001) with 1:150 
concentration. 
 
Secondary antibody 
• Alexa Fluor 488 Goat Anti-Rat IgG (H+L) (Life Technologies #A-11006) with 
1:100 concentration. 
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